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1.1 DNA DAmAge AND repAir
Since the discovery of DNA in 1869 by Friedrich Miescher our understanding of its function 
has grown considerably. Initially the importance of DNA might not have been appreciated 
but subsequent experimentation, amongst others by Fredrick Griffith (Griffith, 1928) 
and Oswald Avery and co-workers (Avery et al., 1944), laid the foundation for our current 
understanding of DNA being the carrier of genetic, hereditary information. Conservation of 
the genetic information is of great importance as changes, in the form of DNA mutations, 
have the potential to contribute to the development of disease. It can be easily perceived 
that genomic mutations can lead to hereditary illnesses but also cancer, a common non-
inherited disease caused by genetic alterations.
One factor that contributes to mutagenesis is damage to the DNA. DNA can be damaged 
through various processes which can be of endogenous or exogenous origin. Examples 
of endogenous processes that damage DNA are spontaneous deamination of bases or 
depurination of DNA as well as damage inferred through reactions involving reactive 
cellular metabolites such as reactive oxygen species (ROS). In addition to the endogenous 
processes environmental agents can also damage DNA, either through exposure to 
certain chemical compounds or by exposure to ultraviolet (UV) or ionizing radiation (IR). 
Damaged DNA may be toxic for the cell as it can interfere with metabolic processes such 
as transcription and replication which can lead to cell death (Ljungman et al., 1999;Kaina, 
2003). However, perhaps more dangerous is the conversion of DNA damage to a mutation, 
a process that primarily depends on DNA replication. Once a DNA lesion has been 
converted into a mutation all information required to restore the original DNA sequence is 
lost. In contrast to mutations, damaged DNA often represents a reversible situation as the 
damage can be removed in order to reconstitute the original DNA configuration. 
Given the importance of DNA for the health of an organism it is important to realize 
that chemical moieties of DNA are prone to DNA damage formation either by spontaneous 
degradation or attacks by endogenous agents. Although the frequency at which DNA 
lesions are formed within a cell depends to some extend on its environment it has been 
estimated that a human cell is subject to approximately 10.000 depurination events 
per day (Lindahl and Nyberg, 1972) as well as around 10.000 ROS induced DNA adducts 
(Ames and Shigenaga, 1992). Despite these high lesion frequencies the intergeneration 
mutation rate in humans was found to be low at approximately 1.1 × 10-8 per base pair 
per generation, which equates to approximately 70 de novo mutations per diploid genome 
(The 1000 Genomes Consortium, 2010;Roach et al., 2010). To maintain such high level 
of genome integrity cells rely on DNA damage signaling pathways as well as DNA repair 
mechanisms for efficient removal of DNA lesions. Several pathways have been identified 
which respond to different types of DNA lesions (Figure1) (Hoeijmakers, 2001).
Nucleotide excision repair (NER) is a mechanism that is capable of removing a wide 
range of structurally unrelated DNA adducts, including solar UV-induced lesions as well as 
endogenously induced oxidative DNA lesions. The autosomal recessive disorders xeroderma 
pigmentosum, Cockayne syndrome, UV sensitivity syndrome and trichothiodystrophy are 
associated with defects in NER. An overview of NER is given in chapter 2.
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Base excision repair (BER) is a pathway that is responsible for removing endogenous base 
lesions as well as repairing similar lesions generated by environmental agents. Among the base 
damages that are repaired by BER are ROS induced damages as well as base deaminations and 
depurinations. Also single strand DNA breaks are repaired via this pathway. Two subpathways 
have been identified: short-patch BER which depends on polb for resynthesizing a single 
nucleotide (Kubota et al., 1996) and long-patch BER which utilizes pold or pole for repairing 
a two to eight nucleotide gap (Klungland and Lindahl, 1997). Defects in DNA end processing 
factors have been associated with the neurological diseases ataxia with oculomotor apraxia 
type-1 (AOA1) and spinocerebellar ataxia with axonal neuropathy (SCAN1). The BER protein 
uracil-DNA glycosylase (UNG) also functions in immunoglobulin development and mutation 
induction in the respective gene can lead to hyper-IgM syndrome (Imai et al., 2003).
Mismatch repair is a pathway that is central to ensuring the fidelity of DNA replication 
(Hsieh and Yamane, 2008). Its function is to correct base substitution mismatches as 
well as insertion-deletion mismatches that are formed as a result of replication errors. 
Mutations in mismatch repair genes cause Lynch syndrome, a hereditary condition that is 
associated with a high risk of developing colorectal cancer.
Non-homologous end joining (NHEJ) is one of two major pathways that exist for 
the repair of double strand DNA breaks (DSBs). It functions by detecting and tethering 
DNA ends, processing of damaged DNA ends and ligation (Lieber, 2008). This method of 
rejoining broken DNA is regarded as being error prone as it does not require a template 




DNA for repair. As a result, small insertions or deletions can be found at the ligated 
break site. In mammalian cells NHEJ is the dominant pathway for repairing DSBs, in 
particular when cells are in the non-cycling G0/G1 state. Although DSBs can be induced by 
exogenous factors such as ionizing radiation, they are also created during immunoglobulin 
development. Consequently, defects in NHEJ can lead to radiation-sensitive severe 
combined immunodeficiency (RS-SCID) as well as ligase IV syndrome.
Homologous recombination (HR) is the second major pathway for repairing DSBs (Li 
and Heyer, 2008). Lesions that are repaired by HR include IR-induced DSBs, interstrand 
crosslinks and collapsed replication forks. HR repair is dependent on a sister chromatid 
to act as a DNA template and is therefore considered to be relatively error free. The 
requirement for a sister chromatid consequently restricts this form of repair to the S and 
G2 phases of the cell cycle where the chromatids are held in proximity by sister chromatid 
cohesion (Watrin and Peters, 2006). Defects in the HR genes BRCA1 and BRCA2 are linked 
to hereditary breast cancer.
Complementing these repair pathways are the DNA damage signaling cascades which 
regulate processes such as cell cycle progression and apoptosis (see also chapter 5). 
Although DNA repair and DNA damage signaling are distinct entities there exist proteins 
that function in both processes, for example ATM (Lobrich and Jeggo, 2005), the Mre11/
Nbs1/Rad50 complex (Stracker and Petrini, 2011) and the cohesion complex (Yazdi et 
al., 2002;Kim et al., 2002b). While defects in cell cycle checkpoints are an important and 
easily measured consequence of defects in DNA damage signaling, the importance of the 
pathway is likely to reach beyond cell cycle regulation. Phosphoproteomic screens have 
revealed many proteins with diverse functions to be phosphorylated upon DNA damage, 
suggesting their functions may be modulated by DNA damage. One example being the 
regulation of DSB repair through the phosphorylation of Kap1 by the ATM kinase, which is 
a critical event for the repair of breaks in heterochromatinized DNA (Goodarzi et al., 2008). 
1.2 DNA DAmAge AND sigNAliNg
There is overwhelming evidence that recognition of aberrant DNA structures by cellular 
surveillance proteins can initiate DNA damage signaling. Although damage signaling is often 
thought of to be synonymous with DNA damage induced checkpoint activation, it should 
be considered in a broader context of cellular responses to DNA damage. Most notably 
and in addition to checkpoint activation, DNA damage signaling can lead to induction of 
processes such as DNA damage repair, to changes in chromatin structure, transcriptional 
responses and apoptosis. To regulate these processes cells use a plethora of different post-
translational modifications (PTM). Here those events most relevant for NER are described.
It has been long recognized that the checkpoint protein p53 becomes upregulated 
in response to DNA damaging agents such as UV light. In fact, as early as in 1984 it was 
reported by Maltzman and Czyzyk that p53 becomes stabilized in response to both UV and 
4NQO treatment (Maltzman and Czyzyk, 1984). Moreover, these authors noted that while 
cycling cells were particularly efficient in their p53 response, also non-cycling cells were 
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able to induce p53 upon DNA damage, an effect that could be enhanced through the use of 
the DNA synthesis inhibitor hydroxyurea. Back then it was difficult to interpret these data, 
not least because p53 was thought to be an activator of replication rather than a checkpoint 
protein that is frequently mutated in tumours. However, ongoing research over the years has 
given new insights into the molecular mechanisms of both NER (chapter 4) and checkpoint 
activation allowing us to understand, in part, how these processes are linked. 
Atr dependent signaling
ATR is a serine/threonine protein kinase that is part of the PI(3) kinase-like kinase family 
to which also the ATM, DNA-PKcs, mTOR and SMG1 protein kinases belong (Durocher and 
Jackson, 2001;Yamashita et al., 2001;Brumbaugh et al., 2004). ATR together with ATM 
are considered to be the key kinases that orchestrate DNA damage signaling. Moreover 
there is evidence that each kinase is activated by a distinct DNA structure. For ATM it is 
the DNA double strand break (DSB) that is considered to be main activating DNA lesion 
(Lee and Paull, 2005), although other stressors can activate ATM as well (Bakkenist and 
Kastan, 2003;Kanu and Behrens, 2007;Soutoglou and Misteli, 2008). ATR in contrast is 
activated by single stranded DNA (ssDNA) containing ssDNA/dsDNA junctions (Zou and 
Elledge, 2003;MacDougall et al., 2007;Costanzo and Gautier, 2003).
Activation of ATR is particularly important in sensing DNA replication stress (Guo et al., 
2000) and to prevent untimely entry into mitosis (Cliby et al., 1998;Nghiem et al., 2001). 
Detection of ssDNA and initiation of the DNA damage checkpoint is, however, a process that 
requires several other proteins in addition to ATR itself (figure 1). ATR forms an obligate 
dimer with ATRIP (Cortez et al., 2001) and it is the latter subunit of the complex that can 
interact with ssDNA bound RPA (Zou et al., 2003). However, recruitment of ATR to ssDNA is by 
itself insufficient for kinase activation (MacDougall et al., 2007) as ATR signaling was found 
to be dependent on the RAD9-RAD1-HUS1 complex (known as 9-1-1) (Bao et al., 2004). The 
9-1-1 complex has a heterotrimeric structure bearing similarities with the homotrimeric 
PCNA complex (Parrilla-Castellar et al., 2004). Analogous to the loading of PCNA onto DNA 
by the replication factor C (RFC) complex the 9-1-1 complex is loaded onto DNA by an RFC 
complex containing RAD17 (Majka and Burgers, 2003). Loading of either PCNA or 9-1-1 
complexes requires ssDNA/dsDNA junctions but, whereas PCNA is loaded at recessed 3’ 
ends, 9-1-1 is preferentially loaded at 5’ template junctions (Ellison and Stillman, 2003). The 
presence of ssDNA bound RPA is important here as well as this complex directs the loading 
of 9-1-1 towards the 5’ primed DNA (Ellison and Stillman, 2003;Majka et al., 2006).
Both ATR-ATRIP and the 9-1-1 complex are recruited to signaling competent DNA 
structures independently of one another yet the presence of both complexes still does not 
suffice for kinase activation. To achieve activation a direct interaction between ATR and its 
activator TopBP1 (Kumagai et al., 2006;Mordes et al., 2008) is required. A phosphorylation 
site on RAD9, one of the 9-1-1 complex members, facilitates the interaction with the BRCT 
domains of TopBP1 and has been proposed to recruit the protein towards the ATR complex 
(Lee et al., 2007;Delacroix et al., 2007;Furuya et al., 2004;St Onge et al., 2003). However, 
other reports suggest that recruitment of TopBP1 is mediated directly via ATR-ATRIP (Choi 
et al., 2010;Yan and Michael, 2009;Rendtlew Danielsen et al., 2009).
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Once activated, ATR can phosphorylate checkpoint proteins like H2AX, p53 and 
CHK1 (Tibbetts et al., 1999;Liu et al., 2000;Ward and Chen, 2001) which can initiate a 
cell cycle arrest. Also proteins that are crucial for ATR activation like ATRIP, TopBP1 and 
RAD17 are themselves targets for phosphorylation (Cimprich and Cortez, 2008). The 
importance of these phosphorylation events is, however, not known. Moreover, large scale 
phosphoproteomic screens for targets of ATR and ATM have revealed several hundreds 
of different proteins to be targets for these kinases after DNA damage suggesting that 
the DNA damage signaling response might effect many additional processes that are still 
unexplored (Matsuoka et al., 2007;Stokes et al., 2007).
the mDc1 protein complex
A prominent feature of DNA damage mediated ATM/ATR activation, by virtue of H2AX 
phosphorylation, is the assembly of a multiprotein complex at or near the site of DNA 
damage in the vicinity of the kinase. Proteins that have thus far been identified as complex 
members include MDC1, the MRE11/RAD50/NBS1 subcomplex, 53BP1/ULP28, the BRCA1 
complex (BRCA1, BARD1, BRCC36, ABRA1, RAP80), the ubiquitin ligases RNF8/HERC1 
and RNF168, the sumo ligases PIAS1 and PIAS4, as well as UBC9 and UBC13 (reviewed in 
Panier and Durocher, 2009;Zlatanou and Stewart, 2010;Ciccia and Elledge, 2010). Complex 
assembly is achieved through the sequential recruitment of proteins and is regulated by 
post translational modifications like phosphorylation, ubiquitination and SUMOylation. 
Recruitment of the first factor, MDC1, is facilitated by the interaction of the MDC1 BRCT 
domain with phosphorylated H2AX. Subsequent ubiquitination and SUMOylation steps 
are then essential for full complex assembly i.e. the recruitment of 53BP1 and the 
BRCA1 complex. Thus far H2A type histones have been identified as targets for ubiquitin 
modification while BRCA1 was found to be modified by SUMO, however, it is well possible 
that additional proteins might be subject to these modifications.
The biological significance and functions of this multifactorial complex is perhaps not 
fully understood, but it is evident that proteins like BRCA1 and 53BP1 function in the DSB 
repair and checkpoint pathways (FitzGerald et al., 2009;Moynahan et al., 1999;Xu et al., 
1999;Wang et al., 2002;Dimitrova et al., 2008). Furthermore, deficiency in H2AX, MDC1, 
53BP1, RNF8 and RNF168 all result in immunodeficiency (Manis et al., 2004;Ward et al., 
2004;Lou et al., 2006;Stewart et al., 2007;Ramachandran et al., 2010;Celeste et al., 2002).
DNA damage signaling in uV-irradiated cells
In addition to the response to DSB, several components of the MDC1 complex, including 
MDC1, RNF8 and 53BP1 have been shown to respond to UV-induced DNA damage in an 
ATR dependent manner (Marteijn et al., 2009;Jowsey et al., 2007). This response is not 
restricted to replicating cells but also occurs in non-cycling (G0/G1) cells where it depends 
on functional NER (Marteijn et al., 2009). It should, however, be noted that the complex 
composition differs in quiescent cells when compared to replicating cells as at least one 
of its components (BRCA1) is expressed at very low levels in non-dividing cells (Chen et 
al., 1996;Choudhury et al., 2004; chapter 4). The functional importance of the UV-induced 
MDC1 complex in quiescent cells has yet to be established. It is clear that ATR dependent 
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signaling does not affect NER dependent removal of 6-4PP (Auclair et al., 2008; chapter 4) 
although it is very likely that repair of 6-4PP triggers this response.
Better understanding of which factors contribute to UV mediated checkpoint signaling 
came from studies using cells with genetic defects in various NER genes. It was demonstrated 
that impairment of TC-NER results in high p53 expression following treatment with either 
UV or inhibitors of transcription elongation. These observations led to the conclusion that 
most probably persistent stalling of RNA polymerase II initiated this signaling response 
(Ljungman and Zhang, 1996;Ljungman et al., 1999;Yamaizumi and Sugano, 1994). However, 
it has also been demonstrated that repair of DNA lesions by GG-NER could itself contribute 
to checkpoint signaling (Matsumoto et al., 2007;Marti et al., 2006). Surprisingly, even in the 
absence of both GG-NER and persistent RNA polymerase stalling DNA damage checkpoints 
are still activated through an alternative mechanism involving the endonuclease APE1 
(chapter 4). It is surprising that although the DNA damage checkpoint can be induced 
through distinct mechanisms, they all depend on the ATR kinase to transduce the signal 
(chapter 4; O’Driscoll et al., 2003;Derheimer et al., 2007).
Poly(ADP-ribosylation) (PAR) is a post translational modification that plays key roles in a 
wide variety of processes (reviewed in Krishnakumar and Kraus, 2010) including DNA repair. 
The PAR modification is catalyzed by members of the poly(ADP-ribose) polymerase (PARP) 
family to which currently 17 proteins are ascribed. Of these the founding member, PARP1 
as well as PARP2 have been implicated in DNA repair (de Murcia et al., 1997;Wang et al., 
1997;Schreiber et al., 2002).The PAR modification is thought to assert its function through 
two different mechanisms. Firstly, the addition of ADP-ribose moieties might directly 
modulate the activities of the target protein through both steric as well as charge effects. 
Secondly, PAR structures can promote the recruitment of other proteins that contain PAR-
specific binding motifs. Currently 3 such sequences have been identified: an 8 amino acid 
basic residue rich cluster (Gagne et al., 2008), the PAR-binding zincfinger (PBZ) (Ahel et al., 
2008) and the macrodomain (Timinszky et al., 2009). A variety of DDR proteins contains 
PAR-binding motifs, although the significance of these motifs for the protein function in 
many cases has not been determined. For some of these proteins, however, PAR-dependent 
recruitment to sites of DNA damage has been observed, for example XRCC1 (Okano et al., 
2003), CHFR (Ahel et al., 2008), APLF (Rulten et al., 2008;Kanno et al., 2007;Bekker-Jensen 
et al., 2007) and ALC1 (Gottschalk et al., 2009; Ahel et al., 2009; chapter 3).
Several DNA repair pathways utilize the PAR modification, most notably SSB repair and 
DSB repair (both microhomology mediated end joining and homologous recombination) 
(Wang et al., 2006;Hochegger et al., 2006), although a role in NER has also been proposed 
(Ghodgaonkar et al., 2008;Berger et al., 1980). The mechanisms by which PARP activity 
enhances NER are not fully understood but involve both TCR protein CSB as well as GGR 
(Flohr et al., 2003; chapter 3). The role of PARP in GGR is dependent on UV-DDB, although it 
is unclear whether UV-DDB directly activates PARP or whether other proteins are involved. 
The consequence of PARP activation and subsequent PAR synthesis is the recruitment of the 
chromatin remodeling protein ALC1, which is necessary for efficient repair of CPD lesions 
(chapter 3). The implication of PARP1 in CSB dependent repair of DNA lesions is based on 
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the epistatic relationship between the two proteins (Flohr et al., 2003). How PARP1 regulates 
CSB function or visa versa is currently unknown. CSB has a putative PAR binding site (Gagne 
et al., 2008); however, it is unclear if and how this contributes to the proteins function.
1.3 cohesiNopAthies AND DNA DAmAge
The term cohesinopathy is used to indicate diseases that affect the function of the 
cohesin complex. To date three such syndromes have been described i.e. Cornelia de 
Lange Syndrome (CdLS), Roberts Syndrome / SC phocomelia (RBS) and Warsaw Breakage 
Syndrome (WABS). Disease causing mutations have been identified for all three syndromes 
and are predicted to affect sister chromatid cohesion (SCC). The establishment and 
dissolution of SCC has been studied in some detail and it is clear that defects in this 
process compromise chromosome segregation. In little over a decade it has, however, 
become apparent that the function of cohesin reaches beyond its role in mitosis by 
participating in gene regulation (Rollins et al., 1999), DNA repair (Klein et al., 1999) and 
DNA damage signaling (Kim et al., 2002b). The underlying mechanisms for these diverse 
processes are not understood in detail, but it is likely that the unique ability for cohesin to 
shape chromatin topology has led to diversification of its function.
The cohesion complex consists of four subunits: Smc1, Smc3, Rad21 and either one 
of the SA1 or SA2 paralogues. Both Smc1 and Smc3 are members of a family of proteins 
known as the structural maintenance of chromosomes superfamily. Smc1 and Smc3 
form long antiparallel intramolecular coiled coils by folding back on themselves at a 
central hinge domain, allowing the N- and C- termini of the protein to interact and form 
a functional ATPase (Losada and Hirano, 2005). The ATPase heads of Smc1 and Smc3 are 
linked by the Rad21-SA1/SA2 heterodimer which, combined with the interaction between 
the Smc1 and Smc3 hinge domains results in a ring-like structure. How cohesin rings 
interact with chromosomes in order to establish SCC is not exactly known. One model, 
known as the embrace model, sees both sister chromatids encircled by a single cohesin 
ring (figure 2) (Gruber et al., 2003). An alternative model, the handcuff model, envisions 
that both sister chromatids are individually encircled by a cohesin ring, which than are 
linked together via SA1/SA2 (Zhang et al., 2008b).
In addition to cohesin ring components, several accessory factors are required for 
cohesion regulation. Loading of cohesin onto chromatin requires the NIPBL-Scc4 complex 
(also referred to as Scc2-Scc4) (Ciosk et al., 2000). Although SCC can only be established 
during or after replication, cohesin is already bound to chromatin in G1 phase cells. It is, 
however, during S phase that cohesin becomes associated with chromatin in a far more 
stable manner (Gerlich et al., 2006). It is probable that this increased stability is the result 
of SCC establishment during replication, a process that requires Ctf18 (Lengronne et al., 
2006;Terret et al., 2009) and the Esco1 and Esco2 paralogues (Skibbens et al., 1999;Toth 
et al., 1999). The latter two proteins both have acetyltransferase activity and acetylation of 
Smc3 is a critical event for establishing SCC (Zhang et al., 2008a;Rolef Ben-Shahar et al., 
2008;Unal et al., 2008). Acetylation of Smc3 decreases the association of Wapl and Pds5 
with cohesin and hence might regulate stability of the ring (Rowland et al., 2009;Terret et 
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al., 2009). Another, rather enigmatic, factor implicated in establishing SCC is DDX11 (ChlR1). 
The DDX11 homologue in S. cerevisiae was shown to physically and genetically interact 
with Eco1, the yeast Esco1/2 homologue (Skibbens, 2004;Parish et al., 2006). Depletion 
of DDX11 in human cells resulted in abnormal SCC, although it is unclear how the protein 
contributes to cohesion. The fact that it has DNA dependent helicase activity and interacts 
with replication associated proteins like Ctf18-RFC and Timeless would indicate it functions 
in cohesion establishment rather than maintenance (Farina et al., 2008;Leman et al., 2010).
Defects in various genes can cause cohesinopathy in humans. CdLS was originally found 
to be associated with heterozygous mutations in the NIPBL gene (Krantz et al., 2004;Tonkin 
et al., 2004), responsible for cohesin loading. Also the structural cohesin components SMC1 
and SMC3 were found to be affected in CdLS (Musio et al., 2006;Deardorff et al., 2007). RBS 
on the other hand is caused by mutations in ESCO2 (Vega et al., 2005), whereas DDX11 was 
found to be defective in WABS (van der Lelij et al., 2010). While on the cellular level defects 
in SCC are evident in all three syndromes, clinical features such as growth and mental 
retardation, craniofacial anomalies and limb deformities indicate normal development is 
disrupted, possibly due to altered gene expression and cell differentiation (Dorsett, 2007). 
This suspected link between cohesin and gene regulation was strengthened when it was 
found that cohesin binds to the same genomic regions as the CCCTC-binding factor (CTCF) 
(Stedman et al., 2008;Wendt et al., 2008;Parelho et al., 2008;Rubio et al., 2008). CTCF 
has been implicated in diverse regulatory functions including transcriptional activation/
repression and imprinting (Phillips and Corces, 2009). It has now emerged that cohesin 
shapes local chromatin topology at specific loci which is likely to modulate gene activity 
(Nativio et al., 2009;Hadjur et al., 2009;Hou et al., 2010;Mishiro et al., 2009) and thus 
would provide a basis for the observed developmental abnormalities in cohesinopathies.
Studies in S. pombe initially identified RAD21 as an important factor in DNA double 
strand break (DSB) repair (Birkenbihl and Subramani, 1992). However, subsequent studies 
Figure 2:model of replication fork stalling and Atr activation. DNA lesions can stall replicative DNA 
polymerases d and e. When the helicase becomes uncoupled from the arrested leading strand 
polymerase e continuous unwinding of the parental DNA duplex by the MCM helicase creates a stretch of 
RPA bound ssDNA. Downstream reinitiating replication creates an 5’primer ssDNA/dsDNA junction that 
allows loading of the 9-1-1 complex by RAD17-RFC. Independently, the ATR-ATRIP complex is recruited 
to ssDNA through the interaction of ATRIP with RPA. Recruitment of TopBP1, which interacts both with 
RAD9 as well as ATR-ATRIP, promotes the activation of the ATR kinase activity.
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demonstrated that other cohesin subunits are also important for this process when it 
became clear that establishing SSC was crucial for efficient DSB repair (Sjogren and 
Nasmyth, 2001). When it was found that CdLS was caused by defects in NIPBL, the question 
was how patient derived cells would respond to DNA damaging agents. As described in 
chapter 6 CdLS cells are indeed sensitive for DNA damage, in particular for the crosslinking 
agent mitomycin C. A similar sensitivity towards DNA damage was also observed in RBS 
(Van den Berg and Francke, 1993;Gordillo et al., 2008;van der Lelij et al., 2009) and WABS 
(van der Lelij et al., 2010) cells.
The reason why a deficiency in SCC results in sensitivity for DNA damaging agents is 
thought to lay in defective homologous recombination. When a DSB is created cohesin is 
recruited to the break site and establishes de novo cohesion (Kim et al., 2002a;Strom et 
al., 2004;Unal et al., 2004). This increased SCC is believed to bring the sister chromatids 
into close proximity thereby enhancing repair. Surprisingly, however, when a single 
DSB was introduced this not only led to increased SCC near the break site, but also on 
undamaged chromosomes (Strom et al., 2007;Unal et al., 2007). In yeast damage induced 
recruitment of cohesin near break sites is dependent on components of the DSB repair and 
signaling pathways such as Mre11, Mec1 and Tel1 (ATR and ATM in human) as well as H2AX 
phosphorylation (gH2AX). Establishing cohesion at the DNA break site also requires the 
acetyltransferase activity of Eco1. In undamaged cells the activity of this protein is impaired 
once S phase induced SCC has been established (Strom et al., 2007;Unal et al., 2007); a 
DSB would therefore need to activate the protein. This is achieved via phosphorylation 
of serine 83 of Mcd1 (Scc1) by the Chk1 kinase (Heidinger-Pauli et al., 2008). Chk1 is an 
effector kinase in the Mec1/Tel1 signaling pathway and is activated upon DNA damage. 
Figure 3: model for cohesin establishment at the replication fork. During the cell cycle cohesion can 
dynamically interact with chromatin aided by NIPBL-Scc2 (not shown). Sister chromatid cohesion is 
established during S-phase in a replication dependent manner requiring the Ctf18-RFC complex and 
Esco1/2. Acetylation of Smc3 by the Esco1 or 2 proteins destabilizes the interaction of Pds5a or its 
paralog Pds5b with Wapl, causing a transition of cohesion to a more stable chromatin binding state.
INTRODUCTION1
16
Once phosphorylated, Mcd1 is acetylated by Eco1 generating a cohesin complex capable 
of establishing SCC (Heidinger-Pauli et al., 2009). Interestingly, as activity of the Chk1 
kinase, once activated, is unlikely to be restricted to the break site it is possible that Mcd1 
on other chromosomes is also targeted for phosphorylation, explaining the trans effect for 
de novo SCC after DNA damage.
Currently it is unclear if damage induced cohesion establishment is regulated in a similar 
manner in human cells. It is, however, without question that the that the ATM/ATR kinases 
play an important role in cohesin function as SMC1 and SMC3 are targets for damage 
induced phosphorylation (Yazdi et al., 2002;Kim et al., 2002b;Luo et al., 2008). Failure to 
phosphorylate SMC1 results in both checkpoint and repair defects (Kitagawa et al., 2004). 
Although the role of cohesin in checkpoint activation is independent of sister chromatid 
cohesion (Watrin and Peters, 2009), it is unclear whether the ability to establish damage 
induced cohesion is compromised when SMC1 or SMC3 cannot be phosphorylated. From 
phospho-proteomic screens designed to identify ATM/ATR targets it is also evident that 
SMC1 and SMC3 are not the only proteins in the cohesion pathway that are phosphorylated 
(Matsuoka et al., 2007;Stokes et al., 2007). Both CTF18 and ESCO1 were found to be 
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A network of DNA damage surveillance systems warrants genomic stability under 
conditions where cells and organisms are continuously exposed to DNA damaging agents. 
This network includes DNA repair pathways, but also signaling pathways that activate cell 
cycle checkpoints, apoptosis, transcription, and chromatin remodeling. Among the various 
repair pathways, nucleotide excision repair (NER) is a highly versatile and evolutionary 
conserved pathway with an intriguing wide substrate specificity; this pathway removes 
structurally unrelated bulky DNA lesions from the genome such as sunlight induced 
photolesions, bulky adducts formed by polycyclic aromatic hydrocarbons, cisplatin 
intrastrand crosslinks and alkylation products. The common features of these lesions are 
the variable degree of DNA helix distortion inflicted and their potency to block replication 
and transcription. The importance of functional NER for human health is highlighted by the 
existence of rare autosomal recessive human disorders such as xeroderma pigmentosum 
(XP). Affected individuals, characterized by a defect in NER, suffer from hypersensitivity to 
sunlight and display strongly enhanced cancer susceptibility in sunlight exposed parts of 
the skin. Mammalian NER involves multiple proteins (in excess of 30) and carries out the 
repair reaction in a highly orchestrated fashion.
In this book chapter we discuss the current knowledge of the molecular mechanisms 




Through evolution a network of DNA damage surveillance systems has evolved to warrant 
genomic stability under conditions where cells and organisms are continuously exposed 
to genotoxic agents present within the environment or exerted by endogenous processes. 
This network not only includes DNA repair pathways, but also signaling pathways that 
activate cell cycle checkpoints, apoptosis, transcription, and chromatin remodelling. The 
mechanisms by which eukaryotic cells sense DNA damage and activate signaling pathways 
are still poorly understood. One of the challenges is to understand how cells are capable to 
sense, recognize and repair low levels of different DNA lesions in their genomes at various 
stages of the cell cycle and in different chromatin environments. 
A limited set of DNA repair pathways is capable to repair the large variety of 
structurally different DNA lesions that are formed in the genome. Nucleotide excision 
repair (NER) is a highly versatile and evolutionary conserved repair pathway that removes 
structurally unrelated bulky DNA lesions from the genome such as bulky adducts formed 
by polycyclic aromatic hydrocarbons, cisplatin intrastrand crosslinks and alkylation 
products. The common features of these lesions are the variable degree of DNA helix 
distortion inflicted and their potency to block replication and transcription elongation. 
In fact, NER is the only repair pathway in humans to remove the toxic and mutagenic 
photodimers from sunlight exposed parts of the skin. Mammalian NER involves multiple 
proteins (in excess of 30) and carries out the repair reaction in a highly orchestrated 
fashion involving a number of defined steps: (I) lesion recognition, (II) DNA unwinding 
and lesion demarcation, (III) dual incision and release of the incised fragment and (IV) 
gap filling by repair synthesis and ligation. 
Two mechanistically distinct NER subpathways have been identified: Global genome NER 
(GG-NER) is capable of repairing DNA lesions in chromatin of different compaction levels 
and different functional states throughout the cell cycle. A subpathway of NER designated 
transcription-coupled repair (TC-NER) enables efficient repair of RNA polymerase II 
(RNAPII) blocking DNA lesions and allows quick resumption of transcription. The existence 
of three rare autosomal recessive human disorders i.e. xeroderma pigmentosum (XP), 
Cockayne syndrome (CS) and trichothiodystrophy (TTD) all associated with sensitivity to 
sunlight and NER deficiency, highlights the importance of functional NER for human health. 
Cells from XP patients are sensitive to UV (ultraviolet)-light and chemicals inducing bulky 
DNA lesions, and complementation studies revealed eight genes involved in the disease 
(XPA–XPG and XP Variant; see also chapter by A Lehmann). Complementation studies 
have revealed two CS complementation groups, CS-A and CS-B. In addition to XP and CS 
patients, a third group of UV sensitive and cancer prone patients has been identified that 
encompasses individuals exhibiting both XP and CS symptoms.
Although NER removes a variety of structurally unrelated lesions from the genome, we 
will concentrate on NER in UV-irradiated mammalian cells since UV-induced pyrimidine-
pyrimidone (6-4) photoproducts (6-4 PP) and cyclobutane pyrimidine dimers (CPD) 
(figure 1) are the lesions most intensively studied and as such paradigmatic for NER. 
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Figure 1: structure of uV induced DNA photolesions. (A) pyrimidine-pyrimidone (6-4) photoproduct 
(6-4PP), (B) cis-syn cyclobutane thymine (pyrimidine) dimmer (CPD)
2.1 globAl geNome repAir (gg-Ner)
Cells of all XP patients (except XP variant) were found to be defective in global genome 
repair of UV-induced photolesions. The identification of the different XP complementation 
groups led to the isolation of the XP genes and encoded proteins and allowed reconstitution 
of the process in vitro using purified proteins and naked DNA harboring a specific lesion. 
The first steps in NER, i.e. DNA lesion recognition and dual incision, require all XP factors 
(XPC, XPA, XPG, ERCC1-XPF) together with other factors (RPA, TFIIH). In addition, the in 
vitro reaction requires RF-C, PCNA, DNA polymerase e and DNA ligase I for repair synthesis 
(Aboussekhra et al., 1995). This scheme represents the proteins to perform NER in vitro; 
additional factors are required for in vivo NER on chromatinized DNA templates. 
2.1.1 DNA lesion recognition in gg-Ner
Although XPA was originally proposed to be the principal damage recognition protein, it is 
now well established that GG-NER is initiated by the XPC protein which forms a trimeric 
complex with hHR23B (the human homologue of Rad23) and CEN2 (Masutani et al., 
1994;Volker et al., 2001;Sugasawa et al., 1998;Araki et al., 2001). In vivo the recruitment 
of NER proteins to UV damage is abolished in XPC deficient cells, indicating that assembly 
of the NER complex is strictly XPC dependent. Mobility studies on GFP-tagged XPC suggest 
that the majority of XPC-hHR23B molecules (>90%) transiently interact non-specifically 
with genomic DNA (Hoogstraten et al., 2003;Politi et al., 2005;Hoogstraten et al., 2003). 
In fact, the general affinity of the complex for DNA and its specific affinity for photolesions 
such as CPD and 6-4PP are relatively low in vivo (Moser et al., 2005). The capacity of 
XPC-hHR23B to recognize a broad spectrum of structurally unrelated lesions might be 
understood from the observation that XPC binds to the accessible non-damaged DNA 
strand opposite to a DNA injury (Sugasawa and Hanaoka, 2007;Min and Pavletich, 2007). 
Although the XPC-hHR23B complex acts as the principle initiator of NER, its action is 
preceded by the heterodimeric UV-DDB complex consisting of the p48 and p127 proteins, 
products of the DDB2 and DDB1 genes respectively (Keeney et al., 1993). In fact, repair of 
CPDs requires functional UV-DDB (Tang et al., 2000) and, in addition, UV-DDB significantly 
stimulates the repair of 6-4 PPs particularly at low UV doses (Hwang et al., 1999;Moser 
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et al., 2005). Microinjection of purified UV-DDB was originally found to restore the repair 
defect of XP-E cells as measured by unscheduled DNA synthesis. Subsequently it was found 
that the XP group E phenotype is caused by mutations in the DDB2 gene, encoding the p48 
protein (XPE). The general affinity of UV-DDB for DNA is much higher (100–1000-fold) 
than that of XPC-hHR23B, while the specific affinity for 6-4PP is comparable (Batty et al., 
2000). DDB2 is part of a functional CUL4A-based E3 ubiquitin ligase through its interaction 
with DDB1 (Groisman et al., 2003) and also binds to UV lesions as an active E3 ubiquitin 
ligase independent of XPC. UV irradiation activates the E3 ubiquitin ligase activity of the 
DDB2 complex by the binding of the ubiquitin-like protein Nedd 8 to the Cullin 4A. Several 
substrates for ubiquitylation were identified, including DDB2 itself, XPC and histones H2A, 
H3 and H4 (Kapetanaki et al., 2006;Sugasawa et al., 2005;Wang et al., 2006). The current 
view is that ubiquitylation (at least partly) facilitates NER: ubiquitylation of XPC enhances 
its affinity for DNA (both damaged and non-damaged DNA) whereas ubiquitylation of 
histones facilitates the access of repair proteins to DNA damage in chromatin by weakening 
the histone-DNA association. Interestingly and less well understood, ubiquitylated DDB2 is 
quickly targeted for degradation after UV (Sugasawa et al., 2005;Rapic-Otrin et al., 2002) 
even in the presence of large numbers of unrepaired photolesions.
As a general mechanism it was proposed (Moser et al., 2005) that UV-DDB forms 
a stable complex when bound to DNA damage such as UV-induced 6-4PP, allowing 
subsequent repair proteins, starting with XPC-hHR23B, to accumulate and to verify the 
lesion, ultimately resulting in efficient repair. The fraction of 6-4PP that can be bound 
by UV-DDB is limited due to the low cellular quantity and fast UV dependent degradation 
of DDB2. In cells lacking UV-DDB a slow XPC-hHR23B dependent pathway is capable of 
repairing 6-4PP whereas repair of CPD is virtually absent.
2.1.2 Assembly of the preincision complex
Upon the recognition of lesions by a concerted action of UV-DDB and XPC-hHR23B, 
the latter recruits the multiprotein transcription factor TFIIH via direct protein-protein 
interactions (figure 2). The TFIIH complex is composed of a seven-subunit core containing 
two XP factors (XPB, XPD, TTD, p34, p44, p52, p62) and a three-subunit kinase complex 
(Cdk7, cyclin H and MAT1) termed the CAK unit. The complex exhibits dual functions i.e. it 
plays a role in RNAPI and RNAPII driven transcription as well as in NER. The XPB subunit of 
TFIIH is an ATP-dependent helicase that mediates unwinding of promoter DNA in a 3’-5’ 
orientation during transcription initiation, whereas the XPD subunit of TFIIH is a 5’-3’ATP 
dependent helicase. Interestingly, the unwinding step of the damaged DNA during NER 
requires only the XPD helicase activity, whereas the ATPase activity of XPB is dispensable 
for NER (Coin et al., 2007). A two-step mechanism underlies the opening of the damaged 
DNA to allow assembly of the NER preincision complex: TFIIH mediates the initial opening 
after which RPA, XPA and XPG bind to obtain full opening of approximately 30 nucleotides 
around the lesion (Evans et al., 1997). XPA stimulates the ATPase activity of TFIIH whereas 
RPA and XPG stabilize the repair intermediate and contribute to full opening around the 
lesion. Since TFIIH functions in both transcription initiation and NER, it has been proposed 
that the recruitment of TFIIH to UV damage abolishes transcription initiation in UV-
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irradiated cells by a trans mechanism (Mone et al., 2001;Mullenders, 1998). However, 
inhibition of transcription by UV irradiation only occurs by direct interference of damage 
with the transcription machinery (Mone et al., 2001) and does not otherwise affect the 
engagement of TFIIH in transcription (Hoogstraten et al., 2002). 
Replication protein A (RPA) consists of three subunits and is an abundant single-
stranded DNA-binding protein that binds optimally to approximately 30 nucleotides (de 
Laat et al., 1998). During the formation of the preincision complex RPA associates with the 
undamaged DNA strand partially unwound by TFIIH (~8-10 nucleotides) and subsequently 
extends it association to a 30-nucleotide region. This action leads to a separation of the 
DNA strands around the lesion. Importantly, RPA has been shown to interact with several 
core NER proteins including XPA, XPG and ERCC1-XPF. In living cells RPA can assemble into 
the pre-incision complex (consisting of XPC, TFIIH and XPG) in the absence of XPA. This 
complex, however, is insufficient to stimulate the 3’ incision by XPG and incapable to recruit 
the 5’ XRCC1-XPF endonuclease; the latter event requires recruitment of XPA in order to 
assemble the complete pre-incision complex (Rademakers et al., 2003). XPA is essential 
Figure 2: model for global genome Ner. (A) DNA 
damage recognition by UV-DDB and XPC-hHR23B. 
Ubiquitylation of damaged bound XPC and DDB2 
is mediated via DDB1/Cul4A. (B) Assembly of the 
preincision complex. TFIIH is recruited to the lesion 
by the XPC-hHR23B complex, opening up the DNA 
though its helicase activity. The association of 
RPA further stimulates the unwinding. XPA binding 
contributes to damage verification and recruits 
the ERCC1-XPF complex. The ERCC1-XPF and XPG 
endonucleases incise the damaged DNA strand 
both 5' and 3' of the lesion. In addition its incision 
activity XPG also serves to stabilize the open 
DNA bubble structure. (C) Gap filling and ligation. 
Following dual incision the single stranded DNA 
patch is filled by the concerted action of RFC, PCNA 
and DNA polymerase d, whereas XRCC1/Ligase III 
performs the final DNA ligation step. Note that in 
cycling cells DNA polymerase e and DNA Ligase I 
also contribute to repair.
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for GG-NER and it is likely that RPA is required to recruit the XPA protein although direct 
in vivo evidence is lacking. The multiple protein interactions of XPA i.e. the association 
with RPA, and XRCC1-XPF, were demonstrated by the finding that the N-terminus of XPA 
binds to RPA and ERCC1, whereas the C-terminus interacts with TFIIH (Park et al., 1995) 
consistent with a central role for XPA in the formation of the NER pre-incision complex. 
Most notably, XPA deficient cells completely lack incision activity, indicating that XPA plays 
an important role in the coordination of dual incision. The observation that XPA binds 
preferentially to bent or kinked DNA duplexes (Camenisch et al., 2006;Camenisch et al., 
2007) sheds light on its function in NER and links initial damage recognition by UV-DDB 
and XPC-hR23B to XPA recruitment. Both XPC and DDB2 introduce kinks in the DNA upon 
binding and hence might stimulate binding of XPA (Janicijevic et al., 2003). The binding of 
XPA most likely contributes to DNA damage verification in the pre-incision complex: the 
interaction between RPA bound to the undamaged strand and XPA with the kinked DNA 
duplex, provide the molecular tools that allow identification of the DNA lesion in the pre-
incision complex. 
RPA plays a key role at the interface of the pre-and post incision step of NER as the 
protein precipitates in chromatin immunoprecipitation (ChIP) reactions with antibodies 
raised against pre-incision and post-incision proteins (Moser et al., 2007). Analysis of the 
assembly and disassembly of repair proteins on immobilized damaged-DNA templates in 
vitro revealed that RPA remains bound after dual incision and initiates the assembly of 
DNA synthesis factors such as PCNA (Riedl et al., 2003). 
2.1.3 Dual incision step
The two structure specific endonucleases XPG and ERCC1-XPF are involved in dual 
incision 3’ and 5’ of the lesion respectively. In the presence of both proteins, both 5’ 
and 3’ uncoupled incisions have been observed indicating that both incisions are made 
simultaneously (Moggs et al., 1996). The XPG protein specifically incises DNA at the side 
of the junction between single-stranded DNA and double stranded DNA (O’Donovan et al., 
1994) approximately 2-8 nucleotides from the 3’ side of the lesion. The protein interacts 
with RPA and TFIIH and the recruitment of XPG to the preincision complex was shown to 
depend on functional TFIIH. However, the presence of XPG in the pre-incision complex 
was shown to be required for stabilizing the open DNA bubble structure containing the 
DNA lesion, allowing binding and 5’ incision by XRCC1-XPF (Wakasugi et al., 1997). Hence, 
XPG also has a structural role in NER and this goes along with the recent finding that XPG 
may act as a major stabilizing factor by associating with TFIIH (Ito et al., 2007), although 
dynamic measurements support separate moieties rather than a joined complex in vivo 
(Zotter et al., 2006). In cells of XPG patients with a combined XP and CS phenotype, XPG 
fails to associate with TFIIH and as a consequence the CAK subunit dissociates from core 
TFIIH. Deletion mutant analysis of XPG revealed that the so-called spacer region within 
the protein (which is not required for endonuclease activity) contributes to the substrate 
specificity of XPG and is required for the interaction with TFIIH and for NER activity in vitro 
and in vivo (Dunand-Sauthier et al., 2005). 
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The 5’ junction between single-stranded and double-stranded DNA is cleaved by the 
heterodimeric endonuclease ERCC1-XPF approximately 15-24 nucleotides away from 
the 5’ side of the lesion (Matsunaga et al., 1995). The two proteins cannot be isolated as 
separate entities indicating that complex formation underlies the stability of the dimeric 
endonuclease (Sijbers et al., 1996). Both in vivo and in vitro it has been shown that the 
interaction of ERCC1-XPF with XPA is essential for NER and that XPA recruits ERCC1-XPF 
to the pre-incision complex (Volker et al., 2001). The incision activity of ERCC1-XPF is 
stimulated by direct interactions with RPA in model substrates (de Laat et al., 1998). 
Mutations in XPF are associated with mild XP; however, a unique XP-F patient with a severe 
phenotype was recently described displaying signs of accelerated aging (Niedernhofer et 
al., 2006). Moreover, mutations in ERCC1 have so far only been reported for one patient 
with severe clinical features but only a mild repair defect at the cellular level (Jaspers et 
al., 2007). These latter findings suggest additional functions for ERCC1 and XPF. Indeed, 
ERCC1-XPF is involved in several other processes such as homologous recombination, 
repair of interstrand cross-links and telomere maintenance.
2.1.4 the post-incision step in Ner 
Dual incision and removal of the lesion containing single stranded DNA fragment is followed 
by gap filling and ligation, generally termed repair synthesis. The transition between dual 
incision and repair synthesis needs to be coordinated to omit activation of the DNA damage 
signaling and to prevent recombination, the formation of deletions etc. Conceivably the 
incision reactions might not occur simultaneously and might be initiated by ERCC1-XPF 
to start DNA synthesis before XPG cutting takes place (Gillet and Scharer, 2006). An 
alternative mechanism to prevent undesired processing is that one key factor is partner 
in the pre-and post-incision stages of NER and remains bound to the DNA. The two stages 
of NER can be separated in vitro (Riedl et al., 2003) and pre-and post- incision complexes 
have been isolated from living cells (Moser et al., 2007). These analyses revealed RPA as 
common factor in the reaction and showed that RPA remains associated with the DNA upon 
dual incision. In addition to RPA, repair synthesis requires RF-C, PCNA, DNA polymerases 
e and d as well as Ligase I in vitro (Aboussekhra et al., 1995;Shivji et al., 1992;Shivji et al., 
1995); the recruitment of the post-incision factors is entirely depending on dual incision. 
PCNA is a homotrimeric sliding clamp that encircles the DNA and acts as a template to 
allocate DNA polymerases e and d to the DNA (Maga and Hubscher, 2003). Loading of PCNA 
on the DNA requires the clamp loader RF-C and ATP. Recent in vivo experiments showed 
that predominantly DNA polymerase d is recruited to repair patches upon UV irradiation 
in replicating and quiescent cells and that the role of DNA polymerase e is restricted to 
S-phase cells (Moser et al., 2007). Moreover, the surprising finding was recently made that 
under certain conditions (Go cells, DNA synthesis inhibitors) the translesion synthesis DNA 
polymerase κ may also play a role in repair synthesis during NER (Ogi and Lehmann, 2006), 
emphasizing the need to confirm the roles of these late factors in NER in vivo. 
The NER reaction is completed by ligation of the 5’ end of the newly synthesized DNA 
to the original sequence. Although Ligase I is sufficient for sealing nicks during in vitro 
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repair synthesis, XRCC1-LigIIIα appears to be indispensable for ligation of NER-induced 
breaks. Two distinct complexes were identified that differentially carry out gap filling in 
NER (Moser et al., 2007). XRCC1-LigIIIα and DNA polymerase d co-localize and interact 
with NER components in a UV- and incision-dependent manner throughout the cell cycle. 
In contrast, DNA Ligase I and DNA polymerase e are recruited to UV-damage sites only 
in proliferating cells. These findings indicate that cells have differential requirements for 
ligases and polymerases in repair synthesis depending on the cell cycle.
Finally, the progression of NER seems to be controlled and requires the completion 
of the post-incision step in NER. Inhibition of DNA polymerases d and e in non-dividing 
normal human cells by the DNA polymerase inhibitors HU/AraC leads to accumulation of 
DNA strand breaks, DNA damage signaling (H2AX signaling) but also to strong retardation 
of repair of UV induced photolesions such as 6-4PP (Moser et al., 2007). Obviously, efficient 
gap filling by DNA synthesis and ligation of the repair patch is required to drive NER to 
completeness and implicates either the existence of efficient cellular control mechanisms 
or factors that limit the number of (pre-) incision events.
2.1.5 Damage signaling in gg-Ner
It has been long acknowledged that exposure of cells to UV light not only activates NER, but 
also modulates other DNA damage responses impacting cell cycle progression and apoptosis. 
The exact mechanisms underlying the decision in cell fate have long remained obscure. 
However, recent works have begun to uncover the molecular mechanisms determining cell 
fate following UV exposure and demonstrate links between NER and other pathways in the 
DNA damage response. One of the most prominent players in the UV-induced DNA damage 
response would be the ataxia telangiectasia mutated and Rad3-related (ATR) protein. 
ATR is a member of the phosphoinositol-3-kinase like kinase family that also includes the 
ataxia telangiectasia mutated (ATM) protein. It has now become clear that both proteins 
act as one of the earliest components in the damage response, their main function being 
the phosphorylation various proteins to effectively propagate the damage signaling. While 
ATM and ATR share many substrates for phosphorylation, the activating structures for these 
kinases themselves differ. ATM is activated by double stranded DNA breaks (Savitsky et 
al., 1995), whereas it is RPA bound to single stranded DNA what activates the ATR kinase 
at stalled replication forks (Zou and Elledge, 2003). Although it was initially believed that 
the capacity to activate ATR was restricted to cells in S phase, it was later demonstrated 
that H2AX is phosphorylated in an ATR dependent manner following UV exposure of non-
replicating cells (O’Driscoll et al., 2003). The origin of this signaling lies in the formation 
of single stranded DNA patches following the excision of the damage containing oligo by 
GG-NER (Marini et al., 2006;Marti et al., 2006;Matsumoto et al., 2007;O’Driscoll et al., 2003). 
Such RPA containing ssDNA patches would resemble the structures formed after replication 
fork stalling and hence allow ATR signaling via a common mechanism. This allows not only 
the phosphorylation of the many substrates of this kinase, but also serves as a prerequisite 
for ubiquitylation of histone H2A (Bergink et al., 2006).
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Normally the activation of ATR is associated with cell cycle checkpoint arrest and NER 
dependent activation of ATR indeed is able to induce cell cycle arrest outside the S phase 
(Stiff et al., 2008). Whether other processes are affected by this signaling is currently 
unknown. However, one possibility would be that ATR activation could regulate the levels 
of checkpoint protein p53. As a transcriptional regulator p53 mediates the expression of 
genes involved in DNA repair, cell cycle arrest and apoptosis. The fact that both DDB2 
and XPC expression are regulated in a p53 dependent manner allows for the possibility 
that ATR activation could enhance the NER capacity following damage induction. Although 
the existence of such a regulatory mechanism remains to be demonstrated, support 
comes from the observation that cells lacking functional p53 have a deficiency in GG-NER 
(Ford and Hanawalt, 1995). Recent experiments indicate that ATR is indeed important for 
efficient repair of photolesions as ATR deficient cells are profoundly defective in GG-NER 
but, surprisingly, only during S-phase (Auclair et al., 2008). The mechanism underlying this 
cell cycle specific regulation of repair remains to be clarified. Although GG-NER mediated 
signaling is now well established, the first demonstration that UV exposure induced a 
checkpoint response (Yamaizumi and Sugano, 1994) was in TC-NER deficient cells. Here 
checkpoint activation does not depend on processing of UV lesions by NER, but rather 
it is the absence of repair that results in enhanced checkpoint activation. DNA lesions 
that block RNA polymerase II, such as UV lesions, cause a dramatic increase in the levels 
of both normal and phosphorylated p53 when cells are deficient in TC-NER. Despite the 
fact that p53 induction has long been associated with stalled transcription, the molecular 
mechanisms that underlie it remain enigmatic. The identification of ATR as the kinase 
that, in conjunction with RPA, phosphorylates p53 has begun to shed some light on this 
matter (Derheimer et al., 2007). However, this discovery itself raises a question about 
the mechanism of ATR activation at stalled RNA polymerases. The archetypical activating 
structure for ATR is believed to be a single stranded DNA gap and activation of the kinase 
depends on additional proteins (e.g. TopBP1, Rad9) that are independently recruited to 
such substrates (Delacroix et al., 2007;Kumagai et al., 2006). It is questionable whether 
a stalled RNA polymerase confers a structure that resembles gapped DNA, and as such it 
would be of interest to investigate the participation of other factors normally associated 
with ATR signaling in the context of RNA polymerase II mediated signaling.
2.1.6 chromatin structure and Ner
In general, the condensed structure of chromatin poses problems to DNA metabolizing 
processes; notably, NER in a chromatin context is severely inhibited compared to naked DNA 
(Hara et al., 2000). To overcome this barrier, different mechanisms have evolved to remodel 
chromatin enhancing the accessibility of damaged DNA for repair proteins. In addition, 
following removal of the lesion and completing of the post incision stage of NER, cells need 
to restore the original chromatin structure to maintain the epigenetic information (Green 
and Almouzni, 2002). Finally, there is clear evidence that repair efficiencies differ greatly 
in various chromatin environments but the underlying mechanism is not well understood 
(Mullenders et al., 1991). Two major mechanisms may alter chromatin structure: 
posttranslational modification of histone tails and ATP dependent chromatin remodelling. 
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As mentioned in section 1.1, the role of UV-DDB in NER has revealed unexpected 
complexities as this complex associates with proteins that are involved in chromatin 
remodeling (acetylation) and ubiquitylation (Groisman et al., 2003;Datta et al., 2001); the 
latter activity is related to the participation of DDB1 and DDB2 in a large complex making 
up a ubiquitin ligase together with Cul4A and Roc1. The ligase activity of this complex 
is regulated by the COP9 signalosome (CSN). The ubiquitin ligase activity is stimulated 
by UV (at least with respect to GG-NER) leading to poly-ubiquitylation and subsequent 
degradation of DDB2 itself; importantly, ubiquitylation of XPC does not serve as a signal for 
degradation, but merely stimulates the activity of XPC–HR23B by an unknown mechanism. 
It is conceivably that the ubiquitylation of histones and DDB2 may lead to increased 
accessibility of the site of damage by removal and/or loosening of DNA–histone contacts 
and the displacement of UV-DDB from the lesion. 
One of the important changes after UV irradiation is the appearance of hyperacetylated 
histones, most notably shown by the inhibition of histone deacetylases (HDAC) that trigger 
genome-wide histone hyperacetylation at both histone H3 and H4 upon UV irradiation. 
Recently, histone acetyl transferases (HAT) such as the HAT p300 (Fousteri et al., 2006) 
and Gcn5 (Yu et al., 2005) have been suggested to play a role in increasing the accessibility 
of chromatin to NER proteins. A role for p300 in NER is suggested by interactions of p300 
with the repair factors UV-DDB (Rapic-Otrin et al., 2002) and PCNA (Hasan et al., 2001), 
stimulation of repair by p300 in vitro (Frit et al., 2002) and enhancement of NER by the 
histone deacetylase inhibitor sodium butyrate (Ramanathan and Smerdon, 1989). Genetic 
approaches (Smerdon et al., 1982;Mullenders et al., 1986) revealed that histone acetylation 
is not only important for GG-NER but also for TC-NER, although transcriptionally active 
genes themselves are enriched for acetylated histones.
In vitro NER assays using chromatin substrates with defined lesions, generally reveal 
that repair is slow in the nucleosomal DNA with no movement or disruption of nucleosomes 
(Gaillard et al., 2003). Repair measurement of a defined DNA lesion (i.e. 6-4PP) located in 
a dinucleosome chromatin template demonstrated that ATP-dependent remodeling might 
enhance the pre-and postincision steps of NER as dual incision is facilitated by ACF, an 
ATP-dependent chromatin remodeling factor (Ura et al., 2001). The ACF protein moves 
nucleosomes rather than displacing them. Also incubation with the nucleosome remodeling 
complex SWI/SNF and ATP altered the conformation of nucleosomal DNA and promoted 
more homogeneous repair by nucleosome sliding, thereby increasing accessibility to DNA 
(Gaillard et al., 2003;Hara and Sancar, 2003). In vivo data in yeast suggest that SWI/SNF 
has a significant role in modulating the accessibility of UV induced photolesions for the 
NER repair machinery thereby enhancing repair (Yu et al., 2005). Interestingly, the SWI/SNF 
complex and the abovementioned Gcn5 histone acetyl transferase facilitate chromatin 
modifications independent of functional NER, indicating that chromatin remodeling 
precedes NER. In spite of this, and unexpectedly, the homologues of XPC-HR23B in 
yeast (Rad4-Rad23) directly interact with the SWI/SNF remodeling complex via two 
subunits and this interaction was shown to be enhanced following UV irradiation (Gong 
et al., 2006). Taken together the limited data available to date, suggest important roles 
for histone modifying enzymes such as HATs and ATP-dependent chromatin remodelers, 
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yet mechanistic understanding of their impact on NER awaits further experimentation 
particularly to clarify their roles in mammalian NER. 
Several studies have provided evidence for the involvement of the acidic HMG proteins 
that destabilize higher order chromatin structures, in the response to bulky DNA lesions. 
High mobility group protein B1 (HMGB1) binds to and bends damaged DNA and recent 
evidence demonstrates that mouse cells lacking HMGB1 are hypersensitive to the toxic 
effects of UVC radiation and may display reduced NER (Lange et al., 2008). HMGN1 was 
demonstrated to be recruited to TCR complexes (Fousteri et al., 2006) and is exclusively 
involved in TC-NER as HMGN1-deficient mouse cells showed decreased rates of CPDs 
removal in actively transcribed genes (Birger et al., 2003). HMGN1 proteins directly 
compete for DNA binding sites with histone H1, elevate the level of histone H3 acetylation 
(Lim et al., 2005) and modulate the level of histone H3 phosphorylation (Lim et al., 2004). 
It is feasible that the loss of H1 in concert with histone modifications might enhance the 
DNA damage response following UV irradiation, but surprisingly this only affects TC-NER. 
The current models of NER propose that chromatin structure is transiently disrupted 
during the various stages of repair to facilitate access of the repair machinery to DNA 
lesions and to carry out the subsequent steps. As a final step it is then necessary to restore 
the preexisting chromatin structure. A central question is whether chromatin restoration 
involves recycling of parental histones or new histone incorporation. The chromatin 
assembly factor (CAF-1), a key factor involved in histone deposition, plays a role in the 
restoration of chromatin following gap filling and ligation. In living cells this protein is 
recruited to sites of UV-induced DNA damage in a NER-dependent manner (Green and 
Almouzni, 2002); a process that is possibly mediated by PCNA (Gerard et al., 2006). The 
role of CAF-1 as chromatin assembly factor was further highlighted by the observation that 
histone H3.1 was assembled de novo at repair sites, reflecting a chromatin restoration step 
following NER (Polo et al., 2006). Hence, chromatin restoration after DNA damage is more 
than recycling of histones and may represent an imprint for newly repaired chromatin.
Taken together, it appears that repair proteins, DNA and histone binding proteins and 
chromatin modifiers play a key role in modulating the accessibility of nucleosomal DNA to 
the repair machinery as well as in the restoration of the chromatin state following repair. 
However, it is also evident that we are only beginning to understand the modifications that 
are required to allow NER in different chromatin environments.
2.2 trANscriptioN coupleD repAir 
As pointed out, stalled transcription elongation by a DNA lesion is counteracted by the 
activation of a specialized NER subpathway named transcription coupled repair (TC-NER). 
A hallmark of TC-NER is the accelerated repair of DNA lesions (most notably demonstrated 
for UV-induced CPD) in the transcribed strand of active genes and the inability of TC-NER 
deficient cells to resume DNA damage-inhibited DNA and RNA synthesis (van Oosterwijk et 
al., 1996;Mayne and Lehmann, 1982;van Oosterwijk et al., 1996). Obviously, the elongating 
RNA polymerase II (RNAPIIo) when stalled at a lesion efficiently triggers the recruitment 
of TC-NER specific factors and NER proteins. Once the lesion has been recognized, all 
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subsequent steps leading to assembly of a functional NER complex require the same NER 
core factors as described for GG-NER (figure 3). TC-NER is a strongly conserved repair 
pathway identified in a variety of organisms including bacteria, yeast and mammals. In 
UV-irradiated E. coli cells, a 130 kDa protein encoded by the mfd gene (termed TRCF: 
transcription-repair coupling factor) was found to be essential for TC-NER (Selby et al., 
1991). This protein releases the RNA polymerase and transcript from the DNA in an ATP 
dependent manner and also facilitates repair of DNA damage by attracting NER factors, in 
particular UvrA. Also in mammalian cells specific factors for TC-NER have been identified. 
Measurements of UV–photolesions in transcriptionally active genes of cells derived from 
various UV sensitive patients identified impaired TC-NER in cells from individuals suffering 
from Cockayne syndrome (CS). CS is a rare disorder that is associated with a wide variety of 
clinical symptoms including dwarfism, mental retardation, cataract and eye abnormalities 
as well as photosensitivity, but no enhanced susceptibility to cancer. As a consequence, 
these patients die at an early age and CS has been classified as a premature aging 
syndrome. Complementation studies have identified two CS complementation groups, 
CS-A and CS-B. A third group encompasses patients with mutations in XPB, XPD or XPG 
genes exhibiting both XP and CS symptoms. The CSB gene encodes a 168 kDa protein that 
contains helicase domains (strong homology to similar domains in SNF2-like proteins) 
and that displays DNA-dependent ATPase and DNA binding activity, but no helicase activity. 
Also, the bacterial and yeast counterparts of CSB, i.e. Mfd and Rad26 respectively, are DNA 
dependent ATPases. In addition, CSB has nucleosome remodelling activity and binds to 
core histone proteins in vitro (Citterio et al., 2000) and transcriptome analysis of CS-B 
cells revealed deregulation of gene expression similar to that caused by agents that 
disrupt chromatin structure (Newman et al., 2006).
The CSA protein contains WD-40 repeats (a motif involved in protein-protein 
interactions) and is part of an E3-ubiquitin ligase (E3-ub ligase) complex consisting of 
DDB1, Cullin 4A and ROC1/Rbx1 proteins (Groisman et al., 2003). In response to UV the 
COP9 signalosome (CSN) was found to associate with the CSA complex resulting in the 
inactivation of the ubiquitin ligase activity of the CSA complex in TC-NER. 
XAB2 is an XPA binding protein and an essential factor in TCR, but so far mutations 
in XAB2 have not been associated with UV sensitive patients. The protein is involved in 
pre-mRNA splicing and transcription, interacts with chromatin bound stalled RNAPIIo 
complex in a UV- and CS-dependent manner and might function as a scaffold for protein 
complex formation in TC-NER (Kuraoka et al., 2008). Finally, deficiency in HMGN1 (a 
nucleosome binding protein) leads to UV-B sensitivity in HMGN1 knock out mice and 
impairs TC-NER in UV-C irradiated mouse embryonic fibroblasts. Interestingly, HMGN1 
interacts with UV-stalled RNAPIIo and this interaction depends on CS proteins (Fousteri 
et al., 2006).
2.2.1 molecular models for tc-Ner
The additional involvement of RNAPII in TC-NER replaces the requirement for XPC-HR23B 
and UV-DDB to identify DNA lesions, as is the case in GG-NER. Instead the system 
utilises a factor that is capable to couple blockage of transcription by DNA damage to 
2NUCLEOTIDE EXCISION REPAIR
39
efficient DNA damage recognition and repair. The transcription-repair coupling factor in 
mammalian cells appears to be CSB: a DNA dependent ATPase that interacts with RNAPII 
even in undamaged cells (van Gool et al., 1997). Mu and Sancar (Mu and Sancar, 1997) 
showed that purified human excision repair factors and a DNA substrate analogous to a 
transcription bubble terminating at a CPD, are capable to excise the lesion independent 
of XPC. Hence the transcription bubble may substitute for XPC function, which in GG-NER 
causes the two damaged base pairs to flip out of the double helix.
Persistent blockage of transcription activates a stress response leading to stabilization 
of p53 and specific modifications of p53 at Ser 15 providing a strong signal for apoptosis in 
cultured cells and in the epidermis of mice (Ljungman et al., 1999;van Oosten et al., 2000). 
To relieve the strong apoptotic signal the cell has to remove the transcription blockage; 
however, the stalled RNAPII is likely to shield the DNA lesion and prevents access to the 
NER machinery. Two scenarios exist to cope with this problem. One potential mechanism 
would be that the RNAPII is displaced from the DNA or removed by ubiquitylation and 
subsequent degradation by the proteosome thereby making the lesion available for the 
NER machinery. This mechanism has been described for bacterial TC-NER as Mfd releases 
RNAP and recruits repair proteins (Selby and Sancar, 1994). In mammals such a scenario 
would require the recruitment of NER proteins by the action of CS proteins. 
Another possible mechanism is that TC-NER occurs without displacement/removal 
of RNAPIIo but requires conformational changes of RNAPII to allow access to the DNA 
lesion and resume transcription. Particularly the XPG endonuclease in concert with the 
Figure 3: model for transcription coupled Ner. (A) 
During transcription CSB dynamically interacts with 
elongating RNAPII. (B) Stalling of RNAPII on DNA lesions 
stabilizes the interaction of CSB with the polymerase. 
(C) The stalled RNAPII/CSB complex allows for the 
recruitment of the core NER factors as well as the CSA/
DDB1/CSN ubiquitin ligase complex. Conformational 
changes to the stalled RNAPII complex imposed by 
TFIIH and XPG would allow access to the damaged 
DNA strand. (D) The association of CSA with the stalled 
polymerase enables the recruitment of additional 
repair factors like HMGN1 and XAB2.
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basal transcription factor TFIIH have been implicated in an ATP dependent remodelling 
of the arrested RNAPII, allowing incision 3’ of the lesion without the need for CSB (Sarker 
et al., 2005). Although in vitro experiments indicate a prominent role of XPG in the early 
stages of TC-NER, recruitment of XPG to stalled RNAPII in intact cells requires functional 
CSB (Fousteri et al., 2006). Upon binding to stalled RNAPIIo, CSB functions as a coupling 
factor that mediates the recruitment of subsequent NER repair factors TFIIH, XPG, RPA 
and ERCC1-XPF. Indeed, live cell imaging revealed that GFP-tagged CSB interacts with 
the transcription machinery in the presence of DNA damage. Recruitment of CSA is CSB 
dependent and required for binding of both HMGN1 and XAB2 but is dispensable for the 
recruitment of pre-incision NER proteins. The emerging picture of TC-NER is rather complex 
and not well understood at the molecular level. Most strikingly, repair of transcription 
blocking lesions in mammalian cells occurs without displacement of the stalled RNAPIIo 
and requires at least two essential assembly factors with differential modes of action: CSB 
as a repair–transcription coupling factor to attract the core NER pre-incision factors and 
CSA to recruit chromatin remodelers. However, the precise role of CSB ATP-ase activity and 
the CSA associated the E3-ubiquitin ligase complex in TC-NER are not known.
2.3 Ner DeFicieNcies AND cANcer
As pointed out, inherited defects in the NER pathway are manifested in at least three different 
diseases: XP, CS and the photosensitive form of trichothiodystrophy (TTD). Of these, only 
patients with XP are prone to sunlight-induced skin cancer, although patients with CS and 
the photosensitive form of trichothiodystrophy (TTD) are clearly UV-sensitive. For most 
cancers the causative agent is unknown but skin cancer is a notorious exception. In fact, XP 
is a paradigm for a causal link between defective DNA repair and exposure to an exogenous 
(environmental) component i.e. sunlight, as XP patients have a >1000-fold increased risk 
to develop skin tumors primarily at sun-exposed sites of their body. Mutation analysis of 
TTD revealed a complicated genotype as patients have been identified with mutations in 
the XPB, XPD and TTDA genes, all components of the TFIIH complex. Since TFIIH functions 
both in DNA repair and transcription it is assumed that photosensitive TTD patients have 
a defect in both processes; these patients are characterized by sulphur-deficient brittle 
hair and nails, ichthyosis, neurological/developmental abnormalities and short life span. 
Finally, patients exist that belong to the XP-B, XP-D or XP-G complementation group that 
display severe features of CS (early death and neurological/developmental abnormalities) 
and XP (skin lesions and skin cancer). 
As mentioned above, the most overt phenotype of XP patients is their enhanced 
susceptibility to develop skin cancer including basal cell carcinomas (BCCs) and squamous 
cell carcinomas (SCCs) but also melanomas. Increased cancer susceptibility is not only 
seen at the sun-exposed parts of the body but is also evidenced by a low incidence of 
internal tumors. Since epidemiological data on the relationship between skin cancers and 
ambient solar UV radiation are very restricted, animal models i.e. (transgenic) mice, have 
been used to study the process of UV carcinogenesis in depth and to gain quantitative 
data on tumor development and dose, time and wavelength of the UV radiation and genetic 
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make-up. Transgenic hairless mice (to facilitate UVB irradiation and the identification of 
tumors) mimicking the human XP phenotype have been extremely useful in studying the 
role of (exogenously-induced) DNA damage in mutagenesis, carcinogenesis and aging. 
The protective role of GG-NER and TC-NER against the acute (i.e. erythema, apoptosis, cell 
cycle arrest) and long term (i.e. skin cancer, aging) effects of genotoxic (UV-B light, bulky 
chemicals) exposure has been dissected in mouse models with defined mutations in NER 
genes, i.e. XPE (DDB2), XPA (defective in GG-NER and TC-NER), XPC (defective in GG-NER) 
or CSB (defective in TC-NER) deficient mice. DDB2−/− mice are deficient in GG-NER of CPD, 
but otherwise TC-NER proficient. XPA−/− and CSB−/− mice appeared to be 10-fold more 
sensitive to the acute toxic effects of UV-B light (erythema/edema of the skin) and to the 
polycyclic aromatic hydrocarbon DMBA (lethality) compared to normal, XPC−/− or DDB2−/− 
mice (Wijnhoven et al., 2001;Berg et al., 1998). The difference in UV-B sensitivity relates to 
enhanced apoptosis and severe cell cycle arrest of epidermal keratinocytes in XPA−/− and 
CSB−/− mice (van Oosten et al., 2000;Stout et al., 2005). These results highlight TC-NER as a 
profound survival pathway and identify TC-NER as the principal defense mechanism towards 
the deleterious effects of transcription blocking DNA lesions by counteracting apoptosis 
and cell cycle arrest. However, this increased survival occurs at expense of increased 
mutagenesis manifested by the fast appearance of epidermal patches expressing mutant 
p53 in UV-B irradiated XPC−/− mice (Rebel et al., 2005) but also by increased spontaneous 
mutagenesis in lymphocytes (Wijnhoven et al., 2001). Mutation spectrum analysis showed 
that almost all UV-B light induced mutations in rodent and human were at dipyrimidine 
positions with C→T transition mutations being the most prominent. The latter is caused 
by three factors. Firstly, DNA polymerase η preferentially incorporates adenine residues 
opposite to non-instructional lesions. Secondly, 5-methylcytosines within CPD lesions 
display accelerated deamination rates, resulting in base changes to uracil. Moreover, 
CPDs are formed preferentially at dipyrimidines containing 5-methylcytosine when cells 
are irradiated with UV-B or sunlight. Finally, CC→TT double transitions are caused in 
vivo exclusively by UV-induced pre-mutagenic lesions in XPA and XPC deficient mice and 
human XPC patients (Spatz et al., 2001). Also in tumors isolated from UV-B irradiated 
mice (with high frequencies of p53 mutations) defective GG-NER and TC-NER resulted 
in increased mutations in p53 through UV-targeted dipyrimidine sites but strikingly, only 
XPA−/− and CSB−/− mice developed benign papillomas before squamous cell carcinomas 
(SCC). These papillomas carried mutations in the 12th Hras codon with a dipyrimidine 
site in the transcribed strand; such mutations were not observed in the UV-induced 
SCCs. Evidently, proficient TC-NER prevents Hras mutagenesis and therefore prevents the 
development of papillomas.
Taken together, GG-NER and TC-NER protect against UV-B induced skin cancer in 
mice. Although the mouse cancer data reveals remarkable similarities with skin cancer 
susceptibility in human, striking differences exist as well. Most notably, the XPA−/− mice, 
in contrast to XP patients, do not develop melanoma whereas CSB−/− mice, but not CSB 
patients, are skin cancer prone. The latter is related to the poorly expressed GG-NER system 
in rodents. Unlike human cells, rodent epidermal cells express DDB2 at a low level. Mice 
ectopically expressing DDB2 display delayed onset of squamous cell carcinoma following 
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chronic UV-B light exposure and at the cellular level enhanced repair of UV-photolesions 
(Alekseev et al., 2005;Pines et al., 2008) whereas DDB2−/− mice were hypersensitive to UV-
induced skin carcinogenesis. Ectopic expression of DDB2 in CSB−/− mice counteracts the 
cancer proness of UVB exposed CSB−/− mice indicating that GG-NER serves as a back-up 
system for TC-NER deficiency (Pines et al., in preparation). 
2.4 perspectiVes
Molecular, cellular and animal studies over the last three decades have greatly improved 
our understanding of the interplay between cellular processes (DNA damage, NER 
and transcription) and human disease. However, much is to be learned about the exact 
functions of key players in NER and the mechanisms by which eukaryotic cells sense DNA 
damage in their genome and which signals activate and regulate NER. The mammalian 
genome is protected against genotoxic insults by a network of DNA damage response 
(DDR) mechanisms initiated by sensing of DNA damage or damage-induced chromatin 
alterations through specific sensors. The next stage in the process is to transmit the signal 
to transducers that are able to pass the signal to effectors that control various protective 
pathways i.e. different DNA repair pathways, cell cycle checkpoints, apoptosis, transcription 
and chromatin remodeling. Hence, full understanding of mammalian NER not only requires 
insights into the mechanisms of NER but also the DNA damage signaling cascade. 
Faithful DNA damage processing in various chromatin environments requires process 
control at each individual step including regulation of the expression of NER factors, 
regulation of NER protein activity by post-translational modifications, remodeling of 
chromatin at sites of DNA damage, monitoring progress and completeness of repair and 
checking integrity of chromatin after damage removal. Presently, little is known about these 
regulatory processes and how NER is connected with DNA damage signaling pathways 
i.e. specific sensors of DNA damage (such as UV-induced photolesions) and transducers 
able to pass the signal to downstream effectors i.e. transcription, chromatin remodeling 
and protein modification. Which are the factors that control initiation, progression 
and completion of the NER process? Which factors enable GG-NER activity in different 
chromatin environments such as heterochromatic and euchromatic regions? The ultimate 
goal is to use this information to further improve the mathematical modeling of NER. The 
current model based on in vivo kinetic data (Politi et al., 2005) unveils that a sequential 
assembly mechanism appears remarkably advantageous in terms of repair efficiency and 
suggests that random assembly and preassembly are kinetically unfavorable. 
Multiple gene products are implicated in TC-NER but we lack knowledge of the signals 
that regulate TC-NER and we do not know the precise function of key components in 
TC-NER. Most notably, it is not clear why chromatin remodeling would be required for 
TC-NER in addition to the structural changes that are needed to allow transcription 
of actively transcribed chromatin-embedded DNA substrates. Currently it is not well 
understood which factors or processes are required to resume transcription although it is 
clear that besides TC-NER other mechanisms play a role (Rockx et al., 2000). Of particular 
interest to resolve is the fate of stalled RNAPII when TC-NER fails to operate and to find 
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out which types of oxidative DNA damage (induced by metabolic processes) can inhibit 
transcription in vivo. A stalled RNAPII transcription machinery senses DNA damage and 
leads to a strong signal for apoptosis. Moreover, there is increasing evidence that during 
S-phase collisions of replication forks with transcription complexes stalled at DNA lesions, 
are a very mutagenic event (Hendriks et al., 2008). Hence, it is of pivotal importance to 
dissect the contributions of impaired TC-NER and transcription defects in the aetiology of 
the progeroid, neurodevelopmental disorder of CS.
Knowledge of the NER pathway and repair proteins has lead to the identification of 
inherited polymorphisms of NER genes (SNPs). These SNPs may contribute to variations in 
DNA repair capacity and genetic susceptibility to cancer. Numerous published data provide 
emerging evidence that polymorphisms in NER genes may contribute to the genetic 
susceptibility to cancers in man. However, many of the studies are of limited value because 
of the limited size of the study populations. It is obvious that large and well-designed 
population-based studies are warranted to identify NER genes as biomarkers to screen 
high-risk populations for early detection of cancer. Knowledge of the NER pathway and 
repair proteins can also be applied as basis for enzyme therapy to counteract sunlight 
induced skin cancer. The bacterial DNA repair enzyme T4 endonuclease V packaged in an 
engineered delivery vehicle was shown to be capable of reversing the defective repair in 
xeroderma pigmentosum cells (Yarosh, 2002). Moreover, expression of the CPD-photolyase 
in mouse epidermis is an effective tool to combat UV-B induced non-melanoma skin cancer 
(Jans et al., 2005). These findings directly proof that enhancement of repair activity can 
be used as a therapeutic tool to protect against UVB induced skin cancer although NER 
proteins have not been applied so far.
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AbstrAct 
The WD40-repeat protein DDB2 is essential for efficient recognition and subsequent removal 
of ultraviolet (UV)-induced DNA lesions by nucleotide excision repair (NER). However, how 
DDB2 promotes NER in chromatin is poorly understood. Here, we identify poly(ADP-ribose) 
polymerase 1 (PARP1) as a novel DDB2-associated factor. We demonstrate that DDB2 
facilitated poly(ADP-ribosyl)ation of UV-damaged chromatin through the activity of PARP1 
resulting in the recruitment of the chromatin remodeling enzyme ALC1. Depletion of ALC1 
rendered cells sensitive to UV and impaired repair of UV-induced DNA lesions. Additionally, 
DDB2 itself was targeted by poly(ADP-ribosyl)ation, resulting in increased protein stability 
and a prolonged chromatin retention time. Our in vitro and in vivo data support a model 
in which poly(ADP-ribosyl)ation of DDB2 suppresses DDB2 ubiquitylation and outline a 
molecular mechanism for PARP1-mediated regulation of NER through DDB2 stabilization 
and recruitment of the chromatin remodeler ALC1.
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iNtroDuctioN
Nucleotide excision repair (NER) is a multistep process that mediates the removal of 
structurally and chemically diverse DNA lesions including ultraviolet (UV) light-induced 
cyclobutane pyrimidine dimers (CPD) and 6-4 pyrimidine pyrimidone photoproducts 
(6-4PP). The importance of NER in protecting organisms against solar UV-induced DNA 
damage is underscored by the hereditary disease xeroderma pigmentosum (XP), which is 
clinically characterized by hypersensitivity to sunlight and predisposition to skin cancer 
(Cleaver et al., 2009). XP has been linked to defects in seven proteins (XP-A through XP-G) 
which, with the exception of XPC and XPE (hereafter named DDB2), function in the core 
NER reaction. The proteins encoded by the XPC and XPE genes are involved in the global 
genome NER sub-pathway (GG-NER), but are dispensable for transcription-coupled NER 
(TC-NER) (Cleaver et al., 2009).
Reconstitution of the NER reaction with purified proteins has defined the minimal set 
of proteins required for GG-NER in vitro (Aboussekhra et al., 1995). The initial step of DNA 
damage recognition depends on the XPC-Rad23 complex and subsequently results in 
local DNA unwinding and damage verification by the basal transcription factor TFIIH, the 
single-stranded DNA-binding complex RPA and XPA. Dual incision of the damaged DNA 
strand is carried out by the 5’and 3’ structure-specific endonucleases XPF-ERCC1 and 
XPG, respectively, followed by gap filling and DNA ligation (Aboussekhra et al., 1995). 
DNA damage recognition by XPC involves the detection of unpaired bases (Min and 
Pavletich, 2007;Clement et al., 2010), which renders lesion recognition of minor helix-
distorting lesions such as CPD very inefficient (Sugasawa et al., 2001). In addition to XPC, 
efficient repair of CPDs therefore requires the heterodimeric UV-DDB protein complex 
consisting of the DDB1 and DDB2 subunits (Fitch et al., 2003;Moser et al., 2005). The 
crystal structure of UV-DDB bound to a 6-4PP-containing DNA duplex revealed the direct 
and exclusive binding of DDB2 to the photodimer (Scrima et al., 2008). XP-E cells lacking 
functional DDB2 are deficient in repair of CPD but competent in repair of 6-4PP albeit at 
reduced rates (Hwang et al., 1999;Moser et al., 2005). This partial requirement for UV-DDB 
in GG-NER is reflected in the relative mild sensitivity of XP-E cells to UV-induced cell death 
(Tang and Chu, 2002). Although UV-DDB deficiency impairs repair of photolesions in vivo, it 
is dispensable for NER in vitro (Aboussekhra et al., 1995;Mu et al., 1995;Rapic, V et al., 1998) 
suggesting that UV-DDB is important for the repair of DNA lesions in a chromatin context.
The UV-DDB complex interacts with several factors known to modulate chromatin 
structure such as histone acetyltransferase p300, the STAGA complex (Datta et al., 
2001;Rapic-Otrin et al., 2002;Martinez et al., 2001) and the Cullin-RING ubiquitin 
ligase (CRL4) complex CUL4A-RBX1 (Shiyanov et al., 1999;Groisman et al., 2003). The 
CRL4-DDB2 complex ubiquitylates DDB2 and XPC in response to UV irradiation, which 
facilitates efficient recognition of photolesions by XPC (Sugasawa et al., 2005). Moreover, 
the CRL4 complex also ubiquitylates histones H2A, H3 and H4 (Kapetanaki et al., 2006) of 
which H3 and H4 ubiquitylation affects nucleosome stability (Wang et al., 2006). 
Despite these studies, the molecular mechanisms through which UV-DDB facilitates 
recognition of DNA damage in chromatin remain poorly understood. Here we purified DDB2 
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and associated factors from human cells and identified poly(ADP-ribose) polymerase 1 
(PARP1) as a novel component of the UV-DDB complex. We provide evidence for a central role 
of DDB2-associated PARP1 in mediating poly(ADP-ribose) (PAR) synthesis and recruitment 
of the SWI/SNF chromatin remodeler ALC1 to UV-damaged DNA. Moreover, we show that 
poly(ADP-ribos)ylation of DDB2 itself regulates the stability as well as the chromatin 
retention time of DDB2. Interfering with either PARP1 or ALC1 function impairs CPD repair 
and renders cells highly sensitive to UV irradiation. Together, these findings outline a novel 
molecular mechanism for the DDB2-mediated and PARP1-executed regulation of NER.
results
pArp1 is a component of the uV-DDb complex
To identify novel factors involved in the DNA damage recognition step of GG-NER we isolated 
DDB2-associated protein complexes by chromatin immunoprecipitation (figure 1A-B) and 
analysed purified proteins by mass spectrometry (MS). MRC5 cells expressing FLAG-tagged 
DDB2 were either mock-treated or irradiated with UV-C light (20 J/m2) and incubated for 
five minutes prior to chromatin isolation and immunoprecipitation using FLAG antibody. 
MS analysis identified several proteins known to interact with DDB2, including DDB1, 
CUL4A, CUL4B, and components of the COP9 signalosome (supplementary table 1) 
showing that native DDB2 is indeed isolated from cells using this approach. Interestingly, 
multiple DDB2 peptides were identified by MS with protein weights exceeding 50 kDa in 
UV-irradiated cells but not in mock treated cells (figure 1A), suggesting the presence of 
UV-specific posttranslational modifications of DDB2. In addition to these known factors, 
we also identified poly (ADP-ribose) polymerase 1 (PARP1) as a novel DDB2-associated 
factor. We confirmed the interaction between endogenous DDB2 and endogenous PARP1 
by reciprocal immunoprecipitation experiments (figure 1C) using chromatin prepared 
from UV-irradiated or mock-treated normal human fibroblasts (NHF). These results show 
that UV irradiation stimulates the interaction between the UV-DDB complex and PARP1 on 
chromatin. Moreover, an interaction between recombinant UV-DDB and recombinant PARP1 
could indeed be detected in vitro supporting a direct interaction between these factors 
(supplementary figure 1A-B). To test which subunit of the UV-DDB complex interacts with 
PARP1, we purified GFP-DDB1 or GFP-DDB2 under denaturing conditions from cells. The 
results revealed that both DDB1 and DDB2 interact with PARP1 (figure 1D). Consistent with 
this notion, we found that GFP-DDB2D307Y, which is unable to form a complex with DDB1 
(Luijsterburg et al., 2012), also binds PARP1, indicating that DDB2-PARP1 interaction 
does not require DDB1. To corroborate these findings, we isolated GFP-DDB1 or GFP-DDB2 
from polyacrylamide gels and found both extracted proteins to interact with PARP1 in vitro 
(supplementary figure 1C). Finally, far-western blotting also revealed that both DDB1 and 
DDB2 avidly bind to PARP1 (supplementary figure 1B). Together, our findings reveal a novel 
and direct interaction between the UV-DDB complex and PARP1, which prompted us to 
assess the involvement of PARP1 in modifying DDB2 and regulating NER. 
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Figure1. (A) SDS-PAGE electrophoresis and Coomassie staining of FLAG-DDB2 immunoprecipitates 
obtained from FLAG-DDB2 expressing MRC5 cells mock treated or irradiated with 20 J/m2 UV-C. 
Negative control (NC) indicates the elute obtained from agarose beads incubated with MRC5 
FLAG-DDB2 chromatin. The arrows in the zoom-in window indicate the position of the gel where 
DDB2 and the respective unique-peptides detected by MS (A unique peptide is defined as a peptide, 
irrespective of its length, that exists only in one protein of a proteome of interest). (b) Western blot 
of FLAG-DDB2 immunoprecipitates. Cells were mock treated or irradiated with 20 J/m2 UV-C and 
immunoblotted with DDB1 and DDB2 specific antibodies. Negative control (NC) indicates the elute 
obtained from agarose beads incubated with chromatin from MRC5 FLAG-DDB2 cells. (c) Western 
blot of DDB2 and PARP1 immunoprecipitates from NHF cells mock treated or irradiated with 20 J/m2 
UV-C followed by 5 minutes incubation and immunoblotted against DDB1, DDB2 or PARP1. (D) GFP-
DDB2-PARP-1 binding assay. U2OS cells transfected with the indicated GFP constructs were lysed in 
denaturing buffer and subjected to immunoprecipitation with GFP-TRAP beads and then incubated 
with 100 ng purified recombinant PARP-1. The beads were then processed for immunoblotting. 
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poly(ADp-ribose) chains are synthesized at uV-induced DNA lesions
We first assessed whether poly(ADP-ribose) (PAR) chains are synthesized in chromatin 
containing UV-induced DNA lesions. To this end, we locally irradiated G0/G1 synchronized 
telomerase-immortalized human fibroblasts with UV-C light (254 nm) through a 
polycarbonate mask (Mone et al., 2001). Staining with specific antibodies revealed the 
presence of PAR chains at sites of DNA damage marked by the recruitment of the p89 
subunit of TFIIH or replication factor PCNA known to be involved in NER (figure 2A-B). 
Moreover, PAR staining in Ki67-negative cells confirmed that PAR synthesis occurred at 
DNA lesions in non-proliferating cells underlining the replication-independent nature of 
these events (figure 2C). Finally, chemical inhibition of PARP1 impaired the formation of 
PAR chains at damaged sites (figure 2D) indicating that the activity of PARP1 is responsible 
for PAR synthesis at sites of local UV damage. 
pArg and DNA synthesis inhibition modulate uV-dependent pArylation
We noted during our experiments that the synthesis of PAR chains at DNA lesions was 
only detectable in a subset of cells (figure 2A-B). To gain insight into this phenomenon, 
we locally UV irradiated human fibroblasts with different doses (30 or 100 J/m2) and 
subsequently monitored the formation of PAR chains 30 minutes after irradiation (figure 
2E). The percentage of cells with PAR chains at sites of local damage significantly increased 
between 30 J/m2 and 100 J/m2, but did not exceed 50% of the cells (figure 2E-F). It is 
known that the transient and highly dynamic nature of PAR chains is due to the rapid 
reversal of this modification by the activity of the poly (ADP-ribose) glycohydrolase (PARG) 
(Slade et al., 2011). To increase the steady-state level of UV-induced PAR chains, we 
lowered the levels of PARG by siRNAs. Indeed, depletion of PARG resulted in a significantly 
elevated percentage of cells that displayed PAR chains at DNA lesions, which was roughly 
60% at 30 J/m2 and 75% at 100 J/m2 (figure 2E-F). These findings show that UV-induced 
PAR chains are formed in the majority of cells, but are rapidly reversed by the activity of 
PARG. We then hypothesized that single-stranded DNA gaps transiently generated during 
NER, might elicit the synthesis of PAR chains. In support of this we found that inhibition of 
DNA synthesis and ligation by hydroxyurea (HU) and cytosine-b-arabinofuranoside (AraC), 
known to result in the formation of persistent single-stranded DNA gaps (Overmeer et al., 
2011), resulted in robust PAR synthesis in all UV-irradiated cells (figure 2E-F).
DDb2 mediates pArylation during the pre-incision stage of Ner 
To evaluate whether UV-induced PAR synthesis was exclusively dependent on the presence 
of a single-stranded DNA repair intermediate, we examined PARylation in XP-A cells that 
are unable to perform incision and hence do not accumulate ssDNA (Friedberg, 2001) 
(figure  3C). Indeed, PAR synthesis could not be detected in XP-A cells even following 
treatment with HU and AraC (figure 3A-B), consistent with a role of dual incision in triggering 
these events. Strikingly, however, the formation of PAR chains was still detected in XP-A 
cells upon the depletion of PARG (figure 3A-B), suggesting that PAR chain formation is not 
solely dependent on the formation of ssDNA. Given our finding that UV-DDB interacts with 
PARP1, we addressed whether DDB2 contributes to PAR synthesis at sites of DNA damage. 
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Figure2. (A-b-c-D) NHF cells were locally UV irradiated (100 J/m2), fixed after the indicated time 
and stained with an antibody-recognizing PAR, TFIIH, PCNA or Ki67. PAR colocalizes with the damage 
markers TFIIH and PCNA (A-b) including non-cycling cells (Ki67 negative staining) (c). Treatment 
with a specific PARPi (10μM) resulted in a complete loss of PAR signal (D). Arrows indicate local 
damage sites. Scale bar represent 20µm. (e) NHF cells were transfected with indicated siRNA or 
treated with HU/AraC. 48 hours after transfection the cells were locally UV exposed (30 or 100 J/
m2), fixed after the indicated time and stained with an antibody recognizing PAR or TFIIH. Scale bar 
represent 20µm. (F) The percentage of colocalization of PAR with TFIIH in NHF cells is plotted for 
the different siRNA transfections and HU/AraC treatment. The results are from three independent 
experiments in which about 100 cells per condition were analysed; Error bars indicate standard 
deviation. The data shown are from a single representative experiment out of three repeats.
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Figure3. (A) XP-A cells expressing sh-Control or shDDB2 were transfected with indicated siRNA or 
treated with HU/AraC. 48 hours after transfection the cells were locally exposed to 30 J/m2, fixed 
after the indicated time and stained with an antibody recognizing PAR or TFIIH. Scale bar represent 
20µm. (b) The percentage of colocalization of PAR with TFIIH in XP-A cells expressing sh-Control 
or shDDB2 is plotted for the different siRNA transfections and HU/AraC treatment. The results are 
from three independent experiments in which about 100 cells per condition were analysed; Error 
bars indicate standard deviation. (c) Scheme of the early stage of Nucleotide Excision Repair (D) 
XP-E cells were transfected with indicated siRNA or treated with HU/AraC. The cells were locally UV 
exposed with 100 J/m2, fixed after the indicated time and stained with an antibody-recognizing 
PAR or TFIIH. Scale bar represent 20µm. (e) The percentage of colocalization of PAR with TFIIH in 
XP-E cells is plotted for the different siRNA transfections and HU/AraC treatment. Error bars indicate 
standard deviation. The data shown are from a single representative experiment out of three repeats.
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At later time-points after UV irradiation (30 minutes after 100 J/m2), when stretches of 
ssDNA have been generated, we detected an substantial difference in PAR synthesis 
between normal human cells and DDB2-deficient XP-E cells as only 10% of the XP-E cells 
displayed clear PARylation at damaged sites when compared to normal cells (figures 3D-E). 
However, similar to repair-proficient cells we found inhibition of PAR turnover by PARG 
depletion to increase the percentage of PAR-positive cells to about 40%, while inhibition of 
DNA synthesis resulted in PAR synthesis at all locally damaged sites (figure 3D-E). These 
findings are consistent with the notion that XP-E cells are impaired in dual incision due 
to deficient repair of CPD and underscore the role of ssDNA formation in UV-induced PAR 
synthesis. During the time period of 30 minutes after UV-irradiation, a substantial part of 
repair represents removal of 6-4PP being repaired much more rapidly than CPD. XPE cells 
display efficient repair of 6-4PP under the conditions described in figure 3 (Moser et al., 
2005;Nishi et al., 2009) and all these repair events (in the presence of HU/AraC) provoke 
PAR synthesis although the absolute number of events is lower than in NHF. 
We then took advantage of the finding that DDB2 is very rapidly recruited to UV-induced 
DNA lesions (Luijsterburg et al., 2007) compared to the assembly rates of the pre-incision 
factors and especially those of the post-incision factors (Luijsterburg et al., 2010). We 
therefore examined PAR synthesis very shortly after UV exposure when DDB2 readily 
accumulates, but PCNA recruitment cannot yet be detected (Luijsterburg et al., 2010). At five 
minutes after UV irradiation (30 or 100 J/m2), we could not detect PAR synthesis in normal 
human, XP-A or XP-E fibroblasts, not even when DNA synthesis was inhibited by HU/AraC 
treatment (figure 4). Strikingly, whereas the stabilization of PAR chains by PARG depletion 
(supplementary figure 3E) resulted in clearly detectable PARylation at UV-damaged regions 
in wild-type and XP-A fibroblasts (figure 4A-C-D-E), PAR synthesis at these early time-points 
was completely abolished in XP-E cells even at 100 J/m2 (figure 4B-D). Taken together, our 
results suggest that two temporally distinct waves of PARylation take place at sites of UV-
induced DNA damage. The early (pre-incision) wave of PAR synthesis is fully dependent 
on functional DDB2 whereas the late (post-incision) wave of PAR formation requires the 
generation of single-stranded DNA gaps resulting from dual incision. In concordance, we 
found that PAR synthesis was completely abolished in DDB2 depleted XP-A cells even when 
PARG was depleted (figures 3A-B and 4C-E, supplementary figure 3C). 
pArylation regulates DDb2 release from uV-induced DNA lesions
To gain insight into the role of PARylation in NER complex formation, we investigated the 
assembly kinetics of GFP-tagged DDB2 at UV-C laser-induced DNA lesions. The kinetics of 
GFP-DDB2 accumulation were not affected by PARPi or depletion of PARG (supplementary 
figure 2A-B) indicating that the recruitment of DDB2 is not regulated by PAR chains. 
We subsequently applied fluorescence loss in photobleaching (FLIP) to measure the 
dissociation rate of DDB2 from UV-damaged DNA. Although the dissociation of DDB2 (t1/2 
= 19 seconds) was not affected by PARPi, we measured a prolonged chromatin retention 
time (t1/2 = 27 seconds) upon knock-down of PARG (figure 5A) suggesting that PAR 
synthesis positively affects the retention of DDB2 on UV-damaged chromatin. Likewise, the 
immobilization of GFP-DDB2 following global UV irradiation, as measured by fluorescence 
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Figure4. (A-b) NHF(A) and XP-E(b) cells were transfected with indicated siRNA or treated with 
HU/AraC. 48 hours after transfection the cells were locally UV exposed with 30 or 100 J/m2, fixed 
after the indicated time and stained with an antibody recognizing PAR or TFIIH. Scale bar represent 
20µm. (c) XP-A cells expressing shControl or shDDB2 were transfected with indicated siRNA or 
treated with HU/AraC. 48 hours after transfection the cells were locally UV exposed to 30 J/m2, 
fixed after the indicated time and stained with an antibody-recognizing PAR or TFIIH. Scale bar 
represent 20µm. (D) The percentage of colocalization of PAR with TFIIH in NHF and XPE cells is 
plotted for the different siRNA transfections and HU/AraC treatment. The results are from three 
independent experiments in which about 100 cells per condition were analysed; Error bars indicate 
standard deviation. (e) The percentage of colocalization of PAR with TFIIH in XP-A cells expressing 
sh-Control or shDDB2 is plotted for the different siRNA transfections and HU/AraC treatment. 
The results are from three independent experiments in which about 100 cells per condition were 
analysed; Error bars indicate standard deviation. The data shown are from a single representative 
experiment out of three repeats.
PARP DEPENDENT REGULATION OF NER3
62
recovery after photo-bleaching (FRAP), was significantly reduced following treatment with 
PARP inhibitors (figure 5B), suggesting that PAR synthesis positively affects the retention 
of DDB2 on UV-damaged chromatin. Consistent with these findings, western blot analysis 
revealed that the UV-induced degradation of DDB2 was significantly retarded by PARG 
depletion (figure 5C) when cells were exposed to a UV dose (100J/m2) comparable with 
the UV-laser treatment (figure 5A). Inhibition of PARP activity resulted in accelerated 
degradation of DDB2 following UV irradiation most clearly seen at 30 J/m2. This result 
indicates that PARylation of DDB2 affects its UV-induced degradation presumably by 
affecting ubiquitylation. To address how PARylation modulates the chromatin binding and 
stability of DDB2, we biochemically examined whether UV-DDB is modified by PARP1. In 
vitro PARylation experiments using purified components revealed that both DDB2 and 
DDB1 are directly modified by PARP1 (figure 6A, and supplementary figure 2C). Conversely, 
human DDB2 lacking its first 40 N-terminal amino acids including 7 lysines ,(Fischer et al., 
2011) failed to undergo PARylation (figure 6A). This finding was further substantiated by 
the lack of in vitro PARylation of the zebrafish orthologue of DDB2 (drDDB2) lacking the 
first 93 N-terminal residues (Scrima et al., 2008) showing that the N-terminus of DDB2 
is targeted for PARylation. Both Cul4A or Rbx1 were not modified by PARP1 (figure 6A) 
suggesting that DDB1 and DDB2 are specific targets of PARP1. To assess PARylation of 
DDB2 in vivo, we expressed double-tagged DDB2 in human cells followed by its isolation 
using two consecutive purifications under denaturing conditions in order to disrupt 
protein-protein interactions while preserving post-translational modifications (Figure 6B). 
Using this purification approach we detected robust PARylation of DDB2 in response to UV 
irradiation, while PARylation was virtually absent in mock-treated cells showing that DDB2 
is modified in a DNA damage-specific manner. Strikingly, inhibition of PARP activity, which 
resulted in suppressed DDB2 PARylation, was accompanied by increased level and altered 
spectrum of ubiquitylation of DDB2 (figure 6B). However, it is obvious that lysine residues 
on the N-terminus of DBB2 are the major target of ubiquitylation (Fischer et al., 2011) and 
these might have more impact on DDB2 degradation than modification of lysine residues 
toward the C-terminus when PARP activity is inhibited. These findings identify DDB2 as a 
novel target for PARP1-mediated PARylation and suggest that poly(ADP-ribosyl)ation of 
DDB2 directly suppresses DDB2 auto-ubiquitylation providing a molecular explanation for 
the PAR-dependent stabilization of DDB2 in response to UV irradiation.
DDb2-dependent and -independent recruitment of the chromatin remodeling enzyme 
Alc1 to uV-induced photolesions
Recent studies uncovered that PAR chains mediate the recruitment of PAR-binding proteins 
to single-stranded and double-stranded DNA breaks (Timinszky et al., 2009;Gottschalk et al., 
2009;Ahel et al., 2009). In particular, the macrodomain-containing chromatin remodeling 
enzyme ALC1 promotes PAR-dependent nucleosome remodeling in vitro and is recruited 
to sites of DNA breaks, which prompted us to test whether ALC1 is involved in the repair 
of UV-induced DNA lesions. Staining with a specific antibody revealed that endogenous 
ALC1 was readily recruited to UV-induced DNA lesions shortly after UV exposure (figure 7A). 
Live cell imaging of GFP-tagged ALC1-expressing cells confirmed the rapid, but transient 
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Figure 5. (A) NHF cells stably expressing GFP-DDB2 were transfected with the indicated siRNA or 
treated with PARPi (10μM). 48 hours after transfection cells were UV irradiated using a UV-C (266 
nm) laser. To determine the dissociation kinetics of DDB2 from UV-damaged DNA, the undamaged 
nucleus was continuously bleached and the fluorescence decrease in the local damage was 
monitored. Relative fluorescence was normalized at 100% (before bleach at maximum level of 
accumulation). The half-time (t1/2) of a FLIP curve corresponds to the residence time of a protein 
molecule in the locally damaged area. Error bars indicate SEM. (b) VH10-tert cells stably expressing 
GFP-DDB2 were incubated in CO2-independent microscopy medium supplemented with 1‰ DMSO 
(mock treatment) or 10 µM PARP inhibitor dissolved in DMSO three hours prior to FRAP analysis. 
Cells were mock-treated or globally UV-C irradiated (10 J.m-2) and transferred to the microscope 
chamber in microscopy medium. Cells were incubated on the microscope chamber at 37° for 10 
minutes to allow repair proteins to accumulate at UV-induced DNA lesions after which the mobility 
of GFP-tagged NER factors was analyzed by strip-FRAP. The data were normalized to pre-bleach 
intensity (set to 1) and bleach depth (set to 0). Three independent experiments were performed 
for each condition. (c) Western blot of normal fibroblasts transfected with the indicated siRNA or 
treated with PARPi (10μM). Whole cell extracts of non-irradiated and UV-irradiated cells (30-100 
J/m2) after the indicated time were probed with antibodies against DDB2, PAR or H2B. 
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recruitment of ALC1 to sites of UV-C laser-induced DNA damage (figure 7B). GFP-ALC1 
was rapidly recruited to UV-induced DNA lesions in wild-type (supplementary figure 3B) 
and XP-A cells (figure 7B) shortly after exposure to the UV-C laser and could be completely 
suppressed by addition of the PARPi (supplementary figure 3A). Strikingly, knockdown of 
DDB2 significantly reduced the recruitment of GFP-ALC1 in XPA-deficient cells (figure 7B) 
as well as in repair-proficient cells at early time-points after UV irradiation (supplementary 
figure 3B), suggesting an important role for DDB2 in the recruitment of chromatin 
remodeler ALC1 through PARP1-mediated PAR synthesis. Consistent with our findings 
that two mechanistically distinct PARylation waves exist in response to UV irradiation, we 
found that single-stranded DNA gaps also triggered robust GFP-ALC1 recruitment at later 
time-points after UV irradiation in normal human as well as in XP-E cells (supplementary 
figure 4) whereas recruitment of ALC1 was absent in dual incision-defective XP-A cells not 
even in the presence of HU/AraC (supplementary figure 4). In contrast the stabilization 
of PAR chains by PARG depletion (supplementary figure 4) resulted in clearly detectable 
GFP-ALC1 recruitment at UV-damaged regions in XP-A fibroblasts. In summary, our results 
Figure 6. (A) The N-terminus of DDB2 is targeted for PARylation. In vitro PARylation experiments 
using purified components reveal that both DDB2 and DDB1 are directly modified by PARP1. Human 
DDB2 lacking its first 40 N-terminal amino acids including 7 lysines (dUVDDB), failed to undergo 
PARylation. The zebrafish orthologue of DDB2 (drDDB) lacking the first 93 N-terminal residues is 
also not PARylated in vitro. (b) 6His StrepII-tag DDB2 isolation using tandem purifications under 
denaturing conditions. NHF cells stably expressing 6His StrepII-tag DDB2 were irradiated with 
UV-C light (100 J/m2) in presence or in absence of PARPi (10µM) or mock-irradiated and incubated 
for 30 minutes. The final Strep-Tactin column purifications were separated on SDS-PAGE gels, and 
proteins were visualized with antibodies against DDB2, PAR or Ubiquitin.
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Figure 7. (A) NHF cells were locally UV irradiated (100 J/m2), fixed after the indicated time and 
stained with an antibody recognizing ALC1 or TFIIH. ALC1 colocalizes with the damage marker 
TFIIH. Scale bars represent 20µm. (b) XP-A cells stably expressing GFP-ALC1 were infected with 
the indicated short hairpin RNA. The cells were UV damaged using UV-C (266 nm) laser irradiation. 
GFP fluorescence intensities at the site of UV damage were measured by real time imaging until 
they reached a maximum. Assembly kinetic curves were derived from at least six cells for each 
protein. Error bars indicate SEM. Scale bar represent 20µm. (c) Clonal survival of UV-irradiated 
NHF cells expressing shControl or shALC1 and XPA cells. The percentage of surviving cells is plotted 
against the applied UV-C dose (J/m2). The results are from three independent experiments; Error 
bars indicate standard deviation. Scale bar represent 20µm. (D) NHF cells expressing shControl or 
shALC1 RNAi or treated with PARPi (10μM) were irradiated with 10 J/m2 UV-C, fixed immediately, at 
8 or 24 hours after UV treatment and stained with anti-CPD antibody. (asterisk indicates p<0.05, 
ANOVA) (e) NHF cells expressing shControl or shALC1 or treated with PARPi (10μM) were irradiated 
with 10 J/m2 UV-C, fixed immediately, at 1 or 2 hours after UV treatment and stained with an anti-
6-4PP antibody. The total fluorescence intensity of the nucleus was quantified and divided by the 
surface area, resulting in a specific fluorescence intensity expressed in arbitrary units. Values are 
the result of three independent experiments (100 cells per time point).
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reveal that the chromatin remodeling enzyme ALC1 is recruited to PAR chains synthesized 
during repair by NER through distinct molecular mechanisms.
pArp1 inhibition and Alc1 depletion impair cpD repair and render cells sensitive to uV 
irradiation
Having established that ALC1 is recruited to sites of local damage, we subsequently addressed 
the biological impact of this finding. To this end, we generated a cell line stably expressing 
a shRNA targeting endogenous ALC1. Knock-down of ALC1 rendered cells sensitive to UV 
irradiation compared to control cells (figure 7C), indicating that ALC1 protects cells against 
UV-induced cytotoxicity. Likewise, chemical inhibition of PARP also rendered cells UV 
sensitive (supplementary figure 3D), underscoring an important role for PAR synthesis in 
NER. Finally, we directly measured the repair of UV-induced DNA lesions following a UV dose 
of 10 J/m2 by immunostaining using antibodies against 6-4 PPs or CPDs. While the repair 
of 6-4 PP was not significantly affected, we measured a significant reduction in CPD repair 
upon ALC1 depletion or chemical inhibition of PARP1 (figure 7D-E). Corroborating these 
findings, an ELISA-based assay confirmed that knock-down of ALC1 conferred a significant 
reduction in CPD repair (supplementary figure 5). These findings reveal an unanticipated role 
of PAR synthesis and ALC1 in efficient repair of CPDs by human NER.
DiscussioN
Despite detailed insights into the NER reaction and the core proteins involved (Gillet and 
Scharer, 2006;Sugasawa, 2010), the regulatory pathways that govern NER activity in 
living cells are still poorly understood. Among others, these pathways involve the post-
translational modifications of NER proteins and the activity of chromatin remodelling 
enzymes to optimize repair of DNA damage embedded in chromatin. DDB2 is the first 
NER factor to be recruited to UV-induced DNA lesions (Luijsterburg et al., 2007) and it 
regulates NER by direct DNA lesion recognition (Scrima et al., 2008) and modulation of 
chromatin structure (Palomera-Sanchez and Zurita, 2011). We identified PARP1 as a novel 
DDB2-associated factor in UV–irradiated cells The fact that the interaction between these 
factors occurred in non-diving UV-irradiated human fibroblasts excludes the possibility 
that involvement of PARP1 in NER is merely related to the stalling of replication forks 
(Bryant et al., 2009). Although we found PARP1 as a novel DDB2-associated factor, in vitro 
assays with purified proteins revealed that PARP binds to both DDB1 and DDB2 but with 
higher presence for DDB2. 
We found robust synthesis of PAR chains in nuclear regions containing UV-induced 
DNA lesions that was completely suppressed by chemical PARP inhibition. These findings 
directly link PARP1 to the repair of photolesions and fit with previous observations that UV 
irradiation triggers both stimulation of poly(ADP-ribose) synthesis (Cleaver et al., 1983) 
and association of PARP1 with UV-photolesions in chromatin (Vodenicharov et al., 2005). 
Although these findings clearly implicate PARP1 activity in response to UV irradiation, we 
and others (Bryant et al., 2009;Schultz et al., 2003) failed to detect the recruitment of 
endogenous PARP1 to UV-induced DNA lesions or UV-induced stalled replication forks, 
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which is possibly due to transient nature of its interaction or the abundance of PARP1 in 
the nucleus (Krishnakumar and Kraus, 2010).
Our study identified two distinct molecular mechanisms that orchestrate the synthesis 
of PAR chains at UV-induced DNA damage. Firstly, we show that persistent single-stranded 
DNA gaps generated by inhibition of repair synthesis, elicit DDB2-independent PARylation 
at NER sites. However, a possible role of PARylation in regulation of post-incision repair 
has not yet dissected although recruitment of post-incision factor XRCC1, disassembly 
kinetics of NER complexes (Moser et al., 2007) or sealing of UV–induced single-stranded 
DNA gaps was not impaired by PARP inhibition (Cleaver et al., 1983). Secondly and more 
importantly, we show that DDB2 regulates fast and transient PARylation at sites of UV-
induced DNA damage during the pre-incision stage of NER. One target of PARylation is 
DDB2 itself as shown by PARylated DDB2 purified from UV-irradiated cells. It is likely that 
this modification underlies among others the UV-specific occurrence of DDB2 peptides 
of larger than 50 KDa molecular weight in immunoprecipitates of chromatin bound 
DDB2. The initial DDB2-mediated wave of PAR synthesis does not require incision and is 
regulated by the activity of PARG. Indeed, there is increasing evidence that DNA breaks 
are not an absolute requirement for PARP1 activation (Krishnakumar and Kraus, 2010). 
Several alternative mechanisms to activate PARP1 in the absence of DNA breaks have 
been proposed, including interaction with other proteins (Cohen-Armon et al., 2007), 
or post-translational modifications such as phosphorylation, acetylation (Hassa et al., 
2003;Rajamohan et al., 2009), SUMOylation and ubiquitylation (Martin et al., 2009;Messner 
et al., 2009). In this light, it is feasible that the DDB2-associated E3 ubiquitin ligase activity 
(Shiyanov et al., 1999;Groisman et al., 2003) might activate PARP1. At the same time, it 
is possible that PARP1 activation is modulated by DDB2-mediated acetylation through 
its interaction with histone acetyltransferases p300 and the STAGA complex (Datta et al., 
2001;Rapic-Otrin et al., 2002;Martinez et al., 2001). 
molecular mechanisms for DDb2-mediated and pArp1-executed regulation of Ner
Our data provide mechanistic insights into how DDB2 promotes NER in chromatin through 
two novel mechanisms. On one hand, DDB2 is directly targeted by poly(ADP-ribosyl)
ation and ubiquitylation (Fischer et al., 2011) in response to UV irradiation. As PARylation 
(Messner et al., 2010) and ubiquitylation are targeted to lysine and both modifications 
appear to occur in the same N-terminal region of DDB2, competition between PARylation 
and ubiquitylation of target lysine residues might constitute an important mechanism of 
DDB2 mediated regulation of NER. The in vivo data supports a competition model in which 
the poly(ADP-ribosyl)ation of DDB2 results in increased protein stability and a prolonged 
chromatin retention time on the UV lesion. At the same time poly(ADP-ribosyl)ation of DDB2 
suppresses its UV-induced ubiquitylation and consequently leads to reduced degradation 
of DDB2. Together our data disclose a mechanism by which two opposing modifications 
regulate the steady-state levels and retention time of DDB2 at sites of UV-photolesions. 
On the other hand, DDB2-dependent PARylation events also stimulate the pre-incision 
step of NER. We show that DDB2-dependent PARylation through PARP1 at UV-induced DNA 
lesions targets chromatin remodeler ALC1 to these sites. ALC1 belongs to the Swi2/Snf2 
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ATPase superfamily and through its macrodomain, interacts transiently with chromatin 
that is modified by PARP1. We propose that these protein modifications serve to locally 
modulate chromatin structure through PARP1-stimulated nucleosome sliding to promote 
NER (Gottschalk et al., 2009;Ahel et al., 2009). Consistent with this scenario, we show 
that loss of ALC1 or chemical inhibition of PARP1 resulted in defects in the repair of CPDs 
concomitantly with increased sensitivity to UV exposure, underscoring the importance of 
the DDB2-PARP1-ALC1 pathway in promoting NER. We noted that the defects in CPD repair 
due to loss of ALC1 or PARP1 activity are less pronounced than repair defects caused by 
loss of DDB2 (Pines et al., 2009), suggesting that the essential role of DDB2 in CPD repair 
is not solely due to its recruitment of PARP1-mediated activities, but also involves other 
functions of DDB2 such as its ubiquitin ligase activity. Interestingly, XPC contains a putative 
PAR binding sequence (Gagne et al., 2008), suggesting that UV-DDB dependent PAR may 
promote the accessibility of UV lesions through remodeling of the chromatin structure as 
well as providing an enhancer signal for the recruitment of preincision NER proteins.
A model of DDb2 and pArp1 dependent regulation of Ner 
The high affinity of DDB2 for DNA and its preference for UV-damaged DNA makes UV-DDB 
the most important DNA damage recognition factor for 6-4PP and CPD (Wittschieben et 
al., 2005). UV-DDB is the first NER factor to be recruited to UV damage (Luijsterburg et al., 
2007;Nishi et al., 2009) as part of the Cullin-RING ubiquitin ligase (CRL4) complex CUL4A-
RBX1 (Figure7). As shown for 6-4 PP (Scrima et al., 2008), the CUL4A-RBX1 complex binds 
to photolesions by the WD40 domain of DDB2 and in concert with PARP1 tightly regulates 
steady-state levels and retention time of DDB2 by opposing modifications (PARylation 
and ubiquitylation) of the same N-terminal region of DDB2. The enhanced extension time 
of PARylated DDB2 on UV-damage might be particularly important for CPD photolesions 
that induce much less disruption of base pairing interactions than 6-4PP (Kim and Choi, 
1995) and fully depend on functional DDB2 for their repair. Purified (nonPARylated) 
DDB2 recognizes CPD and 6-4PP with a 5 and 80 fold higher affinity respectively than 
nondamaged DNA (Wittschieben et al., 2005); this affinity of DDB2 for CPD might too 
low for productive repair i.e. recruitment of XPC. We speculate that extended binding of 
PARylated DDB2 to CPD will provoke the induction of chromatin modifications at the site of 
DNA damage to allow productive interaction and ubiquitylation of XPC and UV-DDB required 
for NER (Sugasawa et al., 2005). Underscoring the importance of PAR synthesis in the 
assembly of the pre-incision NER complex, we found that PARP inhibition leads to reduced 
recruitment of the pre-incision factor XPC as shown in our recent work (Luijsterburg 
et al., 2012) whereas depletion of PARG stimulates binding of XPC (Luijsterburg et al., 
2012) and TFIIH (data no shown). Whether UV-DDB activates PARP1 through its E3 
ubiquitin ligase activity or whether PARP1 activation occurs in parallel with or precedes 
ubiquitylation is not clear. PARP1 mediated increase of retention time of DDB2 at UV 
damage and DDB2 protection by suppressing its ubiquitylation-dependent degradation 
argue for PARylation as the initiating event. Moreover, PARP1 might create accessibility 
for recruitment of NER factors by its ability to disrupt chromatin structure by PARylation 
of histones and destabilizing nucleosomes (Krishnakumar and Kraus, 2010). Additionally 
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PARylation of chromatin effectuates recruitment of NER promoting factors such as the 
Swi2/Snf2 chromatin remodeler ALC1 to UV damaged DNA to locally modulate chromatin 
structure through nucleosome sliding (Figure 8) thereby stimulating the recruitment of 
XPC to assemble a functional repair complex. Our study also identified DDB2-independent 
PARylation and recruitment of ALC1 at NER sites that is trigged by transient single-
stranded DNA gaps generated by the dual incision step of NER (figure 8); this process of 
PARylation is amplified by inhibition of DNA repair synthesis. The role of PARylation and 
ALC1 in regulation of post-incision step of NER remains to be resolved. 
Figure 8: model of DDb2 and pArp 1 dependent regulation of Ner. UV-DDB is the first NER factor 
to be recruited to UV damage as part of the Cullin-RING ubiquitin ligase (CRL4) complex CUL4A-
RBX1. This complex binds to UV damage and both DDB1 and DDB2 might be involved in binding 
of PARP1. In concert with PARP1, the CUL4A-RBX1 complex tightly regulates steady-state levels 
and retention time of DDB2 by opposing modifications (PARylation and ubiquitylation) of the 
same N-terminal region of DDB2. Additionally, PARP1-dependent PARylation of chromatin also 
effectuates recruitment of the Swi2/Snf2 chromatin remodeler ALC1 to UV damaged DNA in order 
to locally modulate chromatin structure through nucleosome sliding thereby stimulating the 
recruitment of XPC. The second distinct waves of PARylation and ALC1 recruitment requires the 
generation of single-stranded DNA gaps resulting from dual incision.
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eXperimeNtAl proceDures
cell culture and uV-c irradiation
The following cell lines were used for this study: VH10 hTert (normal human fibroblast, 
NHF), XP25RO hTert (XP-A), GM01389 hTert (XP-E), U2OS and MRC5 fibroblast. Cells were 
grown in DMEM supplemented with 10% fetal calf serum, penicillin and streptomycin. Two 
days prior to experiments medium was changed to DMEM supplemented with 0.2% serum 
fetal calf serum, penicillin and streptomycin. UV-radiation of cells was carried out using 
a 254 nm UV-C source. Local irradiation was performed using 5 μm filters as described 
previously (Volker et al., 2001). UV lamp–induced damage was inflicted using a 254 nm UV 
source (TUV PL-S 9W; Philips). For induction of global UV damage, cells were rinsed with PBS 
and irradiated with 8 or 16 J/m2. For induction of local UV damage, cells were UV irradiated 
through a polycarbonate mask (Millipore) with pores of 8 μm and subsequently irradiated 
with 30, or 100 J/m2.The AZ12640831-009 PARPi was used at a final concentration of 10 
mM and was a gift from AstraZeneca. Cells were pretreated 30 minutes before irradiation. 
generation of cell lines
ALC1 and DDB2 cDNA were cloned into vector pENTR4-GFP-C1 (E.Campeau; addgene: 
w392-1) and were subsequently recombined into pLenti6.3 V5-DEST (Invitrogen) using 
gateway recombination. VH10 hTert or XP25RO hTert fibroblasts were transduced with 
pLenti6.3 GFP-ALC1 or pLenti6.3 GFP-DDB2 lentiviral particles and cultured with 5 mg/ml 
blasticidin (Invivogen) to select for integrands.
For DDB2 isolation a 6 His and strepII-tag were fused to the N-terminus of DDB2. A 
synthetic oligo coding for 6His StrepII-tag was inserted into pENTR4 (invitrogen) and DDB2 
cDNA was subsequently cloned in. Lentiviral particles were generated after recombination 
of this vector to pLenti6.3 V5-DEST and used for transducing VH10 hTert cells.
NHF and XP-A fibroblasts stably expressing short hairpin RNA (shRNA) were generated 
by lentiviral transduction of control, ALC1 or DDB2 targeting constructs followed by 1 mg/
ml puromycin selection. The following shRNA vectors were used: TRCN0000013471 (ALC1); 
TRCN0000083995 (DDB2) and SHC002 (non-targeting control) from the RNAi Consortium 
(Sigma-Aldrich).
rNA interference
Short interfering RNA (siRNA) duplexes used were as follows: smartpool siRNA targeting 
the PARG transcript and smartpool non-targeting siRNA (Dharmacon). Cells were 
transfected using Hiperfect (Qiagen) according to the manufacturer’s protocol. For PARG 
knockdown two sequential transfections were performed. Immunostaining and western-
blot experiments were performed 48 hours after the final transfection.
complex isolation
Isolation of DDB2complex was performed according to published procedures with 
some modifications (Groisman et al., 2003). Briefly, cells were irradiated with UV-C 
at 20 J/m2, and incubated for 5 minutes. To prepare nuclear extracts, cells were 
suspended in hypotonic buffer (10 mM Tris-HCl pH 7.3, 10 mM KCl, 1.5 mM MgCl2, 10 
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mM b-mercaptoethanol, and 0.2 mM PMSF) and disrupted by Dounce homogenization. 
Nuclei were collected by centrifugation at 2000g for 15 min at 4°C and resuspended in 
extraction buffer (15 mM Tris-HCl pH 7.3, 1 mM EDTA, 0.21 M NaCl, 1 mM MgCl2, 10% 
glycerol, 10 mM b-mercaptoethanol, and 0.2 mM PMSF). After incubating on ice for 30 
minutes, the samples were centrifuged at 20,000g for 30 min at 4°C, and the supernatant 
was used as the nuclear extract fraction. The nuclear pellet fraction was washed and 
resuspended in the micrococcal nuclease buffer (20 mM Tris-HCl pH 7.5, 100 mM KCl, 2 
mM MgCl2, 1 mM CaCl2, 0.3 M sucrose, 0.1% Triton X-100, and complete protease inhibitor 
cocktail (Roche). Micrococcal nuclease was added at 3 U/ml and the samples incubated 
for 10 min at room temperature, whereupon the reaction was terminated by adding 5mM 
EGTA and 5mM EDTA. The samples were centrifuged at 2000g for 5 min at 4°C, and the 
supernatant was used as the solubilized chromatin fraction. The UV-DDB complex was 
immunoprecipitated from solubilized chromatin prepared from MRC5 cells expressing 
FLAG-DDB2 by incubating with M2 anti-FLAG agarose ovwernight with rotation. After an 
extensive wash with wash buffer (0.1 M KCl, 20 mM Tris-HCl pH 8.0, 5 mM MgCl2, 10% 
glycerol, 1 mM PMSF, 0.1% Tween 20, 10 mM b-mercaptoethanol), the bound proteins 
were eluted from M2 agarose by incubation for 30 min with FLAG peptide (0.2 mg/ml in 
PBS). The elution procedure was repeated three times.
in-gel tryptic digestion
Immunoprecipitates were separated on SDS-PAGE gels, and proteins were visualized with 
Coomassie (SimplyBlue, Invitrogen). Gel lanes were sliced into 25–30 bands, cut into 
small pieces and washed with 25 mM NH4HCO3 followed by two rounds of dehydration 
with 100% acetonitrile for 10 min. For reduction and alkylation, gel particles were first 
incubated with 10 mM dithiothreitol for 30 minutes at 56°C. Following dehydration with 
acetonitrile, gel plugs were subsequently incubated in 55 mM iodoacetamide for 20 
minutes at room temperature. After two rounds of washing with 25 mM NH4HCO3 and 
dehydration with 100% acetonitrile, the gel particles were completely dried in a centrifugal 
vacuum concentrator (Eppendorf, Hamburg, Germany). Dried gel particles were re-swollen 
for 15 min. on ice by addition of 15 µl of a trypsin solution (12.5 ng/µl in 25 mM NH4HCO3, 
Sequencing grade modified trypsin, Promega, Madison, WI). Following this, 20 µl of 25 
mM NH4HCO3 was added and samples were kept on ice for an additional 30 min. Tryptic 
digestion was subsequently performed overnight at 37 °C. Following tryptic digestion, the 
overlaying digestion-solution was collected. Two additional rounds of extraction with 20 
µl 0.1% TFA were used to extract peptides from the gel plugs and all extracts were pooled.
Nano lc esi ms/ms
Nanoflow LC was performed on an Ultimate LC system (Dionex, Sunnyvale, CA). A volume 
of 10 µL of sample was injected onto a C18 PepMapTM 0.3 mm×5 mm trapping column 
(Dionex) and washed with 100% A (2% acetonitrile in 0.1% formic acid in MQ water, v/v) at 
20 µL/min for 15 min. Following valve switching, peptides were separated on a C18 PepMap 
75 µm×150 mm column (Dionex) at a constant flow of 200 nL/min. The peptide elution 
gradient was from 10 to 60% B (95% acetonitrile in 0.1% formic acid in MQ water v/v) over 
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50 min. The nanoflow LC system was coupled to an HCTultra IonTrap (Bruker Daltonics, 
Bremen, Germany) using a nano-electrospray ionisation source. The spray voltage was set 
at 1.2 kV and the temperature of the heated capillary was set to 165 °C. Eluting peptides 
were analyzed using the data dependent MS/MS mode over a 300–1500 m/z range. The 
five most abundant ions in an MS spectrum were selected for MS/MS analysis by collision-
induced dissociation using helium as the collision gas.
mass spectrometry data analysis
Peak lists were generated using DataAnalysis 4.0 software (Bruker Daltonics) and 
exported as Mascot Generic (MGF) files. These files were searched against the human 
IPI database using the Mascot (version 2.2.1) search algorithm (Matrix Science, London, 
UK) An MS tolerance of 0.6 Da (with # 13C = 1) and a MS/MS tolerance of 0.5 Da was 
used. Trypsin was designated as the enzyme and up to one missed cleavage site was 
allowed. Carbamidomethylcysteine was selected as a fixed modification and oxidation of 
methionine as a variable modification. 
immunofluorescent labelling (iF) and western blotting (wb)
The cells were fixed with methanol/acetone (50%/50%) for 10 minutes at 4ºC. After an 
extensive wash with PBS the cells were incubated for 60 minutes at room temperature 
with buffer contains 0.5% BSA and 0.05% Tween-20 in PBS. Antibody incubations were 
performed at room temperature and cells were counterstained with DAPI. Images were 
captured with a Zeiss Axioplan2 microscope equipped with a Zeiss Axiocam MRm camera 
using either a Plan-NEOFLUAR 40×/1.30 or 63×/1.25 objective. Fluorescence intensity of 
randomly captured images was quantified using Zeiss Axiovision software. For total extract 
the cells were lysed directly in Laemli-SDS-sample buffer. Western blot analysis was 
performed as described previously (Fousteri et al., 2006) and protein bands were visualised 
via chemiluminescence (ECL-Plus, Amersham Biosciences) using Horseradish Peroxidase 
(HP)-conjugated secondary antibodies or via Odyssey Infrared Imaging System (LI-COR) 
using secondary antibodies labeled with IR fluorophores (LI-COR). The following antibodies 
were used: mouse α-DDB2 at 1:500 (IF)- 1:1000 (WB) (MyBioSource); mouse α-Parp1 at 
1:1000 (WB) (Abnova); mouse α-Poly (ADP-Ribose) at 1:100 (IF and WB) (Abcam); mouse 
α-ALC1 at 1:500 (IF)- 1:1000 (WB) (Abcam); mouse α-GFP at 1:5000 (WB) (Roche); goat 
α-DDB1 at 1:1000 (WB) (Abcam); goat α-DDB2 at 1:1000 (WB) (Santa-Cruz); rabbit 
α-Poly (ADP-Ribose) at 1:100 (IF and WB) (BD pharmingen); rabbit α-H2B at 1:5000 
(WB) (Santa-Cruz); rabbit α-PARG at 1:1000 (C-term) (WB) (Origene);mouse α-6-4PP 
and α-CPD at 1:1000 (IF) (CosmoBio) Alexafluor 488 and 555 conjugated antibodies were 
purchased from Invitrogen. 
live cell confocal laser-scanning microscopy
Confocal laser-scanning microscopy images were obtained using a confocal microscope 
(LSM 510 META) with a 63× oil Plan Apochromat 1.4 NA oil immersion lens (Carl Zeiss, 
Inc.) equipped with a cell culture microscopy stage. GFP fluorescence imaging was 
recorded after excitation with a 488-nm argon laser and a 515–540-nm band-pass 
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filter. Fluorescence loss in photobleaching (FLIP) was performed as described previously 
(Houtsmuller and Vermeulen, 2001;Zotter et al., 2006). Kinetics of GFP-tagged ALC1, and 
DDB2 accumulation were performed using a UV-C (266 nm) laser irradiation as described 
previously (Dinant et al., 2007). Briefly, VH10-tert cells stably expressing GFP-DDB2 and 
GFP-ALC1 were incubated in CO2-independent microscopy medium (137 mM NaCl, 5.4 mM 
KCl, 1,8 mM CaCl2, 0.8 mM MgSO4, 20 mM D-glucose, 20 mM HEPES and 10% FCS) and 2 mW 
pulsed (7.8 kHz) diode pumped solid state laser emitting at 266 nm (Rapp OptoElectronic, 
Hamburg GmbH) was used for local UV-C irradiation. To determine the dissociation kinetics 
of DDB2 from UV-damaged DNA, the undamaged nucleus was continuously bleached and 
the fluorescence decrease in the local damage was monitored. Relative fluorescence was 
normalized at 100% (before bleach at maximum level of accumulation). The half-time 
(t1/2) of a FLIP curve corresponds to the residence time of a protein molecule in the locally 
damaged area. Images obtained with the confocal microscope were analyzed using AIM 
software (Zeiss). Fluorescence levels were determined for the specified region where 
damage was induced in addition to the complete nucleus. From these datapoints the 
relative amount of protein in the damaged area was determined in time. 
Fluorescence recovery after photobleaching (FrAp)
VH10-tert cells stably expressing GFP-DDB2 were incubated in CO2-independent 
microscopy medium (137 mM NaCl, 5.4 mM KCl, 1,8 mM CaCl2, 0.8 mM MgSO4, 20 mM 
D-glucose, 20 mM HEPES and 10% FCS) supplemented with 1‰ DMSO (mock treatment) 
or 10 µM PARP inhibitor dissolved in DMSO three hours prior to FRAP analysis. Cells were 
subsequently rinsed with PBS, mock-treated or globally UV-C irradiated (10 J.m-2) and 
transferred to the microscope chamber in microscopy medium (supplemented with DMSO 
or PARP inhibitor). Cells were incubated on the microscope chamber at 37° for 10 minutes 
to allow repair proteins to accumulate at UV-induced DNA lesions after which the mobility of 
GFP-tagged NER factors was analyzed by strip-FRAP. Briefly, FRAP analysis was performed 
by bleaching (5 iterations) a narrow strip (512 x 40 pixels at zoom 8) spanning the nucleus 
with maximal 488 nm laser intensity (AOTF 100%). The re-equilibration of bleached and 
non-bleached molecules was monitored in a region of 512 x 50 pixels (zoom 8) with low 
laser intensity (0.5% for GFP-DDB2) for at least 700 images with a 38 ms time-interval 
between images. The data were normalized to pre-bleach intensity (set to 1) and bleach 
depth (set to 0). Three independent experiments were performed for each condition.
uV survival
Cellular survival of VH10 hTert shControl, VH10 hTert shALC1, and XP-A cells was determined 
using a colony assay. Cells were plated in 10-cm and after 16 hours cells were exposed 
to UV-C (254 nm; TUV lamp; Phillips) and left to grow for 14 days, fixed, and stained with 
methylene blue. Colonies were counted to assess the colony-forming ability.
in vitro polyADp-ribosylation assay
The assay was performed according to published procedures (Deng et al., 2005) using 
recombinant proteins purified as described in Fischer et al. (Fischer et al., 2011).
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DDb2 purification
VH10 hTert cells stably expressing 6His StrepII-tag DDB2 were irradiated with UV-C light 
(100 J/m2) or mock-irradiated and incubated for 30 minutes. Cells were collected and lysed 
in lysis buffer (8 M urea, 2 M NaCl, 25 mM Tris pH 8, 1 mM MgCl2, 0.2 % Triton). The lysates 
were diluted ≥ 7 times, after which 25 benzonase units were added per ml. After incubating 
at room temperature for 30 minutes samples were centrifuged at 16,000g for 10 minutes. 
TALON beads (Clontech) were added to the supernatants and incubated for 4 hr at room 
temperature. After an extensive wash with wash buffer (8 M urea, 25 mM Tris pH 8, 1 mM 
MgCl2, 20mM imidazole), the 6His StrepII-tag DDB2 was eluted by overnight incubation 
with the elution buffer (8 M urea, 25 mM Tris pH 8, 500 mM imidazole, 1 % SDS). The elutes 
were concentrated by Vivaspin centrifugal concentrators (Sartorius) and diluted in Strep-
Tactin buffer (100 mM Tris pH 8, 1 mM EDTA, 150 mM NaCl). A second purification step was 
performed using Strep-Tactin spin columns according to the manufacturer’s protocol (IBA). 
Elutes were separated on SDS-PAGE gels, and proteins were visualized by Western-blot.
gFp-DDb2-pArp-1 binding assay. 
U2OS cells transfected with GFP constructs for 24 hours were lysed in denaturing buffer (20 
mM Tris, pH 7.5; 50 mM NaCl; 0.5% NP-40; 1% Sodium Deoxycholate; 1% SDS; 1 mM EDTA, 
Benzonase final conc. 0,25U/μl) containing protease inhibitor cocktails (Roche) and subjected 
to immunoprecipitation with GFP-TRAP beads (Chromotek) for 1 hours at RT. The beads were 
then washed extensively in a buffer (20 mM Tris, pH 7.5; 50 mM NaCl; 0.5% NP-40; 0.5% Sodium 
Deoxycholate; 0.5% SDS; 1 mM EDTA) that disrupts protein-protein interactions, followed by 
two washes in EBC buffer (50 mM Tris, pH 7.5; 150 mM NaCl; 0.5% NP-40; 1 mM EDTA), and 
incubated with 100 ng purified, recombinant PARP-1 (Sigma) for 2 hours at RT. The beads were 
then washed thoroughly in EBC buffer and processed for immunoblotting. 
in vitro co-immunoprecipitation
UV-DDB, dUV-DDB (DDB2 lacking its first 40 N-terminal amino acids), GFP and PARP-1 
recombinant protein were used to test direct interaction in vitro. The reaction volume was 
adjusted to 400 μL in EBC buffer (50 mM Tris, pH 7.5; 150 mM NaCl; 0.5% NP-40; 1 mM 
EDTA), and 0,5 μg of anti-PARP-1 antibody was added. The mixture was incubated and 
rotated at 4°C for 3 hours. The antigen-antibody complex was captured by incubation with 
15 μl of protein A-agarose beads (GE Healthcare) for 2 hr in cold room. The beads were 
washed extensively in EBC buffer,and resuspended in 20 μL of Laemili sample buffer and 
processed for immunoblotting.
Farwestern analysis
100 ng of UV-DDB and 1000 ng of GFP recombinat proteins were separated by SDS-PAGE 
and transferred to a PVDF membrane. The proteins on the membrane were denaturated 
for 10 min with a 6 M guanidine hydrochloride (GuHCl) solution in HBB buffer (10 mM 
HEPES, pH 7.5, 60 mM KCl, 1 mM EDTA and 1 mM DTT). Proteins were then renaturated in 
the same HBB buffer with progressively decreasing GuHCl concentration. The membrane 
was rinsed extensively in HBB and blocked for 1 hour in blocking solution. Following the 
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membrane was incubated with PARP-1 recombinant protein (10 µg/ml) in HBB for 16 h. 
Unbound proteins were removed with extensive washes for 30 min in the same buffer. The 
PARP-1 binding was visualised by Western-blot.
cpD/6-4 pp elisA
Cells were plated in 96 well plates, irradiated with 10 J/m2 UV and incubated for various 
periods to allow cells to repair DNA photolesions. The cells were fixed with methanol/
acetone (50%/50%) for 10 minutes. After an extensive wash with PBS the cells were 
incubated for 3 minutes at room temperature with 10 mM NaOH. The cells were rinsed 
extensively in PBS and incubated for 60 minutes at room temperature with buffer contains 
0.5% BSA and 0.05% Tween-20 in PBS. The plates were sequentially incubated with TDM-2 
or 64M-2 antibodies specific for CDP or 6-4PP, respectively, and secondary antibody 
conjugated with horseradish peroxidase (HRP). After washings, substrate solution Turbo 
TMB-ELISA (Pierce) was added to the plates and incubated for 15-30 min. Absorbance at 
490 nm was measured using a microplate reader after the addition of 2 M H2SO4.
online supplemental material
Table1 shows the proteins identified in Flag immunoprecipitates material from 
FLAG-DDB2 expressing MRC5 cells mock treated or irradiated with UV-C. Fig. S1 shows 
direct interaction in vitro between DDB2 and PARP-1. Fig. S2 shows that the kinetics of 
GFP-DDB2 accumulation were not affected by PARPi or depletion of PARG. Fig. S3 shows 
transient recruitment of GFP-ALC1 to sites of UV-C laser-induced DNA damage. Fig. S4 
demonstrates that single-stranded DNA gaps also triggered robust GFP-ALC1 recruitment 
at later time-points after UV irradiation in normal human as well as in XP-E cells, whereas 
recruitment of ALC1 was absent in dual incision-defective XP-A cells Fig. S5 shows a 
significant reduction in CPD repair upon ALC1 depletion or chemical inhibition of PARP1. 
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table 1. Proteins identified in Flag immunoprecipitates material from FLAG-DDB2 expressing 
MRC5 cells mock treated or irradiated with 20 J/m2 UV-C. A unique peptide is defined as a peptide, 
irrespective of its length, that exists only in one protein of a proteome of interest. 
-UV +UV 
Protein Protein Score Unique peptides Protein Protein Score Unique peptides 
DDB2 274 9 DDB2 305 13 
DDB1 462 24 DDB1 263 16 
PARP1 172 6 CUL4B 221 9 
CUL4B 65 4 PARP1 126 6 
GPS1 65 1 COPS4 103 3 
CUL4A 44 1 CUL4A 83 1 
GPS1 65 1 
COPS7A 64 1 
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Figure 1s. (A) In vitro co-immunoprecipitation. UVDDB, ΔUVDDB (DDB2 lacking its first 40 
N-terminal amino acids) and PARP-1 recombinant proteins were used to test direct interaction 
in vitro. GFP recombinant protein was used as negative control. (b) Far-western assay. UVDDB 
recombinant proteins were separated by SDS-PAGE, transferred to a membrane and incubated 
with PARP-1 recombinant protein (10 µg/ml). The PARP-1 binding was visualised by Western-
blot. GFP recombinant protein was used as negative control. (c) GFP-DDB2-PARP-1 binding assay. 
U2OS cells transfected with the indicated GFP constructs were lysed in denaturing buffer and 
subjected to immunoprecipitation with GFP-TRAP beads. The elute was separated by SDS-PAGE 
and GFP-DDB1 or GFP-DDB2 were isolated from polyacrylamide gels (red square). The proteins 
were subjected to immunoprecipitation with GFP-TRAP beads and incubated with 100 ng purified 
recombinant PARP-1. The beads were processed for immunoblotting.
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Figure 2s. (A) Real-time recruitment of GFP-DDB2 in NHF at the site of DNA damage using 
UV-C (266 nm) laser irradiation. Scale bar represent 7,5µm. (b) NHF cells stably expressing the 
GFP-DDB2 were transfected with the indicated siRNA or treated with PARPi (10μM). 48 hours after 
transfection the cells were UV damaged using UV-C (266 nm) laser irradiation. GFP fluorescence 
intensities at the site of UV damage were measured by real time imaging until they reached a 
maximum. Assembly kinetic curves were derived from at least six cells for each protein. Relative 
fluorescence was normalized at 0 (before damage) and 100% (maximum level of accumulation). 
Error bars indicate SEM. (c) In vitro PARylation experiments using purified components. Antibody 
against the N-terminal of DDB2 revealed that DDB2 is directly modified by PARP1. DDB2 lacking its 
first 40 N-terminal amino acids (dUV-DDB) was not detectable.
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Figure 3s. (A) Real-time recruitment of GFP-ALC1 in NHF in presence or absence of PARPi (10μM) 
at the site of DNA damage using UV-C (266 nm) laser irradiation. Scale bar represent 7,5µm. (b) 
NHF cells stably expressing GFP-ALC1 were infected with the indicated short hairpin RNA. The cells 
were UV damaged using UV-C (266 nm) laser irradiation. GFP fluorescence intensities at the site of 
UV damage were measured by real time imaging until they reached a maximum. Assembly kinetic 
curves were derived from at least six cells for each protein. Error bars indicate SEM. Scale bar 
represent 20µm. (c) Anti-DDB2 and histone H2B western blots of total lysates from NHF and XP-A 
cells expressing shRNAs targeting DDB2 or a non-targeting shControl (mock). (D) Clonal survival of 
UV-irradiated NHF cells in presence or absence of PARPi (1μM). The percentage of surviving cells is 
plotted against the applied UV-C dose (J/m2). The results are from three independent experiments; 
Error bars indicate standard deviation. (e) Anti-PARG and histone H2B western blots of total lysates 
from XP-A, XP-E and NHF transfected with siRNA targeting PARG or a non-targeting siControl (mock).
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Figure 4s. (A) NHF, XP-E and XP-A cells stably expressing GFP-ALC1 transfected with indicated 
siRNA or treated with HU/AraC were locally UV exposed to 30 J/m2, fixed after the indicated time 
and stained with an antibody recognizing TFIIH. Scale bars represent 20µm. (b) The percentage of 
colocalization of GFP-ALC1 with TFIIH in NHF, XP-A and XP-E cells after 0,5 hours UV local damage 
is plotted for the different siRNA transfections and HU/AraC treatment. The results are from three 
independent experiments in which about 100 cells per condition were analysed; Error bars indicate 
standard deviation. (c) The percentage of colocalization of GFP-ALC1 with TFIIH in NHF, XP-A and 
XP-E cells after 5 minutes UV local damage is plotted for the different siRNA transfections and HU/
AraC treatment. The results are from three independent experiments in which about 100 cells per 
condition were analysed; Error bars indicate standard deviation. The data shown are from a single 
representative experiment out of three repeats.
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Figure 5s. (A-b) NHF cells expressing shControl or shALC1 or treated with PARPi (10μM) were 
irradiated with 10 J/m2 UV-C; CPDs and 6-4 PPs were detected immediately and 24 or 2 hours 
respectively after UV treatment by ELISA assay. Error bars indicate standard deviation. (c-D) XPE 
cells siRNA transfected or treated with PARPi (10μM) were irradiated with 10 J/m2 UV-C; CPDs and 
6-4 PPs were detected immediately and 24 or 2 hours respectively after UV treatment by ELISA 
assay. Error bars indicate standard deviation. The results are from three independent experiments.
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AbstrAct
Activation of signaling pathways by UV light is a key event in the DNA damage response 
and initiated by different cellular processes. Here we show that non-cycling nucleotide 
excision repair (NER) proficient cells initiate a rapid but transient activation of the damage 
response proteins p53 and H2AX; in contrast, repair deficient cells display delayed but 
persistent signaling and additionally inhibition of cell cycle progression upon release 
from G0 phase. In the absence of repair, UV-induced checkpoint activation coincides with 
the formation of single strand DNA breaks by the action of endonuclease Ape1. Although 
temporally distinct, activation of checkpoint proteins in NER proficient and deficient 
cells depends on a common pathway involving the ATR kinase. These data reveal that 
damage signaling in non-dividing cells proceeds via NER dependent and independent UV 
photolesion processing through generation of DNA strand breaks ultimately preventing 
the transition from G1 to S phase.
88
iNtroDuctioN 
Bulky DNA helix distorting lesions such as UV-induced cyclobutane pyrimidine dimers (CPD) 
or 6-4 photoproducts (6-4PP), will interfere with replication and transcription resulting 
in cell death and enhanced mutagenesis (Latonen and Laiho, 2005;Lehmann, 2000). The 
mammalian genome is protected against genotoxic insults by a network of DNA damage 
response (DDR) mechanisms initiated by sensing of DNA damage or chromatin alterations 
through specific sensors. The next stage in the process is to transmit the signal to transducers 
that are able to pass the signal to effectors that control various protective pathways i.e. DNA 
repair, cell cycle checkpoints, apoptosis, transcription and chromatin remodelling. To date, 
nucleotide excision repair (NER) pathway is the only known pathway capable of removing 
CPD and 6-4PP lesions from DNA in human cells. NER consists of the global genome repair 
pathway (GG-NER) and the transcription coupled repair pathway (TC-NER) that remove 
lesions throughout the genome or specifically from the transcribed strand of actively 
transcribed DNA respectively. Defects in GG-NER are associated with the genetic disorder 
xeroderma pigmentosum (XP), for which 7 disease causing genes have been identified (XP-A 
through XP-G). Defects in TC-NER are associated with Cockayne syndrome (CS), a disorder 
that is clinically distinct from XP (de Boer and Hoeijmakers, 2000). 
Activation of the cell cycle checkpoints by signal transduction cascades depends on 
members of the phosphoinositol-3-kinase-like kinase family such as the ATM and ATR 
proteins. Once activated, these kinases phosphorylate downstream targets that are part 
of the DDR like p53 and histone H2AX. In addition, ATR and RNF-8 dependent ubiquitylation 
of histone H2A is an integral part of the UV-induced DDR (Bergink et al., 2006;Marteijn 
et al., 2009). Impaired initiation of signaling, as is the case for ATM and ATR-Seckel cells 
defective in ATM and ATR signaling respectively, results in impaired DNA damage induced 
checkpoint activation (Shiloh, 2003;Alderton et al., 2004). Although both kinases appear 
to have many downstream targets in common, they are activated by different events. 
Whereas ATM becomes activated upon the formation of DNA double strand breaks (DSBs), 
ATR signals after replication fork stalling. This latter signaling is thought to be mediated 
via the single stranded DNA binding protein complex RPA and the subsequent recruitment 
of ATR to these sites via its binding partner ATRIP. Although activation of the ATR pathway 
upon UV exposure was initially shown to occur in S phase cells, later experiments indicated 
this pathway also to be activated in non-dividing human fibroblasts in response to UV 
(O’Driscoll et al., 2003). In the G0/G1 phase of the cell cycle UV-induced checkpoint activation 
has been reported to depend on active NER (Marini et al., 2006;Marti et al., 2006;Hanasoge 
and Ljungman, 2007). One of the essential components in the NER pathway is the RPA 
complex (Araujo et al., 2000). It has been proposed that during NER RPA containing single 
stranded DNA gaps are formed which are substrates for the ATR/ATRIP complex thereby 
initiating the damage signaling (Matsumoto et al., 2007). 
Recent experiments have implicated ATR in the DDR following transcription 
blockage through exposure to UV or transcription blocking chemicals (Jiang and Sancar, 
2006;Derheimer et al., 2007). When exposed to UV, serine 15 phosphorylated p53 
accumulates in normal cells and this is much more pronounced in cells that lack TC-NER 
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such as CS-B and XP-A cells (Ljungman et al., 2001). The ability of XPA deficient cells to 
promote this damage response demonstrates that this response is independent of NER 
induced incisions. It is conceivable that stalled RNA polymerase complexes could adopt 
a chromatin configuration facilitating RPA mediated activation of the ATR kinase. Indeed, 
alterations in the structure of chromatin have previously been proposed to initiate checkpoint 
signaling (Bakkenist and Kastan, 2003). However, whether UV-induced chromatin alterations 
can directly activate the DDR without prior processing of the UV-lesion, has not been fully 
resolved. Most experimental data indicate that initial lesion recognition or processing by 
either transcription, replication or NER is required in order to trigger checkpoint signaling 
by UV-light. Nevertheless, assembly of checkpoint damage sensors at non-processed UV 
damage sites has also been reported (Jiang and Sancar, 2006). Furthermore, experiments 
using Saccharomyces cerevisiae indicated that UV induced checkpoint activation can occur 
independent of replication or NER (Zhang et al., 2003;Giannattasio et al., 2004) initiated by 
breakage of DNA strands possibly due to spontaneous decay of damaged DNA (Giannattasio 
et al., 2004). Also, non-dividing NER deficient XP-A cells have been shown to accumulate 
PCNA foci late after UV irradiation by an unknown mechanism (Miura et al., 1992).
Here we investigate the DDR in non-dividing cells after UV exposure. We show that 
repair proficient and repair deficient cells display a distinct, but temporally different 
damage response after UV-C irradiation. In both normal and GG-NER deficient cells this 
response depends on the ATR kinase and results in activation of the G1 checkpoint. In the 
absence of repair, the UV-induced checkpoint activation coincides temporally with the 
formation of single strand breaks as well as damage specific recruitment of the chromatin 
binding factors PCNA, gH2AX and TopBP1. We demonstrate that this process depends, at 
least in part, on the activity of Ape1. Our data supports a model of checkpoint activation 
in the absence of repair as a consequence of NER independent UV lesion processing that 
ultimately prevents the transition from G1 to S phase. 
results
enhanced uV-induced damage signaling in quiescent fibroblasts deficient in gg-Ner and 
tc-Ner
To examine how UV-induced DNA lesions activate the DNA damage response (DDR) in non-
dividing cells, we measured p53 and serine 15 phosphorylated p53 levels in normal, CSB and 
XPC deficient human fibroblasts following treatment with UV-C light. We checked the non-
dividing state of the primary human fibroblasts after reaching confluence by BrdU or EdU 
labeling: the frequency of positive cells amounted less than 4% depending on the cell strain 
used. Two hours after exposure to 8 J/m2 of UV, repair proficient normal human fibroblasts 
(NHF) displayed an induction of phosphorylated p53 (Fig. 1A), but at later time points the 
levels of p53 phosphorylation were reduced. In contrast, exposure of CSB deficient cells 
lacking functional TC-NER resulted in both phosphorylation and accumulation of p53 that 
was most pronounced between 8 and 72 hours after UV exposure (Fig. 1A). These data are 
consistent with previous reports demonstrating that both active GG-NER and persistent 
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transcription blockage by UV activate p53 (Ljungman et al., 2001;Yamaizumi and Sugano, 
1994;Marini et al., 2006). To determine if UV lesions activate the DDR independently of 
GG-NER or UV-induced transcription blockage, we examined GG-NER deficient XP-C 
fibroblasts that repair transcribed DNA and can overcome RNA polymerase stalling. In 
XP-C cells the amount of phosphorylated p53 was marginally enhanced 2 hours after UV 
exposure, but steadily increased up to 72 hours (Fig. 1A). The increase in phosphorylation 
went together with an increase in the total level of p53 as well as induced expression of the 
G1/S checkpoint regulator protein p21. Prolonged activation of this checkpoint cascade 
was also observed in XP-A cells lacking both GG-NER and TC-NER (Fig. 1A). Although both 
XP-A and CS-B cells efficiently accumulated p53 and p21, a reduction in protein levels 
was observed at 72 hours post UV. This reduction coincided with increased cell death 
as shown by activated caspase 3 (Fig. 1A) which is a consequence of their deficiency in 
TC-NER (Andera and Wasylyk, 1997;Ljungman and Zhang, 1996). No decrease in viability 
was observed in either normal or XP-C cells. Despite the absence of GG-NER in XP-C cells, 
the repair of transcribed DNA in these cells is as efficient as in normal cells (Venema et al., 
1991). These results therefore suggest that non-repaired UV lesions provoke a checkpoint 
response independent of both NER and DNA replication.
Xp-c cells are arrested in g1 after uV
We hypothesized that the constitutive phosphorylation of p53 and the upregulation of p21 
in XP-C cells after UV would impact the G1 to S phase transition when cells are stimulated 
to divide. In contrast, the transient upregulation of p53 and p21 in normal repair proficient 
cells is expected to only temporarily delay cell cycle progression. To test this hypothesis, 
normal and XP-C cells were arrested in the G0/G1 stage of the cell cycle by serum starvation 
and subsequently stimulated to enter S phase by reintroducing serum. Next, we analyzed 
the cell cycle distribution in normal and XP-C cells after different recovery periods following 
UV irradiation or mock treatment (Fig. 1B). Mock treated normal and XP-C cells enter S 
phase 15 hours after release from the low serum block. When cells were UV-irradiated at 
the G1/S transition, both normal and XP-C cell populations showed a significant fraction 
of cells progressing into S phase despite the presence of UV-photolesions (Fig. 1C and 
supplementary figure S6). UV irradiation of normal human cells just prior to serum block 
removal, resulted in a reduced progression into S phase when compared to cells exposed 
just before S phase entry. This was unexpected, as normal cells will repair a large fraction 
of the UV-photolesions during the intervening 15 hours. The reduced S phase entry 
therefore most likely reflects the transient upregulation of checkpoint proteins in normal 
cells. Extended incubation of normal human cells in G0 after UV exposure reduces the level 
of phosphorylated p53 and p21 and lead to unperturbed entry of normal cells into S phase 
(Fig. 1C). XP-C cells, however, were strongly arrested in G1, when irradiated just prior to 
serum block removal, with only few cells reaching S phase. Moreover, the impaired S phase 
entry could not be alleviated by allowing the cells more time to recover after UV exposure 
(Fig. 1C), demonstrating that S phase entry of XP-C cells was persistently restricted 
following UV exposure. This cell cycle block coincided with the extended induction of the 
checkpoint proteins p53 and p21 in XP-C cells as shown in Fig 1A. 
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Figure 1: The p53 signaling pathway is activated in confluent fibroblasts deficient in GG-NER, 
TC-NER or both subpathways. (A) Confluent normal human fibroblasts (NHF), CS-B, XP-A and 
XP-C fibroblasts were exposed to 8 J/m2 UV-C and analyzed 2, 8, 24, 48 and 72 hours later with 
the indicated antibodies. The lane denoted with minus (-) sign indicates unexposed sample. (B) 
Schematic overview of the experiment design for flow cytometry. Confluent NHF and XP-C cells 
were maintained in G0 by low serum (0.2% FBS). At various times samples were irradiated with 8 J/
m2, as indicated by lightning bolts. At time 0 hr medium containing 20% FBS and EdU was added to 
all samples with the exception of the G0 control. At times 0 hr and 15 hr mock irradiated samples (fix 
0 hr, fix 15 hr) were fixed to validate the absence of S phase cells. All UV exposed samples, as well as 
an unexposed control (fix 24 hr) were collected at time 24 hr. (C) XP-C cells are blocked in G1 after 
UV exposure. Bar graph indicating the progression from G0/G1 to S phase relative to the unexposed 
control NHF and XP-C cells (fix 24 hr) as determined by EdU incorporation. Values were normalized 
by setting the S phase population in unexposed cells to 100%. The percentage of S phase cells (not 
normalized) in unexposed NHF and XP-C samples (fix 24 hr) was 67% and 34% respectively.
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persistent phosphorylation of histone h2AX in uV-irradiated gg-Ner deficient cells
Activation of the cell cycle checkpoints by signal transduction cascades depends on members 
of the phosphoinositol-3-kinase-like kinase family such as the ATM and ATR proteins. Once 
activated, these kinases phosphorylate downstream targets that are part of the DDR like p53 
and histone H2AX. In repair proficient human cells histone H2AX is phosphorylated following 
the formation of DSBs and during apoptosis, but also after UV exposure of both dividing and 
stationary cells (Marti et al., 2006;Ward and Chen, 2001). We locally UV-irradiated quiescent 
repair proficient and deficient fibroblasts to examine phosphorylation of H2AX. Shortly after 
local UV irradiation repair proficient human cells displayed H2AX phosphorylation (gH2AX) 
at the UV spots, but this phosphorylation disappeared in time (Fig. 2A) most likely due 
to excision of UV photoproducts. This rapid phosphorylation was absent in XPA and XPC 
deficient cells, however, gH2AX became clearly visible in local UV-spots at later time points 
(24 and 48 hours). At these late time points the frequency of colocalization of UV spots 
(CPD) with gH2AX (Fig. 2B) in XP-A and XP-C cells was 98% or more. Similar results (Fig. 
2C) were obtained with NER deficient primary mouse dermal fibroblasts derived from XPA-/- 
knock out mice (Nakane et al., 1995;de Vries et al., 1995) although the gH2AX signal was 
lower at 1.5 hours after UV relative to human cells, possibly due to low DDB2 expression in 
mouse cells (Pines et al., 2009). Together these data provide evidence for the existence of 
an additional DNA damage signaling route independent of stalled replication forks or active 
NER (Marini et al., 2006;Marti et al., 2006;Ward and Chen, 2001).
To check whether delayed phosphorylation of H2AX is a general feature of cells lacking 
functional NER proteins, we quantified the amount of immunostained gH2AX. In normal 
human cells H2AX became phosphorylated within 90 minutes following UV exposure (8 
J/m2) and returned to control level within 24 hours (Fig. 2D and supplementary fig. S1). 
Similar to normal cells, XP-E cells (proficient for TC-NER but defective in GG-NER of CPD) 
(Hwang et al., 1999) and CS-B cells are capable of forming gH2AX within 90 minutes after 
UV (Fig. 2D), most likely reflecting their ability to efficiently remove 6-4PP. In contrast, both 
XP-A and XP-C cells failed to display gH2AX during the first 90 minutes post UV; instead, 
a strong gH2AX signal appeared in both cell strains 24 and 48 hours after UV exposure. 
In XP-C cells the amount of gH2AX continued to increase up to 48 hours, although at 24 
hours the level of gH2AX was lower when compared to XP-A cells. 
Interestingly, despite having defects in NER, neither XP-E nor CS-B cells displayed persistent 
H2AX phosphorylation even though the absence of a functional TC-NER pathway in CS-B cells 
resulted in robust activation of checkpoint proteins (Fig. 1A), (Ljungman et al., 2001). The 
delayed formation of gH2AX in XP-A and XP-C cells is therefore more likely a consequence of 
impaired GG-NER. Corroborating this, we also observed gH2AX 24 hours after UV in XP-F and 
XP-G cells, both of which have a defect in the GG-NER pathway (Supplementary Fig. S1).
the Atr-topbp1 pathway is activated in both normal and gg-Ner deficient cells
H2AX is a known phosphorylation target of the ATM, ATR and DNA-PKcs kinases. Using 
immunofluorescence we quantified gH2AX in normal, AT (deficient in ATM) and ATR-Seckel 
(deficient in ATR) cells following UV exposure. Whereas quiescent AT cells phosphorylated H2AX 
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Figure 2: histone h2AX is persistently phosphorylated in gg-Ner deficient cells. (A) Confluent 
NHF, XP-A and XP-C fibroblasts were locally exposed to 20 J/m2 UV-C and immunostained for 
gH2AX at the indicated times. (b) Local irradiated XP-C cells (20 J/m2) showing co localization of 
gH2AX with CPD. Ki67 negative staining shows gH2AX formed in non cycling cells. (c) Confluent 
mouse XPA+/- and XPA-/- dermal fibroblasts locally exposed to 20 J/m2 UV-C and immunostained for 
gH2AX at indicated times. (D) Confluent fibroblasts were globally irradiated with 8 J/m2 UV-C and 
immunostained for gH2AX and ki67. The gH2AX signal intensity was determined for ki67 negative 
cells. Histograms are means of at least three independent experiments. Error bars indicate SEM.
as efficiently as normal cells upon UV, gH2AX formation was severely impaired in ATR-Seckel 
cells (Fig. 2D) in agreement with previous reports (Matsumoto et al., 2007;O’Driscoll et al., 
2003). Next we identified the kinase responsible for delayed UV-dependent phosphorylation 
of H2AX in GG-NER deficient cells. Treatment of XP-C cells with the ATM kinase specific 
inhibitor KU55933 did not impair UV-mediated phosphorylation of H2AX (Supplementary Fig. 
S1). As ATR is activated after UV in NER proficient cells we tested if a similar, albeit delayed, 
activation occurs in NER deficient cells. siRNA mediated knockdown of ATR in normal human 
cells (Supplementary Fig. S1) resulted in a reduction of H2AX phosphorylation similarly to 
ATR-Seckel cells (Fig. 3A). Depletion of ATR in XP-C cells also resulted in a profound reduction 
in gH2AX levels 24 hours following UV exposure, establishing a role for ATR kinase in delayed 
DNA damage signaling. This conclusion is further corroborated by siRNA mediated depletion 
of TopBP1 (Supplementary Fig. S1), an ATR interacting protein and crucial activator of the 
ATR kinase during replication stress (Kumagai et al., 2006;Delacroix et al., 2007). Following 
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exposure to UV-light, both normal and XP-C cells treated with TopBP1 siRNA failed to 
phosphorylate H2AX, whereas control siRNA did not affect gH2AX formation (Fig. 3A). These 
data indicate that NER dependent repair of UV lesions as well as persistent non-repaired UV 
lesions initiate checkpoint signaling by an ATR and TopBP1 dependent pathway. 
Using immunofluorescence we were unsuccessful to visualize the recruitment of ATR 
or its binding partner ATRIP to sites of local UV damage in either normal or XP-C cells. 
Possibly, low levels of target protein or insufficient affinity of antibodies prevented the 
detection of minor changes in protein distribution. Despite the inability to detect ATR 
and ATRIP, we did observe a UV dependent colocalization of TopBP1 with gH2AX in normal 
human cells one hour after local UV exposure (Fig. 3B). At this time point neither TopBP1 
nor gH2AX spots were visible in XP-C cells. In contrast, gH2AX and TopBP1 co-localized in 
UV spots in XP-C cells 24 hours after treatment.
The binding of ATR and ATRIP to DNA is mediated by the single stranded DNA binding 
protein complex RPA (Zou and Elledge, 2003). Apart from its function in ATR checkpoint 
activation, RPA is a core component of NER. In both normal and XPA deficient cells 
RPA localized at local UV-damage within 30 minutes after irradiation, whereas no such 
localization was found in XP-C cells (Rademakers et al., 2003) (Fig. 3C). XP-A and XP-C cells 
differ in the compositions of preincision NER complexes. Whereas XP-A cells are capable to 
assemble an abortive preincision complex including RPA (Volker et al., 2001;Rademakers 
et al., 2003), XP-C cells only recruit DDB2 (Wakasugi et al., 2002). However, RPA was 
recruited to local UV spots in XP-C cells 24 hours after UV demonstrating a central role 
for RPA in UV damage signaling in both normal and GG-NER deficient cells. In spite of this, 
reduction of ATR activity has no impact on NER, as removal of 6-4PP lesions in ATR-Seckel 
cells was as efficient as in normal cells (Supplementary Fig. S2).
gg-Ner deficient cells accumulate DNA breaks
The UV-dependent checkpoint response in GG-NER cells implicates a direct activation by 
UV lesions in chromatin, or activation as a consequence UV lesion processing. Because 
DNA damage mediated H2AX phosphorylation is generally associated with chromatin 
containing either single strand gaps or DSBs, we examined the presence of UV induced 
DNA breaks by the alkaline comet assay. In NER proficient cells increased DNA tailing was 
detected one hour after exposure to UV, indicating the presence of DNA breaks (Fig. 4A). 
No increased tailmoments were observed in either XP-A or XP-C cells, indicating that the 
breaks in normal cells represent incisions by NER. As expected, only relatively few breaks 
were detected in normal cells 24 hours after 8 J/m2 of UV, when repair of UV-photolesions 
is almost complete. In contrast, both XP-A and XP-C cells accumulated DNA breaks 24 
hours post treatment. As the alkaline comet assay detects both single as well as double 
stand DNA breaks, pulsed field gel electrophoresis was performed to specifically detect 
DSBs in UV-irradiated cells. However, this analysis revealed no clear differences between 
normal and XP-C cells (Supplementary Fig. S3). We note here that, due to the limited 
sensitivity of the assay low frequencies of DSBs will not be detected.
Upon exposure to ionizing radiation (IR) gH2AX is known to form nuclear foci that are 
thought to represent sites of DSBs. Comparison of the nuclear distribution of gH2AX in 
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IR and UV treated normal and XP-C cells revealed a clear difference. Whereas one Gy of 
IR induced few but distinct large nuclear foci, UV exposure resulted in a more granular 
appearance of gH2AX consisting of many small and less intense nuclear foci when 
compared to IR induced foci (Fig. 4B). We observed no difference in morphology between 
gH2AX nuclear staining in normal cells 1.5 hour after UV exposure and XP-C cells 24 hours 
after UV exposure, consistent with the UV induced activation of the ATR/TopBP1 pathway in 
both normal and XP-C cells. Together these data show that upon UV exposure DNA breaks 
are generated in cells deficient in GG-NER. Furthermore, the comet assay, the dependence 
on ATR as well as the morphological appearance of the gH2AX foci all suggest that the 
majority of these DNA breaks are single stranded. 
Figure 3: the Atr-topbp1 pathway is activated in both normal and gg-Ner deficient cells. (A) 
gH2AX formation in cells treated with control, ATR or TopBP1 siRNA and either non-exposed or 
irradiated with 8 J/m2 UV-C. NHF and XP-C cells were immunostained 1.5 and 24 hours after 
exposure respectively (b) Immunolocalization of gH2AX and TopBP1 after local irradiation with 20 
J/m2. NHF and XP-C cells were stained 1.5 and 24 hours after treatment. (c) Immunolocalization 
of RPA after local exposure to 20 J/m2 UV-C.
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Figure 4: gg-Ner deficient cells accumulate DNA breaks. (A) Stand-break induction after exposure 
to 8 J/m2 UV-C measured by alkaline comet assay. Breaks were quantified as comet tailmoments. 
Histograms are the means of at least three independent experiments ± SEM (b) gH2AX formation 
after 1 Gy IR (0.5 hour) and UV. NHF and XP-C cells were irradiated with 8 J/m2 UV-C and stained 
1.5 hour and 24 hours later respectively. 
DNA synthesis factors are recruited to uV damage in gg-Ner deficient cells
To gain further insight into the mechanism leading to DNA break formation in XP-C cells 
we investigated the recruitment of various repair proteins to sites of UV damage. Upon 
replication fork stalling the DNA repair proteins RAD51, BRCA1 and FANCD2 form nuclear 
foci (Tibbetts et al., 2000;Pichierri and Rosselli, 2004), but non of these proteins were 
recruited to local UV-spots in non-dividing normal or XPC deficient cells (Supplementary 
Fig. 4). However, chromatin bound PCNA was recruited early after UV irradiation in normal 
human cells whereas PCNA binding in XP-A and XP-C cells was delayed (Fig. 5A).
PCNA is involved in NER by facilitating the loading of DNA polymerases on chromatin 
(Shivji et al., 1992). Indeed, concomitant with PCNA we found DNA polymerase d (pol d) to be 
recruited to local UV-spots in both normal and repair deficient cells (Fig. 5A). Unexpectedly, 
western blot analysis for PCNA in UV-exposed chromatin fractions revealed high molecular 
weight PCNA (Fig. 5B) co-migrating with ubiquitinated PCNA from UV-exposed cycling cells 
(Kannouche et al., 2004;Ogi et al., 2010). In S phase cells PCNA ubiquitination activates 
translesion synthesis (TLS) (Hoege et al., 2002). Also in quiescent repair deficient cells 
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we found a pronounced accumulation of the TLS polymerase η (pol η) at local UV-spots 
late after exposure (Fig. 5C). We note here that also in normal cells some pol η and PCNA 
localized at damaged DNA 24 hours after UV, particularly at high UV doses (Fig. 5C). 
Although we were unable to detect DNA synthesis 24 hours after UV using BrdU, consistent 
with previous findings (Miura et al., 1992), a low level of incorporation was detected by EdU 
labeling in line with the recruitment of pol d and pol η in XP-A cells (supplementary Fig. S6).
DNA break induction in uV-irradiated Xpc cells is mediated by Ape1
We focused on Ape1 as a possible candidate to incise UV irradiated chromatin of NER 
deficient cells. Although Ape1 is the major endonuclease in base excision repair (BER), it 
has also been implicated in repair of oxidatively damaged bases and exocyclic bulky DNA 
lesions by a process termed nucleotide incision repair (NIR) (Daviet et al., 2007;Ischenko and 
Saparbaev, 2002). Moreover, the observation that XPC-/- mice with one functional Ape1 allele 
displayed an increased predisposition to UVB-induced skin cancer (Cheo et al., 2000) points 
to a role of Ape1 in UV lesion processing. We used siRNA to deplete Ape1 to assess a potential 
role in the generation of DNA breaks in NER deficient cells. A limited depletion of Ape1, in the 
order of 50%, resulted in markedly lower levels of gH2AX and chromatin associated PCNA in 
UV-irradiated XP-C cells (Fig. 6A). Single cell analysis confirmed that cells expressing low 
amounts of Ape1 have reduced levels of gH2AX (Supplementary Fig. S5) and alkaline comets 
revealed significantly fewer breaks in Ape1 depleted cells when compared to non-depleted 
cells (Fig. 6B). To establish a direct activity of Ape1 on UV damaged DNA we performed an 
in vitro endonuclease activity assay using purified Ape1 protein. As shown in Fig. 6C, Ape1 
incised an oligonucleotide containing a single 6-4PP albeit with low efficiency, whereas an 
identical non-damaged oligonucleotide remained uncut. The incised fragment was identical 
in size as the UVDE cut 6-4PP oligonucleotide, indicating that Ape1 incises, primarily, 
directly 5’ of the lesion. Cutting of a single CPD containing oligo was very much reduced 
when compared to an oligo harboring a 6-4PP (Fig. 6C). These results are consistent with 
the finding that in vivo photoreactivation of CPD had no effect on gH2AX formation whereas 
photoreactivation of 6-4PP strongly reduced the gH2AX formation (Fig. 6D). Together these 
data demonstrate the ability of Ape1 to incise UV damaged DNA in vivo particularly at 6-4PP. 
DiscussioN 
persistent uV damage triggers the DDr in non-dividing mammalian cells
UV light provokes an ATR kinase mediated damage response initiated by stalled replication and 
transcription as well as repair. Although transcription arrest and GG-NER have been identified 
as events that elicit phosphorylation of p53 (Ljungman et al., 2001;Marini et al., 2006), these 
studies only addressed early events following damage induction (i.e. up to 8 hours). In this 
study we examined the damage response for more extended time periods. We show that also 
a deficiency in GG-NER is sufficient to activate the DDR in UV-irradiated non-dividing XP-C 
and XP-A cells. Checkpoint proteins p53 and p21 continued to accumulate in time in TC-NER 
proficient XP-C cells without apparent cell death consistent with other findings (McKay et al., 
2000). We propose that in the absence of stalled replication and transcription, non-repaired 
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Figure 5: DNA synthesis factors are recruited to uV damage in gg-Ner deficient cells. (A) UV 
dependent localization of Triton X-100 insoluble PCNA and pol d in NHF, XP-A and XP-C cells after 
local exposure to 20 J/m2 UV-C. (b) PCNA western blot of NHF and XP-C chromatin fractions either 
mock treated or exposed to 8 J/m2 UV-C. (c) UV dependent localization of Triton X-100 insoluble 
PCNA and pol η in NHF, XP-A and XP-C cells after local exposure to 20 J/m2 or 60 J/ m2 UV-C.
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UV photolesions elicit an ATR dependent damage signaling response ultimately preventing 
G0/G1 cells to enter S phase upon proliferation stimulus. It is very unlikely that the dominant 
mechanism to activate ATR in nondividing XP-A and XP-C cells is the direct recognition 
of UV lesions by checkpoint proteins. Based on in vitro experiments Choi et al (Choi et al., 
2007) suggested that ATR in the presence of TopBP1 is capable to phosphorylate Chk1 in the 
presence of DNA containing bulky base lesions such as the UV mimicking lesion N-acetoxy- 
acetylaminofluorene adduct. Two observations strongly argue against this mechanism: 
Figure 6: DNA break induction in uV-irradiated Xp-c cells is mediated by Ape1. (A) Western blot 
of XP-C cells following treatment with Ape1 siRNA. Soluble and chromatin fractions were obtained 
24 hours after either mock treatment or exposure to 8 J/m2 UV-C. (b) DNA break induction in XP-C 
cells either mock treated or treated with Ape1 siRNA. Alkaline comets were measured 48 hours after 
exposure to UV-C and are the average of four independent experiments. Statistical analysis using 
Student’s t-Test shows P<0.046 for UV exposed cells (P<0.05 was considered significant). Error 
bars indicate SEM. (c) Endonuclease activity assay on 30 mer oligonucleotides either undamaged 
or with a defined 6-4PP or AP site. Samples were either mock treated or incubated with purified 
Ape1 or UVDE. (D) Confluent XP-C cells were infected with lentivirus expressing either 6-4PP 
photolyase (top panel) or CPD photolyase (bottom panel). Cells were irradiated with 10 J/m2 and 
photoreactivated for 1 hour. 48 hours after UV cells were fixed and stained either for gH2AX and 
6-4PP (top panel) or gH2AX and CPD (bottom panel). Arrows indicate cells that photoreactivated 
UV lesions. Approximately 10 cells were examined for both photolyases. 
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firstly, the absence of TopBP1 localization at UV damaged DNA at early times in vivo and 
secondly, the slow kinetics of checkpoint activation in XP-C cells. 
single strand DNA gaps trigger the DDr
A likely explanation for the checkpoint activation is the accumulation of single strand DNA 
gaps in XP-C and XP-A cells despite their repair defect. Single stranded DNA coated with 
RPA is the archetype structure for activating the ATR kinase. RPA coated single stranded 
DNA gaps formed during NER provoke a signaling reaction as demonstrated by the rapid 
induction ATR mediated damage signaling in repair proficient cells (Matsumoto et al., 2007). 
Our data reveals that H2AX is also phosphorylated in GG-NER deficient human cells and in 
mouse XPA-/- knock out dermal fibroblasts; the latter exclude residual GG-NER to account for 
gH2AX formation. The ATR and TopBP1 dependent phosphorylation of H2AX in UV-irradiated 
cells is most likely mediated by single strand breaks given that single stranded DNA can 
induce H2AX phosphorylation at serine 139 (Matsumoto et al., 2007;Ward and Chen, 2001) 
and that kinetics of gH2AX formation mimic the slow induction of DNA strand breaks.
The role of RPA in recruiting the ATR/ATRIP signaling complex (Zou and Elledge, 2003) 
is exemplified by its late (24 hours) localization at UV damage in XP-C cells. Yet, binding of 
RPA to chromatin per se is not sufficient for ATR activation as XP-A cells very rapidly recruit 
RPA to UV photolesions as part of an abortive NER reaction (Rademakers et al., 2003) 
without instant formation of gH2AX. In XP-A cells gH2AX was only present after formation 
of DNA breaks (24 hours after UV), in line with reports showing that the ATR activator 
TopBP1 is loaded onto chromatin via the Rad9-Hus1-Rad1 (9-1-1) clamp (Delacroix et al., 
2007) which in turn is loaded on recessed DNA ends (Ellison and Stillman, 2003;Zou et al., 
2003;Bermudez et al., 2003;Majka and Burgers, 2003). Moreover, different compositions 
of abortive preincision NER complexes might affect this loading process indicated by 
different levels of gH2AX in XP-A and XP-C cells in spite of similar DNA break frequencies. 
In XP-A cells TFIIH, XPG and RPA are assembled in a preincision complex (Volker et al., 
2001;Rademakers et al., 2003), whereas in XP-C cells only DDB2 is recruited (Wakasugi 
et al., 2002).We speculate that the preincision complex in XP-A cells facilitates a more 
open DNA structure that is more prone to induce late DNA damage signaling explaining the 
differences in H2AX phosphorylation between XPA and XPC cells at 24 hr.
In summary, DNA strand breaks activate the UV induced DDR and although we cannot 
exclude a role of DSBs, our data favor a key role for single stranded DNA gaps in the UV 
induced signaling in NER deficient cells. This conclusion is based on the presence of RPA 
and the ATR dependent signaling after UV, whereas the ATM kinase, activated upon DSBs, 
did not contribute to gH2AX formation.
early and late uV-responses in cs-b cells are activated by different mechanisms. 
Whereas the early UV response in CS-B cells is nearly indistinguishable from GG-NER 
proficient cells (i.e. gH2AX and SSBs were transiently detectable after UV exposure) we note 
that phosphorylation of p53 in CS-B cells persisted for up to 72 hours, whereas SSBs and 
gH2AX no longer exceeded the background level of non UV-irradiated cells. Hence, formation 
of ser15 phosphorylated p53 generally followed the kinetics of H2AX phosphorylation except 
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for CS-B cells. This is in spite of the fact that phosphorylation of p53 due to transcription 
stalling is mediated by ATR (Derheimer et al., 2007). The absence of breaks suggests that p53 
phosphorylation is mediated by a different mechanism possibly independent of the 9-1-1 
clamp and TopBP1 or, alternatively, phosphorylated p53 in CS-B cells might represent a 
stable form of p53, resistant to degradation and dephosphorylation during this time course.
persistent 6-4pp provoke the formation of single strand gaps and trigger the DDr.
The kinetics of H2AX phosphorylation in XP-E cells lacking functional DDB2 (Hwang et al., 1999) 
mimicked the kinetics of repair proficient normal human cells despite their deficient CPD repair. 
Likewise, wildtype mouse dermal fibroblasts that lack significant repair of CPDs due to much 
reduced expression of DDB2 (Tan and Chu, 2002;Itoh et al., 2004;Pines et al., 2009) do not 
display late gH2AX phosphorylation, whereas XPA-/- mouse dermal fibroblasts displayed H2AX 
phosphorylation. Photoreactivation of 6-4PP in UV irradiated human XP-C cells abolished H2AX 
phosphorylation, whereas photoreactivation of CPD had no effect. We conclude, that the late 
appearance of gH2AX in NER deficient cells is primarily caused by non-repaired 6-4PP. 
Ape1 initiates a DDr in non-dividing repair deficient cells. 
In vitro Ape1 is capable of incising 5’ of a defined 6-4PP and to much lesser extent CPD 
suggesting that Ape1 might incise UV-irradiated chromosomal DNA in vivo and induce DNA 
breaks in repair deficient cells. Consistently, UV irradiation of Ape1 depleted XP-C cells 
lead to reduced levels of DNA breaks, gH2AX and chromatin associated PCNA through a 
mechanism divergent from oxidative DNA damage repair (Jiang et al., 2008;Vasko et al., 
2005). Ape1 participates in base excision repair as the major endonuclease, cleaving 5’ of 
abasic sites. Although this is considered to be its dominant function, Ape1 has also been 
implicated in the processing of oxidatively damaged bases by nucleotide incision repair 
(NIR), a process in which Ape1 removes aberrant nucleotides without prior removal of 
the damaged base (Daviet et al., 2007;Ischenko and Saparbaev, 2002). In addition, Ape1 
mediated cleavage of exocyclic bulky adduct containing DNA has also been demonstrated 
(Hang et al., 1996). For both oxidative and exocyclic DNA lesions the endonucleolytic incision 
was immediately 5’ of the lesion. We speculate that direct recognition of UV lesions (i.e. 
6-4PP) by Ape1 leads to incision activity analogous to the Schizosaccharomyces pombe 
UV damage endonuclease (UVDE) (Takao et al., 1996). The UVDE protein efficiently incises 
UV photolesions directly 5’ to the lesion, thereby facilitating repair. In addition UVDE incises 
abasic sites, dihydrouracil and mismatches (Goosen and Moolenaar, 2008) thus sharing the 
broad substrate specificity displayed by Ape1. Although these proteins are not structural 
homologues, the mechanism of lesion processing is similar: following the 5’ incision, both 
Ape1 and UVDE require PCNA and the Fen1 5’ to 3’ exonuclease activity to subsequently 
remove the damaged nucleotide. Consistent with our results it has been shown that a single 
incision 5’ to a UV lesion is sufficient for loading PCNA on DNA (Staresincic et al., 2009).
PCNA responds to UV damage in a NER and replication independent manner (Li et al., 
1996;Miura et al., 1992), however, it is questionable whether this truly results in complete repair. 
Firstly, UV exposure of XPA deficient cells is accompanied by a very modest level of DNA synthesis 
only traceable by sensitive EdU labelling. Secondly, the increased levels of ubiquitinated PCNA 
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together with recruitment of the TLS polymerase η in UV-exposed repair deficient cells, resemble 
the response of S-phase cells to UV damage (Kannouche et al., 2004). Effective loading of pol η 
requires a stalled ubiquitinated PCNA clamp (Zhuang et al., 2008) providing a further indication 
that the incised DNA cannot be readily repaired. Furthermore, ubiquitination of PCNA depends 
on RPA coated single stranded DNA (Davies et al., 2008). The accumulation of RPA containing 
repair intermediates supports our hypothesis that UV lesion processing activates the ATR 
checkpoint kinase. Further repair would require the removal of damaged nucleotides, a process 
that, if analogous to NIR, would depend on the 5’ to 3’ exonuclease activity of Fen1. However, in 
contrast to single oxidized bases, this step would require the removal of two covalently linked 
bases in the case of 6-4PP. Whether Fen1 actually engages in the process of lesion removal and 
is capable to remove 6-4PP remains to be determined.
Together the data suggest that Ape1 initiates processing of UV lesions by creating 
single stranded DNA nicks that are converted into DNA gaps; these events are unlikely to 
result in repair of the lesions. As a consequence DNA damage signaling, as evidenced by 
phosphorylation of H2AX and p53, invokes a pronounced cell cycle arrest. This underlines 
the importance of NER in counteracting the effects of Ape1 mediated UV lesion processing 
as demonstrated in mouse cancer studies. XPC-/- mice with one functional Ape1 allele, 
display an increased predisposition to UVB-induced skin cancer when compared to 
XPC-/- mice (Cheo et al., 2000). However, the Ape1 haploinsufficiency with respect to skin 
cancer predisposition is only manifest in the absence of functional NER. We speculate 
that Ape1 haploinsufficiency in the absence of GG-NER reduces the cutting of persistent 
photolesions and thereby activation of cell cycle checkpoints allowing damaged cells to 
enter S phase and accumulate mutations.
We noticed that high dose UV exposure of repair proficient human cells (when NER 
saturates) induces similar effects as seen in repair deficient cells, i.e. delayed recruitment 
of PCNA, pol η and gH2AX, indicating that retarded or incomplete repair of UV photolesions 
in normal cells activates the DDR as well. Human skin epidermis from healthy individuals 
accumulates nondividing basal cells that contain high levels of unrepaired damage 
(Mitchell et al., 2001). The accumulation of DNA damage might be due to differences in the 
expression of repair genes in these epidermal cells. In addition it is known that nondividing 
mammalian cells including melanocytes and keratinocytes can be stimulated to divide by 
external stressors such as UV-light (Cohn et al., 1984) and 12-O-tetradecanoylphorbol-
13-acetate (TPA) (Nijhof et al., 2007) in the presence of DNA damage. Therefore, this newly 
identified pathway might be relevant for the general population as well.
mAteriAl AND methoDs
cell culture
Fibroblasts utilized in this study: VH10 hTert (control), CS1AN hTert (CS-B), XP21RO hTert 
(XP-C), XP25RO hTert (XP-A), AT4BI (AT), GM01389 (XP-E) and GM18366 (ATR-Seckel). Cells 
were grown in DMEM supplemented with 10% fetal calf serum, penicillin and streptomycin. 
Three days prior to experiments medium was changed to DMEM supplemented with 0.2% 
serum fetal calf serum, penicillin and streptomycin. 
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The KU55933 ATM inhibitor was used at a final concentration of 10 mM and was a gift 
from Kudos Pharmaceuticals. Cells were pretreated 30 minutes before irradiation.
For the expression of photolyase, lentiviral vectors were created by Gateway 
recombination of 6-4PP and CPD photolyase genes into the pLenti6.3/V5-DEST vector 
(invitrogen). Virus was made using the ViraPower HiPerform Lentiviral Expression System 
(Invitrogen). Confluent cells were infected and UV irradiated three days after infection. 
Directly after UV cells were exposed to photoreactivating light (425 nm) for one hour. 48 
hours after UV exposure cells were fixed and immunostained.
rNA interference
Short interfering RNA (siRNA) duplexes used were as follows: 5’-AACGAGACUUCUGCGGAUUGC 
(ATR) (Wang and Qin, 2003), 5’-UACUCCAGUCGUACCAGACUU (Ape1), smartpool siRNA 
targeting the TopBP1 transcript and smartpool non-targeting siRNA (Dharmacon). Cells 
were transfected using Hiperfect (Qiagen) according to the manufacturer’s protocol. 
For Ape1 knockdown two sequential transfections were performed. Immunostaining and 
comet assay experiments were performed 48 hours after the final transfection.
immunofluorescence and western blotting
The following antibodies have been used: mouse α-PCNA (Abcam ab29 clone number 
PC10), rabbit α-polη (Abcam Ab17725), rabbit α-TopBP1;(Abcam ab2402) mouse α-gH2AX 
(Upstate 05-636 clone JBW301); rabbit α-H2B (Upstate 07-731) mouse α-p53 (Santa 
Cruz Biotechnology (DO-1): sc-126), rabbit α-p21 (Santa Cruz Biotechnology (C-19): 
sc-397), rabbit pold (Santa Cruz Biotechnology (H-300): sc- 10784); rabbit α-p53 ser15 
(Cell Signaling Technology #9284); rabbit α-Caspase-3 (Asp175) (5A1)(Cell Signaling 
Technology #9664); mouse α-RPA(Calbiochem NA19L), rabbit α-ATR (Oncogene research 
products PC538), mouse α-actin (Sigma A3853), rabbit α-Ape1 (Novus Biologicals 
NB100-101), rabbit α-Rad51 was a gift from Dr. R. Kanaar; mouse α-6-4PP was a gift 
from Dr. O. Nikaido, Alexafluor 488 and 555 conjugated antibodies used were purchased 
from Invitrogen. HRP conjugated antibodies were purchased from Dako.
For local UV irradiation, the cells on coverslips were covered with an isopore polycarbonate 
filter with pores of 8 mm diameter (Millipore, Badford, MA) during UV irradiation with the 
Philips TUV lamp (Volker et al., 2001). Subsequently, the filter was removed, the medium 
was added back to the cells and cells were returned to culture conditions. 
For fluorescent labelling the cells were fixed either immediately in 3% formaldehyde in 
PBS followed by 10 min 0.5% Triton X-100 or after 10 min incubation with CSK buffer (100 
mM NaCl, 300 mM sucrose, 10 mM PIPES pH 6.8, 3 mM MgCl2, 0.5% Triton X-100) on ice. 
Antibody incubations were performed at room temperature and cells were counterstained 
with DAPI. Images were captured with a Zeiss Axioplan2 microscope equipped with a Zeiss 
Axiocam MRm camera using either a Plan-NEOFLUAR 40x/1.30 or 63x/1.25 objective. 
For quantification of fluorescent signals the camera exposure time was set based on the 
signal intensity in NHF 1.5 hr after UV; moreover, the exposure time remained constant for 
samples within an experiment. Fluorescence intensity of randomly captured images was 
quantified using Zeiss Axiovision software.
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EdU labelling of cells was done by addition of 10 mM EdU to the culture medium. EdU 
was detected using Invitrogens EdU imaging kit following the manufacturer’s protocol.
The chromatin fractions for western blot were prepared by incubating cells for 10 min 
in CSK buffer containing protease inhibitors on ice followed by centrifugation. The pellet 
was resuspended in CSK buffer and sonicated.
comet assay
Alkaline comet assay was performed as described previously (Cramers et al., 2005) with the 
following modifications: electrophoresis was performed for 15 min at 1 V cm-1; slides were 
stained with SYBR Green I (Invitrogen) and automated analysis was performed using a Zeiss Axio 
imager.M1 with Plan-APOCHROMAT 10x/0.45 objective and Metasystems CometScan software. 
Flowcytometry analysis
EdU was added to the cells 24 hours before fixation except for the ‘fix 15 hr’ samples 
which were incubated with EdU for 15 hours. Cells were collected and stained for EdU 
and DNA using the Click-iT EdU flow cytometry assay kit from Invitrogen according 
to the manufacturer’s protocol. Cells were analyzed using a BD LSR II flowcytometer 
(BD Biosciences) using FACSDiva 5.0 software. Results were analyzed with WinMDI 2.8 
software. Experiments were done twice and also with single parameter (PI) flow cytometry.
Ape1 endonuclease activity assay
The Ape1 endonuclease activity was determined by an oligonucleotide cleavage assay 
as described previously (Yacoub et al., 1997). Reaction mixtures (20 μl) containing the 
recombinant protein Ape1 (1 pmol) (Pines et al., 2005) or UVDE (1 pmol) (Moser et al., 
2005), 0.040 pmol of 5’-32P end- labelled double-stranded oligonucleotide, 50 mM HEPES, 
50 mM KCl, 10 mM MgCl2, 1 mg/ml BSA and 0.05% Triton X-100 (pH 7.5) were incubated 
for 5 min at 30ºC. The reaction was terminated by addition of 3 μl 0.33 M EDTA, 3.3% SDS 
and 2.4 μl glycogen (4 μg/μl) followed by ethanol precipitation. The incision products were 
separated on a 20% polyacrylamide gel containing 7 M urea.
The following DNA substrates were used: 5’-CTCGTCAGCATCTTCATCATACAGTCAGTG 
(undamaged), 5’-CTCGTCAGCATCTTCATCATACAGTCAGTG (6-4PP) and 5’-CTCGTCAGCATC–
TCATCATACAGTCAGTG (AP site), where ‘TT’ or ‘-‘ indicate the position of the 6-4PP and 
abasic site respectively.
supplemeNtAry DAtA
Supplementary data is available at Journal of Cell Science Online.
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Figure s1. (A) Confluent normal and XP-C fibroblasts were globally irradiated with 8 J/m2 UV-C 
and sampled 1.5 hrs, 4 hrs, 8 hrs and 24 hrs later. Cells were immunostained for gH2AX and ki67 
and the gH2AX signal intensity was determined for ki67 negative cells. (B) gH2AX formation 24 
hours after 30 J/m2 local UV exposure in XP-F (XP24KY) and XP-G (XP2BI). (C) Inhibition of ATM by 
KU55933 in XP-C cells does not prevent gH2AX formation. ATM inhibitor or solvent was added 30 
min before mock treatment or exposure to 8 J/m2 UV. Cells were analyzed 16 hours after UV. (D) 
Western blot of XP-C cells showing siRNA-mediated knockdown of ATR and TopBP1. Knockdown 
levels were determined 48 hours after siRNA transfection.
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Figure S2: Impaired ATR signaling does not affect NER efficiency. Normal and ATR deficient 
fibroblasts were exposed to 15 J/m2 UV-C. Cells were stained with a 6-4PP specific antibody and 
lesion removal was measured by quantitative immunofluorescence. Blue circles indicate normal 
cells; red squares indicate ATR deficient cells. Graphs represent the average of three independent 
experiments. Error bars represent SEM.
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Figure s3: pFge of normal and Xp-c cells after exposure to 30 J/m2 uV-c (right panel). Left panel 
shows X-ray treated XP-C cells as a reference. Under the electrophoresis conditions used high 
molecular weight genomic DNA remains in the well, while lower molecular weight DNA fragments 
(several Mbp to 500 kbp) are compacted into a single band (Hanada et al. (2007) Nat Struc Mol Biol 
14:1096). The ratio of this low molecular weight (broken) DNA versus high molecular weight DNA 
was quantified with ethidium bromide staining using a Typhoon 9200 scanner.
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Figure s4: rAD51, brcA1 and FANcD2 are not recruited to damaged DNA in g0 cells. NHF and XP-C 
G0 synchronized cells were locally irradiated with 20 J/m
2 and fixed 1.5 hour and 24 hours after UV 
respectively, non chromatin bound proteins were removed by incubation with CSK buffer. A cycling cell 
population was used as control and fixed 8 hours after UV. All cells were stained for gH2AX to mark the 
site of UV damage. Although the RAD51 staining showed some signal in non dividing cells this did not 
preferentially co localize with gH2AX. Also BRCA1 and FANCD2 did not co localize with gH2AX in G0 cells.
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Figure S5: Ape1 depletion attenuates the formation of gH2AX after UV exposure. XP-C cells were either 
mock treated or treated with Ape1 siRNA prior to UV irradiation. 48 hours after 8 J/m2 UV-C cells were 
stained for gH2AX and Ape1 and quantitative immunofluorescence was performed. Each dot represents 
a single cell measurement. Red squares indicate Ape1 siRNA treated cells; Blue circles indicate mock 
treated cells. Left plot represents non-exposed control; right plot represents UV exposed cells.
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Figure S6. (A) Flowcytrometric distributions. Incorporated EdU label was detected with Alexa 
Fluor 488, DNA content was measured using the DNA stain 7-AAD. Red color indicates G0/G1 cells, 
whereas the green color indicates S phase cells. (B) Measurement of DNA repair synthesis using 
EdU incorporation. NHF and XP-A cells were locally irradiated with 20 J/m2 UV and allowed to 
recover for 24 hours in the presence of 10 mM EdU. Cells were fixed and EdU was labeled with Alexa 
Fluor 488. Under these conditions DNA synthesis was readily detected in repair proficient cells. In 
XP-A cells we detected very low levels of EdU at UV irradiated sites (indicated by CPD staining).
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AbstrAct
Cellular responses to DNA damaging agents involve the activation of various DNA damage 
signaling and transduction pathways. Using quantitative and high-resolution tandem 
mass spectrometry we determined global changes in protein level and phosphorylation 
site profiles following treatment of SILAC labeled murine embryonic stem cells with 
the anticancer drug cisplatin. Network and pathway analyses indicated that processes 
related to the DNA damage response and cytoskeleton organization were significantly 
affected. Although the ATM and ATR consensus sequence (S/T-Q motif) was significantly 
over-represented among hyper-phosphorylated peptides, about half of the more than 
2-fold up-regulated phosphorylation sites based on consensus sequence were not direct 
substrates of ATM and ATR. Eleven protein kinases mainly belonging to the MAPK family 
were identified to be regulated in their kinase domain activation loop. The biological 
importance of three of these kinases (CDK7, Plk1, and KPCD1) in the protection against 
cisplatin-induced cytotoxicity was demonstrated by siRNA mediated knockdown. Our 
results indicate that the cellular response to cisplatin involves a variety of kinases and 
phosphatases acting not only in the nucleus, but also regulating cytoplasmic targets 
resulting in extensive cytoskeletal rearrangements. Integration of transcriptomic and 
proteomic data revealed a poor correlation between changes in the relative level of 
transcripts and their corresponding proteins, but a large overlap in affected pathways at 
the level of mRNA, protein and phosphoprotein. This study provides an integrated view on 
pathways activated by genotoxic stress and deciphers kinases that play a pivotal role in 
regulating cellular processes other than the DNA damage response. 
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iNtroDuctioN
Cancer chemotherapy drugs are designed to selectively kill cells that divide rapidly, being 
a main feature of most cancer cells. Cisplatin (cis-diamminedichloroplatinum (II) (CDDP) 
is among the most widely employed drugs in chemotherapy administered as curative 
treatment of several forms of cancer including ovarian, cervical, head and neck, esophagel, 
non-small-cell lung, and especially testicular cancer (Loehrer and Einhorn, 1984;Keys et al., 
1999;Morris et al., 1999). Cisplatin binds to DNA and forms a spectrum of intra- and inter-
strand DNA cross-links as well as mono adducts. These DNA adducts are thought to mediate 
their cytotoxic effects by interfering with transcription and replication, ultimately leading to 
the induction of apoptosis (Todd and Lippard, 2009). Cisplatin adducts distort the DNA 
duplex resulting in the exposure of the DNA minor groove to which several classes of 
proteins can bind, including high-mobility group (HMG) proteins and transcription factors 
that contribute to cisplatin induced toxicity (Wang and Lippard, 2005).
Repair of cisplatin-DNA adducts involves proteins from multiple DNA repair pathways, 
i.e., nucleotide excision repair (NER), homologous recombination, post-replication repair, 
and mismatch repair (MMR) (Wang and Lippard, 2005;Dronkert and Kanaar, 2001). NER 
is the major pathway responsible for the removal of cisplatin-DNA adducts in vitro and in 
vivo (Wang et al., 2003;Furuta et al., 2002) and hence, the marked sensitivity of testicular 
cancer to cisplatin has been correlated with low levels of NER proteins, i.e. XPA and 
ERCC1-XPF (Welsh et al., 2004). DNA damage caused by cisplatin activates several signal 
transduction pathways including MAPK, AKT, c-ABL, and ATM/ATR/DNA-PK dependent 
pathways regulating a variety of processes such as drug uptake, DNA damage signaling, 
cell cycle arrest, DNA repair, and cell death (Wang and Lippard, 2005). 
Treatment of patients with cisplatin is compromised by the substantial risk of severe 
toxicity, i.e. anemia, nausea, and neurotoxicity (McWhinney et al., 2009). Tumors frequently 
become resistant to the drug (Oliver et al., 2010;Borst et al., 2008) and multiple resistance 
mechanisms have been identified, including an increased cellular efflux or a decreased 
cellular import of cisplatin (Safaei and Howell, 2005;Hall et al., 2008). Cisplatin resistance 
can also occur through enhanced DNA damage repair or increased tolerance to DNA 
damage (Borst et al., 2008).
Improvement of cancer therapy mediated by chemotherapeutic drug agents such as 
cisplatin requires better understanding of the cellular pathways underlying toxicity and 
drug resistance. Indeed, most of the recent advances in cancer treatment are based on 
drastic improvements in conceptual understanding of cellular networks. Cellular responses 
to DNA damage such as cisplatin-induced intra- and inter-strand DNA cross-links are 
controlled by a global signaling network called the DNA damage response (DDR) (Jackson 
and Bartek, 2009) and mediated by post-translational protein modifications (Choudhary 
and Mann, 2010). One of the most frequent modifications is the reversible and dynamic 
phosphorylation of proteins at specific serine, threonine, and tyrosine residues that 
control the activity of the majority of cellular processes. It has been estimated that almost 
70% of all proteins in mammalian cells are phosphorylated at some point during their 
expression (Olsen et al., 2010). Key signalling molecules in DDR are the protein kinases 
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ATM (ataxia telangiectasia mutated) and ATR (ATM and Rad3-related) (Bartek and Lukas, 
2007). Matsuoka and coworkers recently identified over 900 phosphorylation sites in about 
700 proteins by phosphoproteome analysis of protein targeted by the ATM and ATR kinases 
after exposure to ionizing radiation (Matsuoka et al., 2007), however knowledge of the 
genome wide protein phosphorylation response to genotoxic insults is still limited. This 
study aimed to identify the molecular processes and cellular pathways that are affected 
after treatment with cisplatin one of the most commonly used chemotherapeutic drugs. 
To achieve these goals, we examined the cisplatin induced stress responses, changes in 
proteins level and global phosphorylation site profiles by quantitative phosphoproteomics. 
Besides activation of the DDR kinases ATM and ATR, we identified 11 other protein kinases 
with altered activities in response to cisplatin. We applied siRNA mediated knockdown to 
demonstrate that 3 kinases have important protective roles in the cellular response to 
cisplatin induced toxicity. Our dataset identified the cytoskeleton as a novel target of the 
cisplatin induced stress response. In addition, integration of transcriptome, proteome and 
phosphoproteome data disclosed a strong correlation in affected pathways at the levels of 
transcription and protein phosphorylation.
results
cisplatin-induced stress responses
Murine embryonic stem (mES) cells were selected as the cellular model for this study since 
they have the unique combination of a virtually infinite lifespan with uncompromised DDR. 
mES cells manage to maintain their genomic integrity through robust defense mechanisms 
against DNA damage, including effective DNA repair and a hypersensitive apoptotic 
response (Tichy and Stambrook, 2008). These characteristics make mES suitable to study 
the molecular events that underlie the cellular responses related to cisplatin induced 
toxicity. To assess the kinetics of the cisplatin-induced stress response, we examined cell 
cycle progression, mitotic index and DNA strand breaks (by staining for gH2AX) in cisplatin 
exposed mES cells over time. Cell cycle analysis following DNA synthesis labeling by EdU 
showed that, in the absence of cisplatin, about 65% of the ES cells were in S phase (G1 
~15% and G2/M ~20%, supplementary figure 1A). After addition of cisplatin, we observed 
a time dependent inhibition of DNA synthesis: the incorporation of EdU was evident at 30 
minutes, decreased after 2 hours, and was completely absent at 4 and 8 hours (figure 1A). 
Inhibition of DNA replication and transcription has been widely considered to be a key to 
the mechanism of cisplatin cytotoxicity (Todd and Lippard, 2009). No significant induction 
of apoptosis (estimated from the subG1 content) occurred during the treatment period 
(figure 1B) in agreement with previous results (Kruse et al., 2007). In the absence of 
cisplatin, about 5% of the cells were in mitosis as estimated by FACS analysis of serine 10 
phosphorylation of histone H3; nocodazole treated cells arrested in G2 or M-phase were 
used as positive control (supplementary figure 1B). The maximal reduction in mitotic index 
was observed after 4 hours of cisplatin treatment and persisted through 8 hours (figure1C). 
Cisplatin mediated DNA damage signaling manifested by gH2AX phosphorylation increased 
THE CISPLATIN REGULATED PHOSPHOPROTEOME5
120
with time, reaching its maximal level at 4 hours post-treatment as evidenced by western 
blot and MS analysis (figure 1D). Together, these time course experiments indicated a 
complete inhibition of DNA synthesis, a significant reduction of mitotic index, and a strong 
induction of DNA damage signaling after 4 hours of cisplatin treatment.
phosphoproteome analysis after cisplatin exposure
Stable isotope labeling by amino acids in cell culture technology (SILAC) (Ong et al., 
2002) was applied to quantitatively and qualitatively analyze genome-wide protein 
phosphorylation events following exposure to cisplatin. mES were grown in media containing 
‘light’ (control cells) or ‘heavy’ (treated cells) labeled forms of the amino acids arginine and 
lysine. Cells were exposed to 5 mM cisplatin for 4 hours, mixed with untreated cells, lysed 
and subsequently digested with trypsin. The 4 hours time point was selected based on 
the kinetics of cisplatin-induced stress responses (see figure 1). Phosphopeptides were 
selectively enriched by means of a two-step phosphopeptide enrichment procedure, i.e., 
SCX (strong cation exchange) chromatography followed by TiO2 column separation and 
subjected to online nanoflow liquid chromatography tandem mass spectrometry (nano-
LC-MS/MS) analysis (Macek et al., 2009). A total of 14 fractions were collected from SCX 
chromatography and after TiO2 enrichment, each fraction was analyzed by high-resolution 
tandem mass spectrometry on an LTQ-Orbitrap Velos MS (Olsen et al., 2009) using Higher-
energy Collisional Dissociation (HCD) (Olsen et al., 2007) for all MS/MS events (figure 1E). 
The tandem mass spectra were identified by Mascot (www.matrixscience.com) and SILAC 
phosphopeptide pairs were quantified using the MaxQuant software suite (Cox et al., 2009) 
and the final dataset showed 11,034 unique phosphopeptides (false discovery rate (FDR) 
of < 1%) originating from 3,395 proteins (supplementary table 1). Most phosphopeptides 
contained only a single phosphorylation site (figure 1F), but multiple phosphorylation sites 
were detected as well. Serine, threonine, and tyrosine phosphorylation sites comprised 
~86.7%, ~13%, and ~0.3%, respectively (figure 1G). 
The quantified phosphorylation site dataset revealed that approximately 4% of 
the phosphopeptides underwent a more than two-fold change in phosphorylation level 
after exposure to cisplatin, corresponding to 183 and 194 up- and down-regulated 
phosphopeptides, respectively. 324 phosphorylation sites were 1.5-2 fold up-regulated, 
while 725 phosphorylation sites were found to be 1.5-2 fold down-regulated (figure 2A and 
supplementary table1). Many of the top 50 up-regulated phosphopeptides stemmed from 
proteins that are known to play key roles in DNA repair, chromatin remodeling, cell-cycle 
checkpoints (G1/S and G2/M) and transcription (figure 2B). Typically, multiple individual 
phosphorylation sites were identified for each protein but, interestingly, 44 proteins (most 
of them related to DNA repair) were found to contain both up-regulated phosphorylation 
sites and down-regulated (dephosphorylated) sites (supplementary figure 2).
To examine general validity of our findings we performed an independent experiment 
in the same ES cell line employing an identical concentration of cisplatin and exposure 
time (4hrs), as well as identical protocols to purify phosphopeptides (supplementary 
figure 6A). The final dataset showed 11,966 unique phosphopeptides (supplementary 
table 6). The quantified phosphorylation site dataset revealed that 224 and 706 up- and 
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Figure 1. (A) mES cells were treated with 5 μM cisplatin for different times (as indicated) followed 
by EdU labeling for 45 minutes. Flow cytrometric analysis evidenced a time-dependent inhibition 
of DNA synthesis. (B) mES cells were treated with 5 μM cisplatin and the subG1 cell content was 
determined by flow cytrometric analysis at different time points (as indicated). (C) Mitotic index 
of mES cells treated with 5 μM cisplatin was determined at different time points (as indicated) by 
flow cytrometric analysis (D) mES cells were treated with 5 μM cisplatin and analyzed 0.5, 2, 4 and 
8 hours later with indicated antibodies. (-) untreated sample. SILAC mass spectrometry spectrum 
of γ-H2AX phosphopepdite and unmodified H2A peptide. (E) Number of phosphopeptides (black 
bars) and unmodified peptides (grey bars) identified by MS analysis. (F) Number of peptides 
containing 0, 1, 2, 3, and 4 phosphorylation sites. (G) Phosphorylation site distribution over serine, 
threonine, and tyrosine residues.
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down-regulated phosphopeptides respectively, underwent more than two-fold change in 
phosphorylation level after exposure to cisplatin (supplementary figure 6C).
cellular network analysis 
Network and pathway analysis using MetaCore software indicated that processes related 
to DDR, i.e. cell cycle control, checkpoint activation, as well as apoptosis, were significantly 
overrepresented among proteins containing up-regulated phosphorylation sites (>1.5-
fold and >2 fold) (figure 2C-E and supplementary figure 3). The central signal transducers 
in the early cellular response to cisplatin are the protein kinases ATM and ATR (figure 3A-B). 
On the other hand, the analysis of proteins containing down-regulated phosphorylation 
sites identified cytoskeleton and mitotic processes (>1.5-fold and >2 fold). Anaphase-
promoting complex (APC), cell adhesion, Rho GTPases (RAC1, Cdc42), and mitosis initiation 
pathways were found significantly affected (figure 2D-F and supplementary figure 3). 
Together, the strong inhibition of replicative DNA synthesis, the formation of DNA strand 
breaks and the reduction of mitotic index fit well with the activation of DDR (i.e., cell cycle 
checkpoints, DNA repair, and apoptosis) and inactivation of processes related to mitosis. 
Analysis of phosphorylation levels revealed the same processes significantly affected by 
cisplatin, when thresholds were set at 1.5 or 2.0 fold changes. This finding indicates that 
fold changes of 1.5 of phospho-protein level is relevant threshold to identify proteins and 
processes related to the genotoxic stress induced by cisplatin. 
Activation of Atm and Atr in response to cisplatin
In line with recent investigations (Matsuoka et al., 2007;Bennetzen et al., 2010;Stokes et 
al., 2007;Bensimon et al., 2010), we found that DNA damaging agents such as cisplatin 
provoke activation of ATM and ATR kinases as the substrate consensus sequence 
(SQ-TQ motif) of these kinases was significantly overrepresented (84 out of 183 peptide 
count) among the more than two-fold up-regulated phosphorylation sites (figure 3A). 
Interestingly, whereas the phosphorylation of S1987, the important SQ motif in murine 
ATM required for its activation (Pellegrini et al., 2006), was found to be up-regulated, 
phosphorylation of SQ motifs in ATR was not detected. Notably, phosphorylation at S440 in 
ATR was found to be up-regulated, suggesting that the activity of this kinase may also be 
modulated by phosphorylation at a site different from the SQ motif. Direct targets of ATR 
and ATM included proteins involved in the initial enzymatic processing step of DNA damage 
such as DNA strand breaks (i.e., Nbs1, Rad50, and H2AX), signaling mediators (i.e., MDC1, 
53BP1), repair factors (i.e., BRCA1, BARD1, FANCD2), and checkpoint activators (i.e., CHK1) 
(Bartek and Lukas, 2007). Interestingly, we identified multiple regulated phosphorylation 
sites on chromatin remodeling proteins (i.e., SMARCAD1, Chd1, Ino80, Rsf1, and HMGA1), 
E3 ubiquitin ligases (i.e., Np95, Ube3a, Huwe1, Rnf2, UBR7, Mdm2, TRIM33, and RNF19A), 
and a SUMO-protein ligase (i.e., RanBP2). Moreover, proteins known to bind cisplatin-
DNA adducts such as the high-mobility group proteins HMGA1 and HMGA2 (Todd and 
Lippard, 2009), revealed altered phosphorylation site abundance after treatment. The 
phosphorylation of the acidic C-terminal tail of HMGA2 has been associated with reduced 
DNA binding activity (Sgarra et al., 2009). Phosphorylation sites S100, S101, and S104 on the 
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Figure 2. (A) Phosphopeptide ratio plot. Red dots indicate phosphopeptides that were found more 
than 2-fold up- or down-regulated after cisplatin treatment; green dots indicate phosphopeptides 
that showed 1.5 to 2 fold up- and down-regulation after cisplatin treatment; blue dots indicate 
phosphopeptides that were not affected by cisplatin treatment. The y-axis represents signal 
intensity of the ions and it is related to the power (~amplitude squared) of the signal sine wave. (b) 
Top 50 up-regulated phosphopeptides. (c) Top 50 Down-regulated phosphopeptides. (D) MetaCore 
network analysis of proteins containing more than 1.5-fold up-regulated phosphorylation sites 
after cisplatin treatment. (e) MetaCore network analysis of proteins containing more than 1.5-fold 
down-regulated phosphorylation sites after cisplatin treatment. (F) MetaCore network analysis 
of proteins containing more than 2-fold up-regulated phosphorylation sites after cisplatin 
treatment. (g) MetaCore network analysis of proteins containing more than 2-fold down-regulated 
phosphorylation sites after cisplatin treatment.
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acidic C-terminal tail and S44 outside that domain of HMGA2 were found down-regulated 
after cisplatin treatment, suggesting an increased DNA binding to cisplatin-modified DNA. 
In contrast, we observed an enhanced phosphorylation of the S102 and S103 sites on the 
acidic C-terminal tail of HMGA1 after cisplatin treatment and, moreover, the phospho-S9 
(SQ motif) was present in the top ten cisplatin up-regulated phosphorylation sites. 
kinase domain loop phosphorylation sites changes by cisplatin stress response
Based on consensus sequence, about half of the more than two-fold up-regulated 
phosphorylation sites were no canonical substrates of ATM or ATR, revealing substantial 
involvement of other kinases in the genotoxic stress response. The activity of many kinases 
is modulated by phosphorylation of the kinase domain loop located between the conserved 
amino acid sequence motifs DFG and APE (Nolen et al., 2004). This domain plays a crucial 
role in substrate recognition. Phosphorylation of residues in this segment is frequently 
required for the correct alignment between the substrate and the catalytic site of the kinases 
(Johnson et al., 1996) and phosphorylation status of the activation loop can therefore be 
used as a proxy for kinase activity. Eleven kinases mainly belonging to the MAPK family were 
identified to be phosphorylated in the activation loop after cisplatin treatment (figure 4A). 
Plk1, a kinases that play essential roles in the regulation of mitosis by coordinating spindle 
assembly and dynamics was found to be specifically dephosphorylated in its activation 
loops after cisplatin treatment. We tested the biological relevance of 11 of the regulated 
kinases for cisplatin induced toxicity by siRNA mediated knockdown and demonstrated a 
novel protective role for 3 of them (CDK7, Plk1, and KPCD1) (figure 4B). In order to test the 
off-target effects, four individual siRNA were used to knockdown CDK7, Plk1, and KPCD1 
respectively and the extent of knockdown was tested by western-blot (supplementary 
Figure 3. (A) Consensus sequence for ATM, ATR, and DNA-PK substrates among the more than 
2-fold up-regulated phosphorylation sites. (b) Consensus sequence for different kinases among 
up-regulated, down-regulated, and unmodified phosphorylation sites.
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figure 4). We note here, that a significant reduction in cell survival was detected for the Plk1 
knockdown in the absence of cisplatin treatment, indicating a critical role of this kinase in 
normal cell growth (supplementary figure 4) (Tyagi et al., 2010). 
effects on mitosis 
Analysis of kinase motifs among the phosphorylation sites showed a significant enrichment 
of CDK, ERK, and Aurora kinase substrates among the down-regulated phosphorylation sites 
Figure 4. (A) Analysis of the kinase domain loop located between the conserved sequence DFG 
and APE. (b) The cellular sensitivity for cisplatin after siRNA knockdown was determined by an 
Adenosine TriPhosphate (ATP) monitoring system. Knock down of CDK7, PLK1, or KPCD1 kinases 
significantly reduced cell survival after cisplatin treatment (Student’s t test). siGFP (control 1) and 
siLAMIN C/A (control 2) were used as negative controls (two independent experiments). (c) Effects 
of cisplatin on cytoskeleton structure. mES cells were exposed for 4 and 8 hours to cisplatin (5μM) 
treatment and stained with DY554-phalloidin and DAPI (nuclei). The arrows indicate microspikes.
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(figure 3B). In response to persistent genotoxic stress, ATM and ATR and the subsequent 
Chk1/Chk2 signaling cascade prevent activation of Cdk1/CyclinB, thereby blocking entry 
into mitosis (Bartek and Lukas, 2007). The depletion of mitotic cells evidenced by FACS 
analysis (figure 1C) is consistent with the activity of these cell-cycle kinases as indicated 
by the phosphoproteomics dataset. Following DNA damage, two mitosis-specific kinases, 
Cdk1 and Plk1, are inactivated by inhibitory phosphorylation (T14 and Y15) (O’Farrell, 
2001) and dephosphorylation (T210) (Tsvetkov and Stern, 2005) events, respectively. T14 
and Y15 phosphorylation of Cdk1 and the dephosphorylation of the activation loop T210 of 
Plk1 were evident in our data (supplementary table 1). Several Plk1 targets involved in 
mitosis have been identified (Nigg, 2001), including FoxM1; this protein was found to be 
dephosphorylated after cisplatin treatment (supplementary table 1). The FoxM1 protein 
is an important transcription factor involved in the regulation of mitotic entry (Laoukili et 
al., 2005;Wang et al., 2005) and phosphorylation of FoxM1 by Plk1 and Cdk1 regulates the 
transcription network essential for mitotic progression (Fu et al., 2008). Remarkably, a wide 
range of proteins related to mitotic events were found to be dephosphorylated, i.e., KNSL1, 
nucleolin, histone H1, and the anaphase-promoting complex (APC). APC is a multisubunit 
protein complex with E3 ubiquitin ligase acitivity essential for the proteolysis process, a 
key mechanism that drives the events of mitosis. APC1, APC2, Cdc20, Cdh1, and Cdc23 
subunits of anaphase-promoting complex were found down-phosphorylated and very likely 
this alteration may facilitate the binding of Emi1, an inhibitor of APC (Torres et al., 2010).
effects on cytoskeleton 
Cellular movement is orchestrated by microtubules and actin cytoskeleton and is controlled 
by the activity of Rho GTPases (Waterman-Storer and Salmon, 1999). Prominent Rho 
GTPase family members are Rac1 and Cdc42, which induce the formation of extensions 
(lamellipodia) and stimulate actin polymerization at the leading edge of the cell together 
with the formation of new adhesion sites to the matrix (Ridley, 2001). Cytoskeleton 
processes and, in particular, Rac-1 (P<10e-5) and Cdc42 (P<10e-4) pathways were found 
affected by genotoxic stress (supplementary figure 3). Proteins associated with RAC-1 and 
Cdc42 pathways i.e., ABR, ECT2, DBL, RacGAP1, p200RhoGAP, ARCGAP22, and ARHGAP12, 
were found to be dephosphorylated on proline-directed serine/threonine sites (potential 
CDK or MAPK substrates) or sites that are targeted by casein kinases (in an acidic amino 
acid context). To study the effect of cisplatin on cytoskeleton structure, we monitored the 
actin organization in mES cells after treatment (figure 4C). Cytoskeleton remodeling and 
specific microspike formation were clearly visible in cells treated with cisplatin, confirming 
the results of the pathway analysis obtained from the phosphoproteome.
proteome and transcriptome 
Non-phosphorylated peptides were analyzed to rule out that changes in overall protein levels 
might be responsible for the observed changes in phosphorylation site levels. Quantitative 
profiles were obtained for 4,349 proteins (figure 5A) out of a total of 5,917 proteins 
(supplementary table 2) based on the quantification of 16,305 non-phosphorylated but 
unique peptides (supplementary table 3). The abundance of most proteins that contained 
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up- or down-regulated phosphorylation sites did not change significantly during cisplatin 
treatment, indicating that the majority of observed phosphorylation changes was not 
due to alterations in protein quantity (figure 5C-D-E). Interestingly, cellular levels of 455 
proteins were found to be altered when proteomics data analysis was performed with a 
statistical rigor of P<0.05. Network analysis identified cytoskeleton remodeling as one of 
the most prominent affected pathways. In particular, the NOTCH signaling pathway was 
statistically found to be significantly affected (supplementary figure 3). Metacore analysis 
shows an enrichment of p53 target genes ie 49 out of 455 proteins, double the expected 
frequency (P<10e-6), suggesting a p53-dependent response in line with previous studies 
(Kruse et al., 2007). We examined how the proteome correlates to the mES transcriptome 
previously generated under identical conditions of cell growth and cisplatin 
exposure (Kruse et al., 2007). Of a total of 3,616 Entrez gene ID shared among the gene 
expression and protein data sets, 386 proteins and 56 mRNAs transcripts were found to 
be significantly affected by cisplatin treatment (p<0.05), with surprisingly only 5 gene IDs 
being in common (supplementary table 5). A selected group of genes was examined by 
RT-PCR and western-blot analysis to quantify gene expression and protein levels in mES 
cells after cisplatin treatment. Indeed significant changes in protein levels were found 
for Cdh1, p53, Centrin2, Mark2 by immunoblotting whereas the corresponding mRNA 
transcripts were not affected after cisplatin (supplementary figure 5). Together, these 
data indicate that alterations in protein and transcript quantaties do not correlate well 
at the individual gene level after cisplatin treatment. In contrast, pathway analysis based 
on transcriptomics, proteomics and phosphoproteomics data revealed a large overlap 
in affected processes (figure 6). Cell cycle was the most prominent pathway affected at 
the transcriptome and phosphoproteome level whereas DNA repair pathways were only 
significantly affected at phosphoproteome level. In contrast, changes at the overall protein 
level primarily involved processes associated with cytoskeleton regulation.
DiscussioN
Cisplatin is a widely used anticancer drug and, therefore, understanding of the molecular 
changes that underlie the biological consequences of treatment with this drug is 
of critical importance. Protein phosphorylation is one of the most prominent post-
translational modifications that are triggered by cisplatin treatment and therefore, 
global phosphoproteome analysis is an excellently suited approach to identify molecular 
components and cellular pathways affected by cisplatin.
Inhibition of transcription and replication by cisplatin induced DNA lesions and 
subsequently the generation of DNA strand breaks activates the ATR and ATM kinases as 
well as p38MAPK/MK2 pathway (Bartek and Lukas, 2007;Reinhardt et al., 2007a;Reinhardt 
and Yaffe, 2009). Consistently, we found up-regulation of S1987 phosphorylation in ATM that 
is required for its activation (Pellegrini et al., 2006). Up-regulation of ATR phosphorylation 
was observed at S440, a site that lacks the SQ motif and likely represents the site targeted 
by the NEK6 kinase. This kinase belongs to a large family of Ser/Thr kinases that have 
critical roles in coordinating microtubule dynamics during mitotic progression (Quarmby 
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Figure 5. (A) Unmodified peptide ratio plot. Red dots, significantly (p<0.001) regulated peptides 
after cisplatin treatment; green dots, significantly (p<0.05) regulated peptides after cisplatin 
treatment; blue dots, unmodified peptides after cisplatin treatment. The y-axis represents signal 
intensity of the ions and it is related to the power (~amplitude squared) of the signal sine wave. 
(b) MetaCore networks analysis of significantly affected proteins (p<0.05) after cisplatin addition. 
(c) Abundance distributions of all proteins and proteins containing up-regulated phosphorylation 
sites (>1.5-fold) (D) Abundance distributions of all proteins and proteins containing down-
regulated phosphorylation sites (>1.5-fold). (e) Abundance distributions of all proteins and 
proteins containing unmodified phosphorylation sites.
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Figure 6: comparison of significantly affected pathways (metacore network analysis) by 
cisplatin at the transcriptomic (mrNAs transcripts p<0.05), proteomic (proteins p<0,05) and 
phosphoproteomic level (phosphoprotein p<0,05).
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and Mahjoub, 2005). This phosphorylation site has not been previously mapped and might 
represent a novel site involved in ATR activation. The top 50 up-regulated phosphorylation 
sites include a significant number of direct ATR and ATM targets related to DDR; most 
notably proteins involved in the processing step of double strand breaks (DSB), DNA damage 
signaling, stalled replication/transcription forks, checkpoint activation and chromatin 
remodeling proteins. In addition, E3 ubiquitin and SUMO-protein ligases were observed to be 
regulated by phosphorylation events highlighting the cross-talk between phosphorylation 
and other post-translational modifications in response to genotoxic stress (Bennetzen et 
al., 2010). In contrast to the large-scale proteomic analysis of SQ specific phosphorylation 
sites in response to DNA damage induced by IR and UV (Matsuoka et al., 2007;Stokes 
et al., 2007), our global phosphoproteomics strategy allowed identification of putative 
ATM/ATR dependent and independent phosphorylation events. Indeed, DNA repair proteins 
such as BRCA1, Rad50, p53BP1, FANCI, and BARD-1 were found to contain up-regulated 
phosphorylation sites unrelated to ATM and ATR activity. As these data are not based on 
direct experimental evidence, we cannot exclude that ATM/ATR may also phosphorylate at 
non-consensus sites. Moreover, 44 proteins (mostly involved in DNA repair and including 
BRCA1 and Ino80, supplementary figure 2) underwent differential phosphorylation of 
adjacent sites (2-5 amino acids). Differential phosphorylation might serve to create a 
molecular switching mechanism (Bennetzen et al., 2010) by a tightly controlled activity 
of several kinases and phosphatases. Different types of post-translational modifications 
controlled by such a mechanism might dynamically regulate the DDR for example the 
assembly and disassembly of factors at sites of damage (Bartek and Lukas, 2007).
Several of the HMG domain proteins recognize cisplatin adducts and display a selective 
affinity for clinically effective platinum drugs (Kartalou and Essigmann, 2001). HMGA 
proteins are expressed at a high levels during embryonic development, whereas they are 
barely detectable in differentiated or non-proliferating cells; noteworthy, these proteins are 
highly re-expressed following neoplastic transformation (Sgarra et al., 2004). HMGA1 and 
HMGA2 were found to be differentially phospho-regulated after cisplatin treatment. To our 
knowledge, these are the first in vivo data showing a discrepancy in phosphorylation state 
between HMGA1 and HMGA2 in response to genotoxic stress. The finding of differential 
phosphorylation profiles within the HMGA family after cisplatin treatment might offer 
potential targets for an improved cisplatin cancer therapy, considering that these proteins 
are overexpressed in cancers of different origins. 
The outcome of an independent replicate experiment with same ES cells demonstrated 
the high reproducibility of the Cisplatin induced protein phosphorylation. The results also 
showed that ATM and ATR consensus sequences were significantly over-represented 
among hyper-phosphorylated peptides (supplementary figure 6D). The phosphopeptide 
ratio correlation between the two replicates is 0.61 (Pearson correlation coefficient, R, 
supplementary figure 6A) based on 7,275 unique phosphopeptide identified in both 
experiments (supplementary table7). These results are close to those achieved in a 
recent study using a similar experimental approach (Rigbolt et al., 2011). A much higher 
correlation (R=0.88) was found when the analysis was limited to putative ATM/ATR 
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substrate peptide ratios (supplementary figure 6A-B-E). Importantly, network analysis 
identified DDR and cytoskeleton regulation as affected cisplatin processes in both 
experiments. Together these results demonstrate the reproducibility and general validity 
of our findings (supplementary figure 6F-G). 
Our results indicate that the cellular response to genotoxic stress involves a large 
variety of protein kinases and phosphatases. Indeed, 11 kinases were identified to be 
regulated at phosphorylation sites-in the activation loop after cisplatin treatment (figure 
4A). Most of those regulated belong to the MAPK family, but kinases not related to the MAPK 
family i.e Plk1 essential in the regulation of mitosis, was found to be dephosphorylated as 
well. Mitogen-activated protein kinases (MAPKs) are critical components of the signaling 
network activated by genotoxic stress and critical in deciding cell fate in response to 
cisplatin (Brozovic and Osmak, 2007). Particularly, in the absence of p53, cells depend 
on p38MAPK/MK2 for cell-cycle arrest and survival after cisplatin (Reinhardt et al., 
2007b). Here we show that the kinase domain of MK14 (p38α) is activated by specific 
phosphorylation of the activation loop TXY motif after cisplatin addition. 
Knock-down of CDK7 significantly increased cell toxicity after cisplatin treatment. 
The cyclin-dependent protein kinase CDK7 forms a trimeric complex with cyclin H and 
MAT1 and is both a Cdk-activating kinase (CAK) (Drapkin et al., 1996;Reardon et al., 1996) 
and an essential component of the transcription factor TFIIH, involved in transcription 
initiation and nucleotide excision repair (Scrace et al., 2008). In addition, knock-down of 
Plk1, and KPCD1 also increased cisplatin mediated cytotoxicity (figure 4B). KPCD1 is a 
member of the protein kinase C (PKC) family involved in extracellular receptor-mediated 
signal transduction pathways (Johannes et al., 1994). The mitosis-specific kinase Plk1 
has been shown to play an essential role in the regulation of mitotic progression, including 
mitotic entry, spindle formation, chromosome segregation and cytokinesis; moreover, 
it has been found to be over-expressed in different types of tumor (Takai et al., 2005). 
Inhibition of Plk1 is an efficient way to establish an irreversible G2 arrest after DNA damage 
induction in specific cancers with non-functional p53. In these cells typical G1 arrest is 
lost in response to DNA damage and cells display a stronger dependency on the G2 DNA 
damage checkpoint for protection against genotoxic insults (van Vugt et al., 2005) Our 
data suggest that the cellular response to inactivate PKL1 is directed towards prevention 
of mitotic entry in favor of apoptosis process (Macurek et al., 2008), that is in according 
to transcriptomics and phosphoproteomics analysis. Currently, several Plk inhibitors are 
in phase I or II clinical studies (Mross et al., 2008;Jimeno et al., 2010;Degenhardt and 
Lampkin, 2010), and in cancers with non-functional p53, Plk1 inhibition serves as a potent 
adjuvant therapy when combined with a DNA-damaging regimen such as cisplatin (Tyagi 
et al., 2010). Together, our results clearly indicate that dissection of the cellular responses 
induced by cisplatin using phosphoproteome analysis in concert with functional genomics 
allows unraveling of targets and pathways that enhance the cytotoxic effects of cisplatin. 
Proteins that were identified to be differentially phosphorylated upon cisplatin treatment 
also belonged to biological processes and structures not classified as or related to core 
DDR processes. In fact, unanticipated processes associated with cytoskeleton events were 
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identified by network analysis of proteins containing down-regulated phosphorylation sites 
and, in particular, Rac-1 and Cdc42 pathways were found affected by cisplatin. The actin 
component of the cytoskeleton is dynamically implicated in a variety of cell functions, 
including regulation of cell shape, adhesion, and motility and recent studies underline 
mechanisms of cisplatin mediated inhibition on invasion and migration of human cancer 
cells (Ramer et al., 2007;Karam et al., 2010;Paduch et al., 2009). Cytoskeleton remodeling 
and specifically the induction of microspike formation was a clear effect of cisplatin 
treatment (figure 4C). These results are in line with reports on microspike formation related 
to Cdc42 (Umikawa et al., 1999). The regulation of phospho state of Rho GTPases (members 
of the Rac-1 and Cdc42 pathways) shown in this study, is consistent with the observed 
cisplatin mediated changes in cell morphology. Moreover, the link between cisplatin and 
Rac-1/ Cdc42 pathways is relevant in view of the fact that Cdc42 activity is associated 
with genome maintenance, cellular senescence regulation, and aging (Wang et al., 2007). 
Although classically regarded as a nuclear DNA damaging agent, recent studies support a 
more promiscuous mode of action for cisplatin (Mandic et al., 2003;Emert-Sedlak et al., 
2005;Safaei et al., 2005;Zeidan et al., 2008). The current phosphoproteome analysis of 
kinases targets and their predicted activated substrates supports this finding by confirming 
previous data and providing evidence for the extra-nuclear targeting function that might 
play a role in cisplatin induced toxicity and in cell motility. A better understanding of the 
mechanisms of cisplatin action may provide novel therapeutic strategies that would block 
metastatic progression and reducing dissemination of tumor cells.
We tested the hypothesis whether changes in transcription profiling after cisplatin 
correlate with changes observed at the protein level. Consistent with previously published 
data (Olsen et al., 2010), we found no clear correlation between changes in the relative 
level of transcripts and corresponding proteins. This lack of correlation might be due to 
the fact that the cellular mechanisms involved in regulation of stability/degradation differ 
between mRNAs and their encoded proteins. This finding indicates that information derived 
from transcriptomic and proteomic analysis is different, but when merged generates a 
more comprehensive view of the signaling pathways affected by stressors. Interestingly, 
the phosphoproteomic analysis performed in our study led to the identification of most 
of the pathways that were affected at the transcriptome or proteome level. However, 
the impact of cisplatin on the DNA damage repair pathways was only manifested in the 
phosphoproteome analysis indicating that phosphorylation events are key to activate 
DNA repair pathways after genotoxic stress induced by cisplatin or in general to genotoxic 
agents that induce replication and transcription blocking lesions.
mAteriAl AND methoDs
cell culture and cisplatin treatment
Cell culture and cisplatin treatment of wild type mES cells (B4418 and HM1 derived 
from C57/Bl6 and OLA/129 mouse genetic background, respectively) were essentially 
performed as previously described (Kruse et al., 2007). Sub-confluent cultures of mES 
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cells were exposed to cisplatin (5 μM), added directly to the culture medium. Cell cultures 
were incubated for different time periods after cisplatin administration (0.5, 2, 4, 8 h). The 
Thermo Scientific Pierce Mouse Embryonic Stem Cell Kit, containing media and reagents 
specifically designed for analysis of protein by mass spectrometry (Thermo Scientific), 
was used for SILAC experiments.
phosphopeptides enrichment 
Isolation and purification of phosphopeptides was performed according to already 
published procedures (Villen et al., 2007) with some modifications. Briefly, cells were 
lysed for 30 minutes in lysis buffer (8 M urea, 50 mM Tris pH 8.1, 75 mM NaCl, 1 mM 
MgCl2, 500 units benzonase and phosphatase inhibitors). Samples were centrifuged for 
15 minutes at 13,000 rpm and protein concentration was established by Qubit Protein 
Assay (Invitrogen). 10 mg of proteins were first reduced with 2.5 mM DTT for 25 minutes at 
60 °C and subsequently alkylated by incubation with 7 mM iodoacetamide for 15 minutes 
at room temperature, protected from light. The alkylation reaction was quenched by 
incubation with 2.5 mM DTT for 15 minutes at room temperature. Protein solution was 
diluted 8-fold with 25 mM Tris pH 8.1, 1 mM CaCl2 and incubated for 15 hr at 37 °C with 100 
µg trypsin (Promega). On the following day, the digestion reaction was stopped by addition 
of TFA to 0.4 % final concentration and the precipitate was removed by centrifugation for 
5 minutes at 3,200 rpm. The supernatant was loaded on a Sep-Pak Vac 1 ml C18 cartridge 
(Waters), desalted by washing with 0.1 % acetic acid and eluted with 0.1 % acetic acid, 
30 % acetonitrile. Eluted peptides were lyophilized and fractionated at 1 ml/min on a 
9.4x200mm 5 µm particle PolySULFOETHYL A SCX column (PolyLC) using a 70 minutes 
gradient from 0 to 75 mM KCl, 350 mM KCl for 38 minutes in 5 mM KH2PO4 pH 2.65, 30% 
acetonitrile. Eighteen fractions with 6 ml eluate were collected, desalted on Sep-Pak Vac 1 
ml C18 cartridge and lyophilized as mentioned before. In the desalting step, the last eight 
fractions were reduced to four fractions by loading two fractions on one cartridge giving 
a total of 14 fractions. After lyophilization, peptides were dissolved in solution A (300 mg/
ml lactic acid, 80 % acetonitrile, 0.1 % TFA) and loaded on a titanium tip column (TopTip 
1 -100 µl, Glycen Corporation) prewashed with elution solution (15 mM NH4OH pH~10.5), 
equilibration solution (0.1 % TFA) and solution A. After sample loading, the tip column 
was washed with solution A and B (80 % acetonitrile (v/v), 0.1 % TFA (v/v)). After washing, 
phosphopeptides were eluted with elution buffer and collected in an equal volume of 2 
% TFA. For desalting, phospeptides were loaded on a Stage Tip C18 column (PROXEON) 
prewashed with methanol, solution B and 0.1 % TFA. The phosphopeptide solution was 
loaded on a Stage Tip, washed with 0.1 % TFA and eluted with solution B. Liquid was 
removed by lyophilization and stored at -80 °C till MS analysis.
mass spectrometric analysis. 
LC-MS/MS
The dried phosphopeptide mixtures were acidified with 5% acetonitrile in 0.3% tri-fluoro 
acetic acid (TFA) to an end volume of 10 uL, transferred to a 96-well plate and analyzed 
by online nanoflow liquid chromatography tandem mass spectrometry (LC-MS/MS) as 
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described previously (Olsen et al., 2009) with a few modifications. Briefly, all nanoLC-MS/
MS-experiments were performed on an EASY-nLC™ system (Proxeon Biosystems, Odense, 
Denmark) connected to the LTQ-Orbitrap Velos (Thermo Electron, Bremen, Germany) 
through a nanoelectrospray ion source.
5 uL of each phosphopeptide fraction was auto-sampled onto and directly separated 
in a 15 cm analytical column (75 µm inner diameter) in-house packed with 3µm C18 
beads (Reprosil-AQ Pur, Dr. Maisch) with a 90 min gradient from 5% to 30% acetonitrile 
in 0.5% acetic acid at a flow rate of 250 nl/min. The effluent from the HPLC was directly 
electrosprayed into the mass spectrometer by a platinum-based liquid-junction.
The LTQ-Orbitrap Velos instrument was operated in data-dependent mode to 
automatically switch between full scan MS and MS/MS acquisition. Instrument control was 
through Tune 2.6.0 and Xcalibur 2.1 Survey full scan MS spectra (from m/z 300 – 2000) were 
analyzed in the orbitrap detector with resolution R=30K at m/z 400 (after accumulation to 
a ‘target value’ of 1e6 in the linear ion trap). The ten most intense peptide ions with charge 
states ≥ 2 were sequentially isolated to a target value of 5e4 and fragmented in octopole 
collision cell by Higher-energy Collisional Dissociation (HCD) with a normalized collision 
energy setting of 40%. The resulting fragments were detected in the Orbitrap system 
with resolution R=7,500. The ion selection threshold was 5,000 counts and the maximum 
allowed ion accumulation times were 500 ms for full scans and 250 ms for HCD. 
Standard mass spectrometric conditions for all experiments were: spray voltage, 
2.2 kV; no sheath and auxiliary gas flow; heated capillary temperature, 275ºC; predictive 
automatic gain control (pAGC) enabled, and an S-lens RF level of 65%. For all full scan 
measurements with the Orbitrap detector a lock-mass ion from ambient air (m/z 
445.120024) was used as an internal calibrant as described (Olsen et al., 2005). A setting 
was also chosen where the additional SIM injection of the lock mass is deactivated, in 
order to save time.
raw ms data analysis
Peptide identification and quantitation by MASCOT and MaxQuant.
Raw Orbitrap full-scan MS and ion trap MSA spectra were processed by MaxQuant as 
described (Cox et al., 2009;Cox and Mann, 2008). In brief, all identified SILAC doublets were 
quantified, accurate precursor masses determined based on intensity-weighing precursor 
masses over the entire LC elution profiles and MS/MS spectra were merged into peak-list 
files (*.msm). Peptides and proteins were identified by Mascot (Matrix Science, London, 
UK) via automated database matching of all tandem mass spectra against an in-house 
curated concatenated target/decoy database; a forward and reversed version of the 
mouse International Protein Index (IPI) sequence database (version 3.37; 102,934 forward 
and reversed protein sequences from EBI (http://www.ebi.ac.uk/IPI/)) supplemented with 
common contaminants such as human keratins, bovine serum proteins and porcine 
trypsin. Tandem mass spectra were initially matched with a mass tolerance of 7 ppm on 
precursor masses and 0.02 Da for HCD fragment ions. Scoring was performed in MaxQuant 
as described previously. We required strict trypsin enzyme specificity and allowed for up 
to two missed cleavage sites. Cysteine carbamidomethylation (Cys +57.021464 Da) was 
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searched as a fixed modification, whereas N-acetylation of proteins (N-term +42.010565 
Da), N-pyroglutamine (-17.026549 Da), oxidized methionine (+15.994915 Da) and 
phosphorylation of serine, threonine and tyrosine (Ser/Thr/Tyr +79.966331 Da) were 
searched as variable modifications. 
peptide filtering and phosphorylation site localization
The resulting Mascot result files (*.dat) were loaded into the MaxQuant software suite 
for further processing. In MaxQuant we fixed the estimated false discovery rate (FDR) of 
all peptide and protein identifications at 1%, by automatically filtering on peptide length, 
mass error precision estimates and Mascot score of all forward and reversed peptide 
identifications. Finally, to pinpoint the actual phosphorylated amino acid residue (s) within 
all identified phospho-peptide sequences in an unbiased manner, MaxQuant calculated 
the localization probabilities of all putative serine, threonine and tyrosine phosphorylation 
sites using the PTM score algorithm as described (Olsen et al., 2006).
phosphorylation site sequence motifs logo plots 
Only peptides with localization probabilities >0.75 were included in the downstream 
bioinformatic analysis (supplementary table 1S). To identify enriched sequence motifs in 
the phosphorylation site dataset we made use of the already published kinase motifs (www.
phosida.com) and an algorithm that extracts overrepresented motifs in a more unbiased 
manner (Soufi et al., 2009). The algorithm was implemented in R (a programming language 
and software environment for statistical computing and graphics) using a Fisher’s exact 
test to iteratively test for position specific over-representation of amino acid groups 
between two lists of prealigned sequences. The perl-package WebLogo was used internally 
in the algorithm to visualize the enriched sequence motifs as logo plots. Grouping of amino 
acids were done by the basis of related chemical properties (acidic, basic, aromatic, 
aliphatic, hydrophilic, amide, polar and cyclic) and alignment was done with a sequence 
window of +/- 6 amino acids surrounding the central phosphorylated serine, threonine or 
tyrosine residue. The iterative nature of the algorithm means it is successively reapplied 
on the result from an analysis – i.e. on both the subset of the lists which contains the most 
significantly overrepresented amino acid group and the subset that does not contain this 
amino acid group. All cisplatin regulated phosphorylation site sequences were compared 
to all unchanging sites and vice versa. We considered a motifs significant if it fulfilled our 
conservative cut-off of P<0.001 on the Bonferroni adjusted P-values. 
Network and pathways analysis 
Network and pathway analysis were performed using MetaCore software (http://www.
genego.com/metacore.php). Proteins containing up-regulated phosphorylation sites 
(>1.5-fold and >2 fold) and down-regulated phosphorylation sites (>1.5-fold and >2 fold) 
were investigated. In most cases high-throughput experiments result in lists of genes or 
proteins of interest. The datasets usually contain anywhere between few dozens and few 
thousand genes/proteins. In MetaCore the significance is evaluated based on the size of the 
intersection between user’s dataset and set of genes/proteins corresponding to a network 
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module/pathway in question, or rather the probability to randomly obtain intersection of 
certain size between user’s set and a network/pathway follows hypergeometric distribution. 
The significance of the networks/pathways is evaluated for whether algorithm has succeeded 
in creating modules that have higher than random saturation with the genes of interest. 
Networks are drawn from scratch by GeneGo annotators and manually curated and edited. 
There are about 110 cellular and molecular processes whose content is defined and annotated 
by GeneGo. Canonical pathway maps represent a set of about 650 signaling and metabolic 
maps covering human biology (signaling and metabolism) in a comprehensive way. 
western blot analysis
Total cell extracts were obtained by direct lysis of the cells in Laemmli-SDS-sample buffer. 
Western blot analysis was performed as described previously (Fousteri et al., 2006) and 
protein bands were analyzed and visualized with the Odyssey® Infrared Imaging System 
(LI-COR) using secondary antibodies labeled with visible fluorophores. Antibodies 
employed were: mouse α-gH2AX (Millipore), rabbit α-H2B (Santa-Cruz), mouse α-p53 
(Santa Cruz Biotechnology DO-1), rabbit α-CDK7 (cell signaling), rabbit α-PLK1 (cell 
signaling), rabbit α-KPCD1 (cell signaling), rabbit α-centrin (cell signaling), rabbit α-E-
cadherin (cell signaling) and rabbit α-mark2 (cell signaling).
Flowcytometry analysis
For cell cycle analysis, samples were either treated with 5 mM cisplatin for 0.5, 2, 4 or 8 
hours or mock treated, after which EdU was added to a final concentration of 20 mM. Cells 
were collected 45 minutes after addition of EdU label and stained for EdU and DNA using the 
Click-iT EdU flow cytometry assay kit (Invitrogen) according to the manufacturer’s protocol.
To determine the mitotic index, samples were either treated with 5 mM cisplatin for 
0.5, 2, 4 or 8 hours, treated with 100 ng/ml nocodazole for 4 hours, or mock treated. Cells 
were collected and 106 cells were fixed with 70% ethanol. Cells were washed with PBS 
and incubated with Rb-α-Phospho (Ser10) Histone H3 antibody (Millipore). After washing, 
samples were incubated with Go-α-Rb Alexafluor 488 antibody (Invitrogen). After washing, 
cells were treated with RNase A (200 mg/ml) and stained with propidium iodide (Biorad). 
Cells were analyzed using a BD LSR II flowcytometer (BD Biosciences) and FACSDiva 5.0 
software. Results were analyzed with WinMDI 2.8 software.
immunofluorescence staining 
Cells were fixed in 4% formaldehyde in CSK buffer (100 mM NaCl, 300 mM sucrose, 10mM PIPES 
pH 6.8, 3mM MgCl2) and permeabilized by treatment with 0.5% Triton X-100 in PBS for 10 min. 
Actin was visualized by DY554-phalloidin (Sigma-Aldrich) and cells were counterstained with 
DAPI. Images were captured with a Zeiss Axioplan2 microscope equipped with a Zeiss Axiocam 
MRm camera using either a Plan-NEOFLUAR 40x/1.30 or 63x/1.25 objective. 
sirNA transfection
HM1 mES cells were transfected with 50nM final concentration of siRNA (Dharmacon), 
targeting for CHK2, CDK7, MAPK2, M3K2, MK14, MARK1, PDPK1, PLK1, KPC1, KPCD1 
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and SG269, as well as siGFP (control 1) and siLAMIN A/C (control 2), which were used 
as negative controls. Transfection was performed using Dharmafect 1 (Dharmacon) 
according to the manufacturer’s instructions. 103 HM1 mES cells were transfected for 16h 
in mClear® 96-well plates (Greiner), and the medium was refreshed every 24h for 48h. 
cell viability assay
At 64h post-siRNA transfection, HM1 mES cells were treated with either vehicle or 
10mM of cisplatin (Ebewe Pharma) for 24h. ATP Lite ™ (Perkin Elmer) was then used 
according to the manufacturer’s instructions for the assessment of cell viability. As an 
additional conformation that cisplatin was inducing apoptosis, the pan-caspase inhibitor 
benzyloxycarbonyl-Val-Ala-DL-Asp (OMe)-fluoromethylketone (zVAD-fmk) (Bachem, 
Bubendorf, Switzerland) was used to inhibit caspases and blocked cisplatin-induced 
apoptosis (supplementary figure 4A).
gene expression analysis
The gene expression levels of Cdh1, p53, centrin2 and mark2 were quantified after exposure 
to 5μM cisplatin for 4 hours using quantitative reverse transcriptase PCR (qRT-PCR). 
The qRT-PCR was performed using the Applied 7900ht real-time PCR detection system 
(Applied Biosystems). In three independent experiments the RNA was isolated from mES 
and purified using an RNeasy-kit (Qiagen). qRT-PCR was performed using the FastStart 
Universal SYBR Green Master (Rox) (Roche) according to the manufacturer’s instructions.
The following primers were used: 
Cdh1 forward: atcctcgccctgctgatt and Cdh1 reverse: accaccgttctcctccgta. 
◊ p53 forward: atgcccatgctacagaggag and p53 reverse: agactggcccttcttggtct.
◊ centrin2 forward: tgagactgggaaaatatcattcaa and centrin2 reverse: caccatctccatctcgatca
◊ mark2 forward: gaaagggacacggagcag and mark2 reverse: ccgcagcatgttggactt.
◊ mRNA expression values were normalized to the housekeeping genes: hypoxanthine-
guanine phosphoribosyltransferase (HPRT).
supplemeNtAry tAbles
Supplementary tables will be available at: http://mcb.asm.org/content/31/24/4964/
suppl/DC1
Supplementary table 1 Phosphopeptides dataset 
Supplementary table 2 Proteins dataset
Supplementary table 3 Peptides dataset
Supplementary table 4 phosphopeptide-data set merged with the protein-data set 
Supplementary table 5 386 proteins and 56 mRNAs transcripts significantly affected by 
cisplatin treatment (p<0.05)
Supplementary table 6 Phosphopeptides dataset replicate experiment
Supplementary table 7 phosphopeptide-data set merged between the two replicate 
phosphopeptide experiments
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Figures1. (A) FACS analysis of B4418 mES cells either mock or cisplatin (5 μM) treated for 4 hours 
and labeled by EdU for 45 minutes. Cells positive for EdU incorporation are indicated by green 
dots. The DNA content was analyzed by propidium iodide staining. (b) FACS analysis of mES cells 
either mock or Nocodazole treated for 2 hours. Cells positive for Phospho (Ser10) Histone H3 are 
indicated by green dots.
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Figures2. (A) Proteins containing both phosphorylated and dephosphorylated sites. (b) Process 
Networks analysis of proteins containing both phosphorylated and dephosphorylated sites 
(MetaCore software). (c) protein-protein interaction map.
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Figures3: topscores of most statistically relevant (lowest p value) pathways obtained from 
phosphopeptides up-regulated more than 1.5 and 2-fold after cisplatin treatment. (A) Cell cycle 
and its regulation. (b) DNA-damage response. (c) Apoptosis. (D) Topscores of, most statistically 
relevant (lowest p value), pathways obtained from phosphopeptides down-regulated more than 
1.5 and 2-fold after cisplatin treatment. (e) Most statistically relevant pathways among of proteins 
with altered expression (p<0.05) after cisplatin treatment. 
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Figures4. (A) Cell viability in presence of cisplatin. siGFP (control 1) and siLAMIN C/A (control 2) 
were used as negative controls. Cell viability could be restored by addition of the pan-caspase 
inhibitor (Z-VAD). (b) Cell viability in absence of cisplatin was investigated after siRNA knockdown. 
Luminescence is relative to control 1. (c) The protein level of CDK7, PLK1, and KPCD1 kinases was 
determined by western-blot to test the protein knockdown for four independent siRNAs. (D) Four 
independent siRNAs for CDK7, PLK1, and KPCD1 kinases were used to test the cellular sensitivity 
for cisplatin by an Adenosine TriPhosphate (ATP) monitoring system. siGFP (control) was used as 
negative controls (two independent experiments).
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Figures5. (A) Relative gene expression levels of Cdh1, p53, centrin2 and Mark2 measured by 
quantitative RT-PCR. mES cells were mock treated (control;black bars) or treated for 4 hours 5μM 
cisplatin (grey bars). (three independent experiments) (b) Relative protein levels of Cdh1, p53, 
centrin2 and Mark2 measured by western-blot between control (black bars) and 4 hours after 5μM 
cisplatin (grey bars) in mES (three independent experiments).
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Figures6. (A) Phosphopeptide ratio plot between the two replicate phosphopeptide experiments. 
ATM/ATR substrate phosphopeptides are represented in red (b) Top 40 ATM/ATR substrates up-
regulated phosphopeptides in the two replicates. (c) Number of phosphopeptides up-regulated (>2), 
down regulated (<0.5), up/unchanged (1.5<ratio>2) and down/unchanged (0.5<ratio>0.66) (second 
experiment). (D) Consensus sequence for ATM/ATR kinases among up-regulated, down-regulated, 
and unmodified phosphorylation sites (second experiment). (e) pS/T-Q motifi phosphopeptide 
ratio plot between the two replicate phosphopeptide experiments. (F) MetaCore network analysis of 
proteins containing more than 2-fold up-regulated phosphorylation sites after cisplatin treatment 
(second experiment). (g) MetaCore network analysis of proteins containing more than 2-fold down-
regulated phosphorylation sites after cisplatin treatment (second experiment).
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AbstrAct
Cornelia de Lange syndrome (CdLS) is a rare dominantly inherited multisystem disorder 
affecting both physical and mental development. Heterozygous mutations in the NIPBL 
gene were found in about half of CdLS cases. Scc2, the fungal ortholog of the NIPBL gene 
product, is essential for establishing sister chromatid cohesion. In yeast, the absence of 
cohesion leads to chromosome missegregation and defective repair of DNA double-strand 
breaks. To evaluate possible DNA repair defects in CdLS cells, we characterized the cellular 
responses to DNA-damaging agents. We show that cells derived from CdLS patients, 
both with and without detectable NIPBL mutations, have an increased sensitivity for 
mitomycin C (MMC). Exposure of CdLS fibroblast and B-lymphoblastoid cells to MMC leads 
to enhanced cell killing and reduced proliferation and, in the case of primary fibroblasts, an 
increased number of chromosomal aberrations. After X-ray exposure increased numbers 
of chromosomal aberrations were also detected, but only in cells irradiated in the G2 phase 
of the cell cycle when repair of double-strand breaks is dependent on the establishment of 
sister chromatid cohesion. Repair at the G1 stage is not affected in CdLS cells. Our studies 
indicate that CdLS cells have a reduced capacity to tolerate DNA damage, presumably as a 
result of reduced DNA repair through homologous recombination.
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iNtroDuctioN
Cornelia de Lange Syndrome (CdLS; OMIM 122470) is a rare multisystem developmental 
disorder with characteristic facial dysmorphia, growth and cognitive retardation, 
malformations of the upper limbs and a variety of other abnormalities affecting a wide 
range of tissues and organs (Jackson et al., 1993;Van Den Berg and Francke, 1993;Ireland 
et al., 1993). The prevalence of CdLS is estimated to be as high as 1/10.000 to 1/30.000 
and most cases are sporadic. CdLS is genetically heterogeneous and at present three 
disease-causing genes have been identified, all of which are implicated in sister chromatid 
cohesion. Approximately half of CdLS patients carry heterozygous mutations in the NIPBL 
gene (Krantz et al., 2004;Tonkin et al., 2004;Gillis et al., 2004;Borck et al., 2004;Bhuiyan 
et al., 2006;Schoumans et al., 2007). Recently, mutations in the X-linked SMC1A gene 
have been identified in about 5% of the CdLS cases. One CdLS patient is currently known 
carrying a mutation in SMC3 (Musio et al., 2006;Borck et al., 2007;Deardorff et al., 2007). 
Primarily truncation mutations and amino acid substitutions have been observed. Large 
rearrangements of NIPBL do occur in CdLS but are likely to be infrequent (Bhuiyan et al., 
2007). The majority of affected individuals carry de novo mutations and only a very few 
familial cases of CdLS have been reported. 
The NIPBL gene is predicted to code for two isoforms of 2804 and 2697 amino acids, 
termed delangin-A and delangin-B, respectively. The human delangin proteins share 
homology with Nipped-B from D. melanogaster and Scc2 from S. cerevisiae. Scc2 and its 
orthologs have an essential role in sister chromatid cohesion, which is crucial for proper 
chromosome segregation during mitosis (Michaelis et al., 1997). In fungi the cohesin 
complex consists of two SMC (structural maintenance of chromosomes) proteins, Smc1 
and Smc3 and two non-SMC proteins, Scc1/Mcd1/Rad21 and Scc3. In vertebrates Scc3 
exists as two isoforms called SA1 and SA2. Live-cell imaging experiments in mammalian 
cells revealed that cohesin dynamically binds to DNA during most of the cell cycle, but it is 
during S phase that cohesin becomes stably bound to DNA to mediate cohesion of sister 
chromatids until segregation (Gerlich et al., 2006). The Scc2 protein in S. cerevisiae is not 
a subunit of cohesin but functions in collaboration with Scc4 as a cohesin loading complex 
(Ciosk et al., 2000). Analogous to the function of Scc2 and Scc4 in S. cerevisiae the NIPBL 
gene product, in conjunction with human Scc4, was shown to facilitate the chromatin 
association of cohesin subunits (Watrin et al., 2006;Seitan et al., 2006). Loading of cohesin 
occurs on unreplicated DNA. Establishment of cohesion between sister chromatids occurs 
during S-phase and is dependent on the acetyltransferase protein Eco1/Ctf7/Eso1 in 
yeast. Although the cohesin complex can be loaded in its absence, Eco1, via its interaction 
with PCNA, facilitates cohesion at the replication fork (Moldovan et al., 2006;Lengronne 
et al., 2006). Recently mutations in the ESCO2 gene, one of the human Eco1 orthologs, 
were shown to be associated with Roberts syndrome (OMIM 268300), a disorder with 
characteristics similar to CdLS (Vega et al., 2005). 
Physical linkage of sister chromatids by the cohesin complex is essential for correct 
chromosome segregation, but is also vital for DNA double-strand break (DSB) repair by 
homologous recombination (HR) during the S and G2 phase of the cell cycle (Sjogren and 
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Nasmyth, 2001). Inactivation of either Scc2/Scc4 or one of the cohesin subunits results in 
a reduced efficiency of postreplicative DSB repair in G2/M cells. Recently, it became evident 
that cohesin is specifically recruited to sites of DSBs. Evidence presented by Ström et 
al. and Ünal et al. showed that the local enrichment of cohesin depends on the Scc2/
Scc4 complex (Strom et al., 2004;Unal et al., 2004). This damage specific recruitment 
of the cohesin complex is however distinct from its normal chromatin binding because 
of the dependence on gH2AX and Mre11 proteins which are required for DSB repair (Unal 
et al., 2004). Based on these data it can be concluded that tethering of the broken DNA 
ends to the sister chromatid is required for efficient repair through HR. Also in higher 
organisms evidence has been obtained for a role of cohesin in DSB repair. Depletion of 
SCC1 in chicken DT40 cells leads to a marked increase in the formation of chromosome 
aberrations after exposure to ionizing radiation and reduced levels of sister chromatid 
exchanges after treatment with 4NQO (Sonoda et al., 2001). Local irradiation of HeLa cells 
showed the recruitment of cohesin to the site of damage (Kim et al., 2002). Additionally, 
in a recent genome wide screen in C. elegans for genes required for resistance to ionizing 
radiation, a homologue of NIPBL, pqn-85, was identified. RNAi mediated ablation of this 
gene resulted in increased sensitivity to radiation and cisplatin (van Haaften et al., 2006).
The implication of cohesin and delangin homologues in the DNA damage responses 
in yeast and higher eukaryotes raises the question if cells derived from CdLS patients 
display increased sensitivity to DNA-damaging agents and defects in DSB-repair. Evidence 
presented here shows a drastic reduced survival after exposure to the DNA interstrand 
cross-link inducing agent mitomycin C (MMC) as well as an increased frequency of 
chromosomal aberrations in response to ionizing radiation at the G2 phase of the cell cycle. 
results
cornelia de lange syndrome is associated with increased sensitivity to DNA-damaging 
agents 
To determine if CdLS is associated with increased sensitivity to DNA-damaging agents 
at the cellular level, we obtained two fibroblast and five B-lymphoblastoid cell lines 
from CdLS patients. To screen for the presence of NIPBL mutations in these lines, exon 
sequences, including exon-intron junctions, were amplified and PCR products were 
analyzed by denaturing high performance liquid chromatography (DHPLC). Heterozygous 
mutations were detected in two B-cell lymphoblastoid lines. Cell line CdLS11165 harbors 
a three base-pair deletion in exon 16 (c.3813delGAA), leading to a lysine (p.Lys1271del) 
deletion in a conserved part of the protein. Line CdLS11167 contains a single nucleotide 
insertion (c.3940_3941ins A) causing a premature stop codon. Using multiplex ligation-
dependent probe amplification (MLPA) analysis a large genomic rearrangement, resulting 
in a duplication of exon 11-22, was identified in cell line CdLS45. In the other four CdLS 
lines no mutations could be detected in the coding region of the NIPBL gene by DHPLC 
and MLPA. Screening for mutations in the SMC1A gene by DHPLC also did not reveal any 
causative genetic alterations in these four patients.
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In budding yeast, the absence of the Scc2/Scc4 cohesin loading complex compromises 
the repair capacity for X-ray-induced DNA breaks (Sjogren and Nasmyth, 2001). However, 
exposure of CdLS45 and CdLS3478 fibroblast lines to increasing doses of ionizing radiation 
did not result in a robust increase in radiation sensitivity as was observed for radiation-
sensitive cells derived from ataxia telangiectasia (AT5BIVA) and severe combined 
immunodeficiency (SCID) (Artemis-6) patients (Figure 1A). Only at the highest dose tested 
both CdLS fibroblasts lines displayed a decrease in survival in comparison to the control 
fibroblasts. At lower doses only the CdLS3478 line reproducibly showed a marginal increase 
in radiation sensitivity in comparison with the three fibroblast lines derived from normal 
individuals. Growth inhibition assays for the five lymphoblast CdLS lines also did not reveal 
a distinct hypersensitivity to ionizing radiation (results not shown). However, exposure to 
the DNA interstrand cross-link-inducing agent mitomycin C revealed a strong increase 
in sensitivity of all fibroblast and lymphoblast CdLS lines (Figure 1B,C). In comparison 
with VH25 and FN1 normal cells, the D10 values (dose of MMC leading to 10% survival) for 
both fibroblast CdLS lines are approximately three-fold lower. Surprisingly, the increased 
MMC-sensitivity of CdLS45 and CdLS3478 is in the range of the MMC hypersensitivity 
of Fanconi’s anemia (FA) (Figure 1B). Likewise, all five CdLS B-lymphoblastoid cell lines 
exhibited enhanced sensitivity for MMC when compared to control cells (Figure 1C). 
Growth inhibition experiments indicate a two-fold reduction of the IC50 values (dose of 
MMC leading to a growth reduction of 50%) of the CdLS lines in comparison with both 
normal human B-lymphoblastoid lines. In contrast to MMC, exposure of CdLS cells to UV-C 
light does not cause increased sensitivity (data not shown).
cdls cells have increased levels of chromosomal aberrations after exposure to ionizing 
radiation
The formation of DSBs after exposure to DNA-damaging agents is counteracted by either 
non-homologous end joining (NHEJ) or homologous recombination (HR). Whereas NHEJ is 
believed to function throughout the cell cycle, HR occurs predominantly during the S and 
G2 phase, when sister chromatids are available as a template for repair synthesis (Takata 
et al., 1998;Rothkamm et al., 2003). The role of delangin and the cohesin complex in DNA 
repair is most likely to enhance linkage between damaged and undamaged chromatids, 
to facilitate efficient repair of the lesion, thereby allowing HR to occur. To investigate the 
role of cohesion in repair of DSBs at different stages of the cell cycle, we first analyzed 
the formation of chromosomal aberrations after exposure to X-rays at the G1 stage of 
the cell cycle. Confluent normal VH10 and CdLS fibroblasts were irradiated with different 
doses of X-rays and the frequency of dicentric chromosomes and acentric fragments was 
determined. Exposure to X-rays resulted in a dose-dependent increase in dicentrics and 
acentric fragments in both VH10 and CdLS3478 cells (Table 1A). Both normal and CdLS 
fibroblast showed a very similar dose-response relation for the formation of chromosome 
aberrations after irradiation with different doses of X-rays (0.25 – 1 Gy).
To determine the induction of chromosome aberrations after irradiation of cells in the 
G2 phase of the cell cycle, metaphase preparations were made 3 hours after exposure to 
X-rays. In this experimental set up, only G2 cells were analyzed (see materials and methods 
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Figure 1: survival of normal and cdls cells after genotoxic treatment. CdLS cell lines are 
represented by open symbols. Data are the average of at least two independent experiments. Error 
bars represent the standard deviation. (A) Clonogenic survival of primary normal (VH10, VH25, 
FN1) and CdLS (CdLS3478, CdLS45) fibroblasts after X-ray exposure. The Aretemis-6 (SCID) and 
AT5BIVA (AT) X-ray sensitive cell lines are shown for comparison. (B) Clonogenic survival of primary 
fibroblasts after MMC exposure. The MMC hypersensitive EUFA423 (FA-D1 / BRCA2) cell line is 
shown for comparison. (C) Growth inhibition assay of normal (JVM, Ramos) and CdLS (CdLS 11165, 
11166, 11167, 11168, 13976) B-lymphoblastoid cells exposed to MMC. The MMC hypersensitive 
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table 1A. X-ray induced chromosomal aberrations in G1 fibroblasts. 
Cell line X-ray dose (Gy) Abnormal cells (%) Dicentrics
Excess of acentric 
fragments
VH10 0 0 0 0
(wt) 0.25 3 2 1
0.5 8 5 3
1 13 9 6
2 25 17 13
CdLS3478 0 1 0 1
(CdLS) 0.25 3 1 2
0.5 7 4 3
1 12 8 5
2 26 18 12
Confluent primary fibroblasts were exposed to X-rays. Chromosomal aberrations are indicated per 100 cells.
for details). In mock treated cells the frequency of chromatid breaks was similar in VH10 
and CdLS3478 cells. After exposure to low doses of X-rays (0.1 and 0.25 Gy), the frequency 
of chromatid exchanges in VH10 and CdLS3478 fibroblasts was comparable. However, an 
increase was observed in CdLS cells following exposure to doses of 0.5 and 1 Gy (Table 1B). 
Exposure to increasing doses of X-rays (0.1 to 1 Gy) also caused a strong increase in the 
level of residual chromatid breaks in CdLS fibroblasts when compared to control cells. At 
the highest dose tested (1 Gy) a four-fold difference was seen in the number of residual 
breaks between CdLS and normal cells. In two B-lymphoblastoid cell lines derived from 
CdLS patients a similar increase in radiosensitivity of G2 cells was observed. The level of 
chromatid-type breaks was drastically enhanced (3–4.5 fold) in both lines tested in 
comparison with normal B-lymphoblastoid cells (Table 1C). In addition to ionizing radiation, 
we also analyzed chromatid-type aberrations after treatment with MMC. In CdLS fibroblasts 
the level of chromatid breaks and exchanges was found to be approximately three-fold 
higher than in normal cells (Table 1D). In CdLS B-lymphoblastoid cells no increase in 
chromatid-type aberrations was observed when compared to normal cells (data not shown) 
despite the strong MMC induced growth inhibition. It is known that B-lymphoblastoid cells 
readily go into apoptosis after inflicting DNA damage (Jha et al., 1995). Therefore severely 
damaged B-lymphoblastoid cells may not reach the next metaphase.
The formation of sister chromatid exchanges (SCE) reflects the occurrence of 
homologous recombination between sister chromatids (Sonoda et al., 1999;Wilson, III and 
Thompson, 2007). As repair of DSBs through homologous recombination is dependent on 
cohesion between sister chromatids, we reasoned that the level of SCE induction may be 
reduced in CdLS cells. To induce SCEs we treated B-lymphoblastoid cells with MMC and 
fibroblast cells with MMC or UV-C light. In contrast to X-rays both agents efficiently induce 
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table 1b. X-ray induced chromosomal aberrations in G2 fibroblasts.
Cell line X-ray dose (Gy) Abnormal cells (%)
Chromatid
Breaks Exchanges
VH10 0 2 2 0
(wt) 0.1 8 8 0
0.25 18 18 2
0.5 29 28 6
1 50 52 10
CdLS3478 0 2 2 0
(CdLS) 0.1 15 16 0
0.25 37 46 2
0.5 74 112 10
1 84 220 16
Asynchronous primary fibroblasts were exposed to X-rays. Chromosomal aberrations are indicated per 
100 cells.
table 1c. X-ray induced chromosomal aberrations in G2 B-lymphoblastoid cells.
Cell line X-ray dose (Gy) Abnormal cells (%)
Chromatid
Breaks Exchanges
Ramos 0 0 0 0
(wt) 0.5 26 44 3
1 52 81 6
CdLS11165 0 2 2 0
(CdLS*) 0.5 52 128 0
1 74 286 10
CdLS13976 0 0 0 0
(CdLS) 0.5 66 158 0
1 84 364 24
Asynchronous B-lymphoblastoid cells were exposed to X-rays. Chromosomal aberrations are indicated 
per 100 cells. Asterisk indicates cells with NIPBL mutation.
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table 1D. MMC induced chromosomal aberrations in primary fibroblasts.
Cell line MMC dose (ng/ml) Abnormal cells (%)
Chromatid
Breaks Exchanges
VH10 0 0 0 0
(wt) 45 18 16 2
CdLS3478 0 0 0 0
(CdLS) 45 34 44 6
Chromosomal aberrations are indicated per 100 cells.
SCEs (Darroudi et al., 1989). As can be seen in Figure 2, SCEs were induced with equal 
efficiency in normal and CdLS B-lymphoblastoid cells after treatment with MMC. Similar 
results were obtained in fibroblasts after exposure to MMC and UV-C light (data not shown). 
Normal rad51 and gh2AX foci formation in cdls cells
A central player in homologous recombination is the Rad51 molecule, a protein that 
promotes pairing and strand exchange reactions (Baumann and West, 1998). Upon 
treatment with DNA-damaging agents Rad51 relocalizes and forms nuclear foci, which 
most probably represent centers of DNA repair (Haaf et al., 1995;Tashiro et al., 2000). To 
determine if reduced cohesin loading affects the ability to form nuclear Rad51 foci, we 
exposed normal and CdLS cells to MMC and X-rays. In untreated cells between 2% and 
5% of the nuclei contained five Rad51 foci or more. After treatment with X-rays or MMC 
between 6% and 31% of the normal and CdLS B-lymphoblastoid cells contained over five 
Rad51 foci (Figure 3A). This indicates that all CdLS cell lines tested are proficient for DNA 
damage induced foci formation although the level of induction varied between different 
Figure 2: sce induction in cdls b-lymphoblastoid cells after mmc treatment. Normal (Ramos) or 
CdLS (CdLS11165, CdLS13976) cells were either mock treated or treated with 45 or 60 ng/ml MMC. 
Asterisk indicates cells with NIPBL mutation.. Error bars represent the standard error of the mean. 
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cell lines. A similar analysis using primary fibroblasts derived from CdLS patients also 
showed normal induction of Rad51 foci after MMC treatment (data not shown). 
Exposure to ionizing radiation leads to phosphorylation of histone H2AX (gH2AX) near 
sites of DSBs which can be visualized as nuclear foci. Because the number of gH2AX foci 
is thought to correlate with the number of DSBs, the analysis of gH2AX foci can be used to 
evaluate the repair capacity of a cell (Rothkamm and Lobrich, 2003). Here we quantified 
the number of Rad51 and gH2AX foci per nucleus after X-ray exposure of exponentially 
growing CdLS and normal fibroblasts. Analysis of gH2AX foci was limited to cells that 
were also positive for Rad51 and presumably represent S or G2 phase cells. No significant 
difference in the number of Rad51 or gH2AX foci was observed between normal and CdLS 
fibroblasts either 12 or 24 hours after irradiation (Figure 3B).
Figure 3: rad51 and gh2AX nuclear foci formation is normal in cdls cells. (A) Rad51 foci in normal and 
CdLS B-lymphoblastoid cells after X-rays (12 Gy) and MMC (2.4 mg/ml for 1 h). Cells containing more 
than 5 nuclear foci were considered as positive. Asterisk indicates cells with NIPBL mutation. (B) gH2AX 
and Rad51 nuclear foci after X-ray exposure (5 Gy). Only cells positive for Rad51 foci were analysed. Data 
are the means of at least 2 experiments. Error bars represent the standard error of the mean.
A
B
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DiscussioN
The Cornelia de Lange syndrome is a dominantly inherited multisystem congenital 
disorder and has been associated with heterozygous mutations in NIPBL, SMC1A or 
SMC3 (Krantz et al., 2004;Tonkin et al., 2004;Gillis et al., 2004;Borck et al., 2004;Bhuiyan 
et al., 2006;Schoumans et al., 2007;Musio et al., 2006;Borck et al., 2007;Deardorff et 
al., 2007;Bhuiyan et al., 2007). Although the clinical manifestations of CdLS have been 
described in great detail, little is known about the characteristics at the cellular level. 
Studies in budding yeast have revealed that a complex consisting of Scc2 and Scc4 is 
required for loading of cohesin onto chromosomes before replication starts. Sister 
chromatid cohesion is established at the replication fork and involves additional proteins, 
including Eco1, Ctf4 and Ctf18 (Lengronne et al., 2006;Skibbens et al., 1999;Hanna et al., 
2001). Establishing cohesion between sister chromatids is essential not only for correct 
chromosome segregation, but also for post-replicative DNA repair. Experiments in yeast 
have shown that repair of DSBs in S- and G2-phase cells requires de novo formation of 
cohesion at the site of the damage (Strom et al., 2004;Unal et al., 2004). To determine if 
CdLS is associated with impaired repair of DSBs, we studied the survival of CdLS cell lines, 
the induction of chromosomal aberrations and the levels of gH2AX and Rad51 nuclear foci 
after treatment with DNA-damaging agents.
Pathogenic NIPBL mutations were identified in three (CdLS11165, CdLS11167 and 
CdLS45) out of seven cell lines examined. In the remaining four CdLS lines no mutations 
were identified in NIPBL or SMC1A, which has recently been implicated in CdLS (Musio et al., 
2006;Borck et al., 2007;Deardorff et al., 2007;Bhuiyan et al., 2007). However, the screening 
methods used cannot exclude the presence of mutations in intronic sequences or in the 
promoter region of the genes. As sister chromatid cohesion involves various factors, the 
presence of disease-causing mutations in additional genes can also not be ruled out.
The induction of chromosomal aberrations (dicentrics and acentric fragments) after 
exposure of G1 CdLS fibroblast cells to X-rays was similar to normal cells. However, both 
CdLS fibroblast and B-lymphoblastoid cells showed a strong dose dependent increase in 
the formation of chromatid exchanges and chromatid breaks when exposed to X-rays in 
the G2 stage of the cell cycle. Our observations are consistent with a defect in DSB repair 
through HR, resulting in delayed and/or aberrant repair of DSBs. In G1 cells X-ray-induced 
DSBs are repaired primarily though NHEJ, while repair of DSBs in S- and G2-phase proceeds 
via NHEJ as well as via HR (Takata et al., 1998;Rothkamm et al., 2003). A G2 specific increase 
in the induction of chromosomal aberrations has previously also been reported for cells 
derived from Bloom syndrome patients (Kuhn, 1980). BLM, the protein affected in these 
cells, is known to function in HR (Cheok et al., 2005), which would suggest that a bias for 
ionizing radiation induced chromosomal aberrations in G2 is a general feature of cells 
deficient in HR. However, in spite of the clear increase in the formation of chromosomal 
aberrations during G2, clonogenic survival of CdLS cells after X-ray exposure did not differ 
significantly from that of control cells. The absence of a hypersensitivity to X-rays in this 
assay might reflect the relative contributions of NHEJ and HR during the cell cycle. In an 
asynchronous population of primary fibroblasts, a large fraction of cells will be in G1 or 
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early S and hence the role of HR in the repair of DSBs is expected to be less important. 
This is opposed to the situation in G2 where the contribution of HR is significant and cannot 
be fully compensated by NHEJ (Godthelp et al., 2002;French et al., 2002;Godthelp et al., 
2006). It should, however, be noted that an increased sensitivity was observed in hTERT 
immortalized human fibroblasts after RNAi mediated knockdown of NIPBL (van Haaften et 
al., 2006). Consistent with our data is the observation that mammalian cell lines containing 
hypomorphic mutations in RAD51C or BRCA2 are hypersensitive to cross-linking agents as 
a consequence of impaired HR but are not or only mildly sensitive for X-rays (Godthelp et al., 
2002;French et al., 2002;Godthelp et al., 2006). Although clonogenic survival assays did not 
reveal a dreastic increase in X-ray sensitivity of CdLS cells, a distinct MMC hypersensitivity 
was observed. All 7 CdLS cell lines tested displayed an increased sensitivity to MMC. Repair 
of cross-links is dependent on several DNA repair pathways, including nucleotide excision 
repair, HR and post-replication/translesion synthesis repair (Lehoczky et al., 2007). DSBs, 
which are presumably formed as intermediates in the repair of interstrand cross-links, are 
processed by HR. No difference in sensitivity was observed between CdLS lines containing 
pathogenic NIPBL mutations (CdLS11165, CdLS11167and CdLS45) and the other four CdLS 
lymphoblast lines without detectable NIPBL mutation. This suggests that these four cell 
lines also have a defect in the establishment of cohesion and that MMC hypersensitivity is a 
general feature of CdLS at the cellular level. The reduced ability to process DNA cross-links 
is further demonstrated by the increased frequency of chromatid exchanges and chromatid 
breaks that is observed in CdLS fibroblasts after MMC exposure.
The formation of SCEs signifies HR between sister chromatids and consequently defects 
in HR affect the induction of SCEs after exposure to DNA-damaging agents (Sonoda et al., 
1999;Wilson, III and Thompson, 2007). Ablation of the cohesion factors Smc3, Scc1 or the 
delangin ortholog Scc2 in chicken DT40 cells or budding yeast were found to impair the formation 
of SCEs (Sonoda et al., 2001;Cortes-Ledesma and Aguilera, 2006). However, in contrast to these 
observations we observed efficient formation of SCEs in CdLS cells after exposure to UV light 
or MMC. One explanation for this apparent contradiction would be that the capacity to repair 
DNA lesions via HR is still substantial in CdLS cells. In the former studies protein levels are likely 
to be reduced to very low levels, whereas in CdLS cells the residual levels of delangin protein 
could be sufficient to induce near normal levels of SCEs. In support of this would be the recent 
observation that FA-D1/BRCA2 patient derived cells, despite being highly sensitive for MMC, are 
also proficient in SCE formation (Godthelp et al., 2006). 
In the current study we observed efficient induction of Rad51 foci in all CdLS 
B-lymphoblastoid cells upon MMC or X-ray treatment (Figure 3A). Apparently, the 
redistribution of Rad51 protein to the site of the damage is not or hardly affected in CdLS 
cells. The variation in the induction of Rad51 foci in the various cell lines is not the result of 
differences in cell cycle distribution, as was shown by FACS analysis, but most likely reflects 
cell line specific differences (data not shown). Analysis of the number of Rad51 and gH2AX 
foci after X-ray exposure of fibroblasts also did not reveal a difference between CdLS3478 
and control fibroblasts. The decline in the number of gH2AX foci after exposure to X-rays 
suggests efficient processing of DSBs in CdLS cells and is consistent with the unperturbed 
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clonal survival observed after X-rays. The reduction of Rad51 foci in time suggests that 
homologous recombination is still possible in CdLS cells. However, due to reduced levels 
of delangin protein, small differences in the recombination efficiency between normal and 
CdLS cells might exist, as implied by the G2 specific formation of chromosomal aberrations. 
In man multiple diseases are known which negatively affect the capacity of cells to 
repair or process DNA lesions, often resulting in a predisposition for developing tumours. 
The occurrence of neoplasms in CdLS individuals however appears infrequent, with only 
four cases being described in the literature (Sugita et al., 1986;Maruiwa et al., 1988;DuVall 
and Walden, 1996). Although our study clearly shows there is an increased susceptibility 
for CdLS cells to form chromosomal aberrations after genotoxic stress, there were no signs 
of chromosomal instability in untreated samples thus corroborating the low incidence of 
tumour development observed in CdLS individuals. Neither did we observe precocious 
sister chromatid separation (PSCS) in CdLS cells as was reported by Kaur et al. (Kaur et al., 
2005). The most striking feature of delangin deficiency in higher eukaryotes, like Drosophila 
and X. tropicalis, is its impact on development. Similarly, mutations in genes involved in 
the establishment of sister chromatid cohesion in man (e.g. ESCO2, NIPBL, SMC1A and 
SMC3) result in Roberts syndrome or CdLS, disorders which are manifested by congenital 
malformations. Despite the recent identification of causal genes associated with these 
syndromes, the underlying mechanisms for the observed clinical features remain obscure. 
Drosophila Nipped-B is involved in the transcriptional regulation of cut and ultrabithorax 
genes, which are involved in embryonic development, in addition to its role in cohesion of 
sister chromatids after replication (Dorsett et al., 2005;Rollins et al., 2004;Rollins et al., 
1999). It is possible that human delangin, like in Drosophila, is also involved in regulation 
of developmental genes, although at present no target genes have been identified. In 
this study we have shown that CdLS, in addition to the established clinical phenotype, is 
characterized at the cellular level by an increased sensitivity to ionizing radiation and MMC. 
This hypersensitivity to DNA crosslinking agents may help improve diagnosis of CdLS and 
other human disorders associated with defects in sister chromatid cohesion. 
mAteriAls eN methoDs
cell culture
Primary fibroblasts were cultured in DMEM (Gibco) supplemented with 10% fetal calf serum 
(Bodinco), penicillin (100 U/ml) and streptomycin (0.1 mg/ml). B-lymphoblastoid cells were 
grown in RPMI 1640 medium Dutch modification (Gibco) supplemented with glutamax (Gibco), 
20 mM sodiumpyruvate (Gibco), 10% fetal calf serum (Bodinco), penicillin (100 U/ml) and 
streptomycin (0.1 mg/ml). The primary fibroblast lines used were normal (VH10, VH25, FN1), 
CdLS (GM00045 and GM03478; obtained from the Coriell Institute), ataxia telangiectasia 
(AT5BIVA), SCID (Aretemis-6), Fanconi anemia-D1 (EUFA423). B-lymphoblastoid cells used 
were normal (JVM, Ramos), CdLS (GM11165, GM11166, GM11167, GM11168 and GM13976; 
obtained from the Coriell Institute) and Fanconi anemia-J (EUFA696). Both Fanconi anemia 
cell lines were kindly provided by Dr. H. Joenje (VUMC, Amsterdam).
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Nipbl and smc1A mutation analysis
Genomic DNA of all CdLS cell lines was isolated and screened for mutations in the NIPBL 
coding region (exons 2-47, for primer sequences and PCR conditions see (8)). Mutational 
analysis of the amplimers was performed by denaturing high performance liquid 
chromatography (DHPLC) (Transgenomic Wave). PCR products with altered DHPLC peaks 
were purified using a QiaQuick PCR purification kit (Qiagen) and sequenced bidirectionally on 
an ABI 377 sequencer. The NIPBL sequence in the NCBI nucleotide database (NM_015384) 
was used as reference to identify mutations. MLPA analyses were performed using MLPA 
kits P141 and P142 (MRC-Holland) according to the manufacturers instructions. All 
probands negative for mutations in NIPBL were screened for the presence of mutations in 
SMC1A (GenBank accession number NM_006306). The complete SMC1A coding region was 
amplified in 22 fragments and analyzed by DHPLC (primer sequences and PCR conditions 
are available on request). Amplification products with altered chromatographic peaks 
were purified and sequenced bi-directionally.
clonogenic survival and growth inhibition assays
Exponentially growing cells were trypsinized and 500-2000 cells were plated in 9 cm dishes 
in duplicate (controls in triplicate), and irradiated or exposed continuously to MMC, in 
complete medium. After 14-17 days the dishes were rinsed with 0.9% NaCl, dried, stained 
with methylene blue (0.25%) and colonies were counted using a light microscope. In all 
experiments, normal fibroblasts were treated in an identical manner to serve as controls. 
For growth inhibition assays B-lymphoblastoid cell cultures were seeded at a density of 
5×104 cells/ml and exposed to X-rays or MMC. Cells were cultured for 3 to 10 days until 
unexposed controls had undergone 3 population doublings, at which point all parallel 
cultures were counted using a Z2 Coulter counter (Beckman Coulter).
chromosomal aberrations and sces
For G1 chromosome aberration analysis primary fibroblasts were grown until confluency 
and kept confluent for 1 week before irradiation. After exposure to 0, 0.25, 0.5, 1 and 2 Gy 
of X-rays, fibroblasts were subcultured and allowed to grow in the presence of BrdU (5 mM) 
for 52 h. Colcemid (25 mg/ml) was added to all cultures 4 h before harvesting. Air-dried 
preparations were made and stained with FPG (Perry and Wolff, 1974). For G2 chromosome 
aberration analysis exponentially growing cells were exposed to 0, 0.1, 0.25, 0,5 and 1 Gy of 
X-rays followed by 3 h incubation in the presence of BrdU and colcemid before harvesting. 
For MMC induced chromosome aberration analysis exponentially growing normal and CdLS 
fibroblasts and B-lymphoblastoid cells were either mock-treated or treated with MMC (45 
or 60 ng/ml) continuously during culturing. Following treatment BrdU was added to the 
medium. Cells were harvested for the analysis of chromosome aberrations at 28 h and 
for SCE analysis at 54 h after MMC treatment, including 4 h incubation with colcemid. For 
chromosomal aberrations 100 mitotic cells were analyzed for each dose, for SCE analysis 
25 mitotic cells were scored for each dose. 
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immunofluorescence labeling and microscopy
To examine gH2AX or Rad51 foci formation, primary fibroblasts were grown on sterile glass 
slides, resulting in sub-confluent cells at time of fixation. B-lymphoblastoid cells were 
grown in tissue culture flasks and transferred to 9 cm culture dishes prior to treatment 
at a density of 0.5×106 cells/ml. For Rad51 foci analysis, cells were either mock-treated 
or treated with MMC (2.4 µg/ml for 1 h) or X-ray irradiation (5 or 12 Gy). After an 8, 12 or 
24 h recovery period, primary fibroblasts were fixed immediately using 2% formaldehyde 
in PBS, and permeabilized for antibody staining with PBS/0.1% Triton X-100. The (mock)-
treated B-lymphoblastoid cells (1× 106) were seeded on poly-D-lysine (Sigma) coated 
glass slides after an 8 or 24 h recovery period and left to attach for 15 minutes prior to 
fixation and permeabilization. Subsequently the slides were blocked for 30 min in PBS/
BSA (0.5%)/glycin (0.15%) and incubated with rabbit anti-Rad51 antiserum (FBE2, kindly 
provided by Dr. F.E. Benson) or mouse anti-gH2AX (Upstate Biotechnology) for 90 min 
in a humidified atmosphere. The slides were washed 3 times in PBS/0.1% Triton X-100 
and incubated with AlexaFluor 488-conjugated goat anti-rabbit or goat anti-mouse IgG 
(Molecular Probes) or Cy3 conjugated goat anti-rabbit IgG (Jackson ImmunoResearch) 
for 1 h at 37ºC in a humidified atmosphere. After 3 washes with PBS/0.1% Triton X-100 
the cells were counterstained with 4’,6-diamino-2-phenylindole (DAPI; 0.1 µg/ml) in 
Vectashield mounting medium (Vector Laboratories).
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respoNDiNg to DNA DAmAge
The genetic material of cells is continually subjected to genotoxic attacks, raising the 
question how the cell can protect itself from the potentially harmful consequences of DNA 
damage. Decades of research have uncovered in increasing detail how cells, from bacteria 
to mammals, have dedicated mechanisms for repairing DNA by removing DNA damage 
and restoring the original sequence. It has also become apparent that the DNA damage 
signaling cascade, through protein phosphorylation, regulates the cell cycle and acts in 
concert with DNA repair to protect genomic integrity and cell viability. In addition, it has 
more recently become apparent that other post-translational modifications (PTM) such 
as poly(ADP-ribosyl)ation (PAR), ubiquitylation and possibly sumoylation have important 
roles in DNA repair. These modifications are likely to have a signaling function but might 
also affect protein function due to imposed structural changes. The stability of the 
nucleotide excision repair factor DDB2 is for example regulated by both ubiquitin as well 
as PAR modifications on the protein (chapter 3). The widespread use of PTM in cells in 
concert with the possibility to target the same protein with different types of PTM adds to 
the challenge of understanding protein function and regulation.
Despite the clear role of phosphorylation in the DNA damage response, results from 
unbiased phosphoproteomic screens suggest that other pathways which are not obviously 
related to DNA damage repair may also be modulated (Bennetzen et al., 2010;Pines et al., 
2011). The biological significance of such changes in the phosphoproteome are, however, 
often unknown and require further study. Nevertheless, it is clear that the most prominent 
changes in the phosphoproteome after cisplatin or ionizing radiation exposure are due to 
activation of PI3 like kinases such as ATM and ATR. These kinases are known to respond 
to DNA damage and are important regulators of cell cycle progression following genotoxic 
stress. What has been surprising, however, is the abundance of ATM/ATR target proteins 
that have been identified in both unbiased screens (Bennetzen et al., 2010;Pines et al., 
2011) and screens specifically directed towards ATM/ATR target identification (Matsuoka 
et al., 2007;Stokes et al., 2007). It can thus be conjectured that processes other than cell 
cycle checkpoints, replication and repair are also regulated through these kinases.
Many of the cell’s proteins can be phosphorylated. However, the phosphoproteome is 
subject to variables such as cell type, phase of the cell cycle and other parameters such as 
DNA damage induced stress. The prevalence of phospho modification is reflected by the 
cohesion complex in which all components (i.e. Smc1α, Smc3, Rad21, SA1/2, Wapl and 
Pds5a/b) undergo multiple phosphorylation events. Consistent with its role in DNA repair 
(chapter 6), DNA damage signaling (Yazdi et al., 2002) and sister chromatid cohesion, 
changes in the pattern of cohesin phosphorylation were observed after cisplatin treatment 
(chapter 5). Although most phospho sites remain unchanged a significant increase or 
decrease of phosphorylation was found on Smc1α, Smc3, SA2, Pds5a/b and Wapl. The 
complex changes in up and down phosphorylation events, are predicted to involve multiple 
kinases and likely reflects cohesin’s diverse role in cell biology. The observed increase 
in putative ATM/ATR dependent phosphorylation of Smc1α and Pds5a could relate to a 
DNA damage signaling function while decreased Wapl phosphorylation, likely due to lower 
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PLK activity, could reflect the decrease in mitotic cells after cisplatin treatment. The 
significance of other changes remains, however, elusive.
The wealth of information obtained from unbiased mass spectrometry based analyses 
can evidently be used to improve our understanding of the interconnectivity of processes 
and pathways and their regulation by phosphorylation. It will allow changes to be observed in 
an unbiased manner after for example treatment with cytostatic drugs or pharmacological 
inhibitors, many of the latter being inhibitors of kinases. Consequently, target proteins 
for kinases can be identified as well as their wider impact on the cell’s phosphoproteome. 
Such a broad view of the changes will allow the identification of pathways that might 
unexpectedly be altered in response to drugs, potentially creating a compensatory effect 
thereby reducing drug efficacy. 
From uV lesioN to DAmAge sigNAliNg
The most prominent response to DNA damage when considering phospho modifications 
relates to the activation of the ATR/ATM family of kinases. Responding to aberrant DNA 
configurations, i.e. double stranded DNA breaks or single stranded DNA, their activation upon 
exposure to DNA damaging agents is expected. Indeed these aberrant DNA structures can 
be induced, either directly or through processing, by a variety of DNA damaging agents such 
as cisplatin, UV or ionizing radiation. The manners by which UV lesions can promote ATM/
ATR activation are manifold. Although it has been suggested on the basis of in vitro studies 
that UV lesions are directly recognized by components of the ATR signaling cascade (Unsal-
Kacmaz et al., 2002), there is no evidence in vivo that ATR kinase is activated directly by UV 
lesions (chapter 4). It should nevertheless be stressed that kinase activation depends on 
processing of the UV lesions such that a DNA configuration is created that supports signaling. 
A process that does lead to UV-induced ATM/ATR activation is DNA replication. As UV 
lesions cannot be passed by replicative polymerases, the presence of UV photolesions 
during replication can potentially lead to uncoupling of the polymerase from the replication 
fork helicase, resulting in extended single stranded DNA regions (Cotta-Ramusino et al., 
2005). It is highly likely that these expanses of ssDNA lay at the base of ATR dependent UV 
mediated signaling during S phase (Byun et al., 2005), although other processes will also 
contribute. While most lesions are likely to be taken care of by DNA repair or translesion 
synthesis the possibility exists that the replication fork cannot recover leading to its 
collapse, a process that is associated with the formation of DSBs. UV lesions can therefore 
albeit indirectly activate ATM signaling.
Signaling is, however, not restricted to cycling cells as various mechanisms exist 
that evoke an ATR response in G0/G1 cells as well. One route to signaling proceeds via 
NER itself. Once a damage containing oligo is removed by NER the resulting structure, 
an approximately 35 nucleotide single stranded DNA gap bound by a single RPA moiety, 
should in principle be able to support ATR signaling. There are, however, two caveats: the 
time that such structures exist and the size of the formed gap. During the process of NER 
the gapped intermediates are expected to exist only transiently as they are removed by the 
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replicative polymerases d or e. Nevertheless, under certain conditions the process of gap 
filling might be attenuated. The abundance of factors required for gap filling such as PCNA, 
DNA polymerase d/e or ligase I is reduced in non-cycling cells (Zeng et al., 1994;Kurki et 
al., 1986;Moser et al., 2007). It can therefore be considered that upon high DNA lesion 
induction there might be an insufficient level of post-incision factors to complete repair, 
thus stabilizing the gapped DNA intermediates. A similar effect has previously been 
demonstrated in primary lymphocytes in which inhibition of repair was observed due to 
very low level of deoxyribonucleosides (Green et al., 1996).
A gap created by NER and covered by a single RPA unit would comply with the known 
structural requirements for ATR activation. Given that ssDNA patch size is a determinant 
for ATR activity, such minimal gaps as generated by NER are expected to promote signaling 
less efficiently then the large ssDNA regions formed after replication stalling (MacDougall 
et al., 2007). In fact, much of the ATR signaling after UV exposure of quiescent cells is 
dependent on the exonuclease EXO1 suggesting extension of the ssDNA gap (Sertic et al., 
2011). It is unclear whether the conversion from a persistent NER gap to a resected gap is a 
ubiquitous event or whether it affects merely a small subset of NER gaps. The mechanism by 
which EXO1 would participate and is recruited to these gaps has also not been established. 
One possibility lies in the presence of a PCNA interaction domain (PIP-box) on EXO1 which 
perhaps could facilitate the recruitment to persistent gaps provided that PCNA, or any 
upstream components essential for PCNA loading, are not rate limiting factors.
Activation of ATR through the resection of NER induced gaps engages the G1/S 
checkpoint, preventing cells from entering S-phase. Such a safeguard would prevent the 
formation of toxic DSBs that are likely to form when replication forks encounter these 
gaps. It can, however, be envisioned that even in non-replicating cells the resection of gaps 
can lead to DSBs i.e. if during resection a ssDNA gap is encountered on the opposite DNA 
strand. The frequency of such events would be predicted to increase exponentially with 
higher DNA damage loads and could potentially lead to chromosomal rearrangements.
While repair of UV lesions via GG-NER contributes to signaling it has also become 
apparent that a failure to swiftly remove lesions equally is a cause for ATR activation. As 
already mentioned it is not the lesion per se, but rather a processed form of the lesion that 
underlies activation. Both in the presence and absence of GG-NER DNA damage signaling 
correlates with the formation of DNA breaks and in the latter case is controlled, at least in 
part, through APE1 dependent processing. Why APE1 acts on UV lesions is unclear. It is known 
that cytosine residues within UV photolesions are more prone to deamination events (Peng 
and Shaw, 1996) which might activate UNG glycosylase and subsequently APE1. Arguing 
against this, however, is the observation that XPE deficient cells that lack the capacity to 
remove CPD, fail to activate ATR when other GG-NER deficient cells do. Alternatively it is 
possible that aberrant nucleotides are a direct target for APE1 endonuclease activity as has 
been demonstrated in vitro (chapter 4, Ischenko and Saparbaev, 2002).
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the eNigmA oF rNA polymerAse Arrest AND sigNAliNg
An additional mechanism that activates DNA damage signaling exists which is mediated 
by RNA polymerase II (RNAPII) arrest (Yamaizumi and Sugano, 1994). This signaling is 
particularly pronounced in TC-NER deficient cells with transcription stalling lesions like UV 
photoproducts and is characterized by high induction of p53. It is more than 10 years ago 
that RNA polymerase stalling, by either DNA damage or RNAPII inhibitors, was shown to 
control signaling yet a mechanistic explanation for this phenomenon has remained elusive. 
Although it is generally assumed that the stalling of RNA polymerase itself is a determinant 
for signaling this has not formally been demonstrated. It would be equally possible that 
indirect effects of transcriptional arrest such as imbalances in RNA transcript levels, the 
release of incomplete transcripts or disruption of RNAPII associated processes such as 
splicing, are causal for the observed p53 activation. However, it has been recently been 
demonstrated that these signaling events are mediated by the ATR kinase (Derheimer et 
al., 2007) although the mechanistic basis for its activation remains unclear. The archetype 
structure for ATR activation based on replication stalling and in vitro studies is an ssDNA 
gap coated with RPA. The formation of such gaps would be predicted to be independent 
of NER mediated incisions given that XPA deficient cells strongly respond to RNAPII 
stalling. Moreover, the activation of p53 in CS-B cells does not necessarily coincide with 
the presence of DNA breaks (chapter 4) or RPA (S. Lagerwerf personal communication). 
Although it cannot be excluded that low frequencies of single strand breaks, not detected 
by the assays used, can support signaling in the context of a stalled RNA polymerase, it 
was also observed that p53 activation did not coincide with phosphorylation of H2AX in 
CS-B cells (chapter 4). When ATR is activated, either upon replication stalling or through 
GG-NER induced ssDNA gaps, it is capable of phosphorylating H2AX. These differences 
between canonical ATR activation and activation through RNA polymerase arrest suggest 
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DNA is the carrier of genetic information and therefore it is important to protect its 
integrity in order to ensure fitness of the organism. There are many sources that generate 
DNA damage i.e. through cellular metabolism and through external exposure like solar 
UV and certain chemicals. To protect against the deleterious effects of DNA lesions cells 
have at their disposal two defense mechanisms. One protective mechanism is to repair 
damaged DNA, for which cells have multiple repair pathways to cope with a wide variety 
of DNA lesions. The second protective mechanism works through signaling pathways 
controlling cell cycle progression and apoptosis, giving cells time to repair damaged DNA 
or to remove damaged cells in order to protect the organism. Chapter 1 and chapter 2 
provide an introduction to various repair pathways and DNA damage signaling.
The UV-DDB complex consisting of DDB1 and DDB2 is the primary factor that detects 
and binds to UV-induced DNA lesions. Consequently, defects in DDB2 result in defective 
nucleotide excision repair (NER). Being the first factor in the NER process as well as the 
factor that binds directly to DNA damage embedded in chromatin leaves open the possibility 
that the local chromatin environment might be subject to DDB2 dependent changes. 
Indeed it has been demonstrated that the UV-DDB associated Cul4/Roc1 ubiquitin ligase 
complex ubiquitylates histones after UV. Chapter 3 describes the identification of PARP1 
as a component of the UV-DDB complex and its possible role in UV dependent chromatin 
remodeling. The induction of UV lesions results in the formation of poly(ADP-ribose) (PAR) 
chains at sites of UV damage. The formation of PAR chains was in part due to the presence 
of single stranded DNA gaps as a result of NER induced incisions. However, part of the PAR 
formation was found to be independent of single stranded DNA yet dependent on DDB2, 
indicating a function during the early stages of NER. In fact, DDB2 itself is a target for 
PARylation and PAR negatively affects the level of ubiquitylation of DDB2. Consistently it 
was observed that stabilizing PAR modifications through depletion of the PAR removing 
enzyme PARG increased the DDB2 chromatin retention time, most likely as a result of 
decreased DDB2 degradation. We also found that the chromatin remodeling protein ALC1 
was also recruited to UV exposed DNA in a PAR dependent manner. This recruitment 
was also observed in XPA deficient cells but was suppressed by DDB2 depletion or PARP 
inhibition. The role of ALC1 in NER was further demonstrated by depletion of ALC1 or by 
PARP inhibition as both treatments resulted in reduced CPD repair.
While UV lesions evoke the activation of PARP and thereby affect repair other post 
translational modifications, most notably phosphorylation, serve to inhibit cell cycle 
progression. Chapter 4 describes the central role of the ATR kinase in activation of cell 
cycle checkpoints after UV exposure. Surprisingly, it was found that checkpoint proteins 
were activated in both normal repair proficient cells as well as in global genome NER 
(GG-NER) deficient cells independent of replication. Activation of p53 was rapid in normal 
cells with p53 levels reducing in time. In contrast, in cells with a defect in GG-NER p53 was 
more delayed to normal cells but, crucially, p53 levels did not diminish. Similar differences 
in kinetics between repair GG-NER proficient and deficient cells were also observed for 
phosphorylation of H2AX and suggest that the underlying cause for checkpoint activation 
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differs between repair proficient and deficient cells. Nonetheless, in both cases the 
activation of checkpoint proteins depends on the ATR kinase. Consistent with the activation 
of ATR, DNA breaks were detected in both normal and repair deficient cells. The latter is 
remarkable as the repair deficiency precludes the formation of DNA breaks as part of the 
NER process. The presence of breaks and their persistent nature in GG-NER deficient 
cells is supported by the recruitment of replication factors PCNA, pold and polη to sites 
of UV damage. These data indicate that rather than being directly activated by UV lesions 
prior processing needs to occur. We show that APE1 exhibits endonuclease activity on UV 
lesions. As the incision by APE1 occurs 5’ of the lesion without removing it this might result 
in a structure that is refractory to repair and eventually provokes ATR signaling.
While ATR and the related kinases ATM and DNA-PKcs are known to respond to DNA 
damage and are likely to phosphorylate several hundred proteins they are not the only 
kinases whose activity is influenced by DNA damage. To gain insight into the dynamics 
of phosphorylation and dephosphorylation following DNA damage, quantitative mass 
spectrometry analyses were performed using the chemotherapeutic drug cisplatin 
(described in chapter 5). We identified 183 phosphopeptides with more than 2-fold 
increase and 194 phosphopeptides that were more than 2-fold decreased phosphorylation 
levels following cisplatin treatment. As expected, many (46%) of the up regulated 
phosphopeptides were phosphorylated at an ATM/ATR consensus sequence. Interestingly, 
some proteins were found to contain both up regulated as well as down regulated sites. 
Possibly this differential phosphorylation signifies some form of molecular switch. We 
also tested the hypothesis that changes in RNA transcript levels correlate with changes 
in protein levels after cisplatin treatment. However, we found no clear correlation between 
changes in transcript and its corresponding protein. In contrast, pathway analysis based 
on transcriptomics, proteomics and phosphoproteomics did reveal a large overlap in 
affected processes. The impact of cisplatin on DNA damage repair pathways was, however, 
only manifested in the phosphoproteome analysis. This suggests that phosphorylation 
events are important for DNA repair pathway activation after genotoxic stress.
Chapter 6 describes how cells from individuals with Cornelia de Lange Syndrome 
(CdLS) respond to genotoxic stress. CdLS is a disease where the function of the cohesin 
complex has been compromised. Cohesin is important for multiple cellular functions i.e. 
maintaining sister chromatid cohesion, gene regulation, DNA repair and DNA damage 
signaling. The identification of disease causing mutations in cohesin and associated 
factors in CdLS individuals prompts the question whether these individuals would be 
at increased risk when exposed to genotoxic agents. Two fibroblast and five B-cell 
lymphoblastoid lines were screened for the presence of pathogenic mutations in the NIPBL 
and SMC1A gene. Mutations in the NIPBL gene were detected in one fibroblast and two 
B-cell lymphoblastoid lines whereas no causative genetic alterations were found in the 
other cell lines. Clonal survival assays indicated that CdLS cells have no clear increased 
sensitivity for ionizing radiation (IR). In contrast, exposure to the DNA crosslink-inducing 
agent mitomycin C (MMC) revealed increased sensitivity of all CdLS lines compared to 
normal controls. Although CdLS cells did not show decreased survival upon IR exposure 
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there was a marked increase in chromosomal aberrations when exposed in G2 but not 
when exposed in G1, suggesting homologous recombination is impaired. Chromosomal 
aberrations were also increased after MMC. It should be noted that the reduced survival 
and increased chromosomal aberrations were observed in al CdLS cells regardless of the 
presence or absence of NIPBL mutations. This study demonstrates that CdLS cells have 
increased sensitivity for certain DNA damaging agents highlighting potential health risk 




DNA is de drager van genetische informatie en het is daarom van essentieel belang om de 
integriteit van deze informatie te beschermen en daarmee het organisme. Beschadiging 
van DNA kan het gevolg zijn van vele processen zoals de vorming van schadelijke 
moleculen door cellulaire metabolismen en door blootstelling aan bepaalde chemicaliën 
in onze leefomgeving of UV-straling van de zon. Om de cel te vrijwaarden van de gevolgen 
van DNA veranderingen beschikt deze over beschermingsmechanismen. Een van de 
mechanismen is om DNA schade te herstellen. Om dit te bereiken beschikken cellen over 
meerdere herstelsystemen die in staat zijn om een breed scala aan DNA afwijkingen te 
corrigeren. Een ander beschermingsmechanisme maakt gebruik van signaaltransductie 
waarbij processen zoals cel cyclus progressie en apoptose (celdood) worden gereguleerd. 
Hoofdstukken 1 en 2 geven een introductie in DNA schade herstelsystemen en signalering.
Het UV-DDB complex bestaat uit DDB1 en DDB2 en is de belangrijkste factor voor 
detectie van en binding aan UV geïnduceerde DNA schade. Defecten in DDB2 resulteren 
dan ook in nucleotide excisie herstel (NER) deficiëntie. De eigenschap om aan beschadigd 
DNA te binden in de context van chromatine opent de mogelijkheid dat het lokale 
chromatine onderhevig is aan UV-DDB afhankelijke modificaties. Hoofdstuk 3 beschrijft 
de identificatie van PARP1 als een component van het UV-DDB complex en de mogelijke 
rol in UV afhankelijke chromatine veranderingen. Behandeling van cellen met UV straling 
resulteert in de formatie van poly(ADP-ribose) (PAR) ketens op de plaats van de schade. 
De vorming van PAR ketens is gedeeltelijk afhankelijk van enkelstrengs DNA formatie 
als gevolg van de NER reaktie. Echter, een gedeelte van de PAR formatie vindt plaats in 
afwezigheid van enkelstrengs DNA en hiervoor is DDB2 essentieel, indicatief voor een rol 
gedurende de eerste stappen van het NER proces. We tonen verder aan dat PAR belangrijk 
is voor de dynamiek en stabiliteit van DDB2 en de rekrutering van de chromatine remodeler 
ALC1. Depletie van ALC1 of inhibitie van PAR resulteert in verminderd herstel van UV schade 
wat de rol van ALC1 in NER onderschrijft.
Naast inductie van PAR resulteert de aanwezigheid van UV schade ook in fosforylatie, 
een andere eiwitmodificatie met een belangrijke rol in de regulatie van de celcyclus. 
Hoofdstuk 4 beschrijft de rol van ATR kinase na blootstelling aan UV. We vinden dat 
activatie van checkpoint eiwitten in zowel normale als globaal genoom NER (GG-NER) 
deficiënte cellen plaatsvindt in een replicatie onafhankelijk proces. Zowel p53 als H2AX 
worden gefosforyleerd zij het met verschillende kinetiek in normale en GG-NER deficiënte 
cellen wat suggereert dat er verschillende processen aan ten grondslag liggen. In beide 
gevallen echter is de activatie afhankelijk van ATR en in overeenstemming hiermee worden 
DNA breuken gedetecteerd in zowel normale als GG-NER deficiënte cellen. Dit laatst is 
opmerkelijk aangezien de deficiëntie het ontstaan van breuken als gevolg van NER uitsluit. 
De aanwezigheid van de replicatiefactoren PCNA, pold en polη bij UV beschadigd DNA is een 
verdere indicatie dat breuken worden gevormd. We tonen aan dat breuken gedeeltelijk het 
gevolg zijn van APE1 endonuclease activiteit op UV schade. Omdat de incisie plaatsvindt 
aan de 5’ zijde van de schade zonder deze te verwijderen resulteert dit mogelijk in een 
structuur welke moeilijk te herstellen is en uiteindelijk leidt tot ATR activatie.
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Hoewel van ATR en de gerelateerde kinasen ATM en DNA-PKcs bekend is dat ze enkele 
honderden eiwitten fosforyleren na DNA schade wordt de activiteit van andere kinasen 
ook door schade beïnvloed. Om inzicht te krijgen in de dynamiek van fosforylatie en 
defosforylatie is kwantitatieve massaspectrometrische analyse uitgevoerd na behandeling 
met het chemotherapeuticum cisplatina (hoofdstuk 5). We hebben 183 fosfopeptides 
geïdentificeerd die meer dan tweevoudig verrijkt waren en 194 fosfopeptides die meer 
dan tweevoudig verminderd waren in fosforylatie niveaus na cisplatina behandeling. Zoals 
verwacht zijn veel (46%) van de verrijkte fosfopeptides gemodificeerd op een ATM/ATR 
consensus sequentie. Opvallend is dat bij sommige eiwitten zowel verrijking als depletie 
van fosforylatie wordt gevonden binnen hetzelfde eiwit. Deze differentiële fosforylatie 
functioneert mogelijk als moleculaire schakelaar. De hypothese dat veranderingen in RNA 
transcript niveaus correleren met veranderingen in eiwit niveaus na cisplatina is ook getest. 
Er is echter geen eenduidige correlatie gevonden tussen veranderingen in transcript niveaus 
en het corresponderende eiwit. Pathway analyse gebaseerd op transcriptomics, proteomics 
en fosfoproteomics laat echter een grote overlap zien in processen. Het effect van cisplatina 
op DNA herstel mechanismen is echter alleen manifest in de fosfoproteome analyse en dit 
suggereert dat fosforylatie belangrijk is voor DNA herstel activatie na genotoxische stress.
Hoofdstuk 6 beschrijft hoe cellen van personen met Cornelia de Lange Syndroom 
(CdLS) reageren op genotoxische stress. CdLS is een ziekte waarbij het cohesin complex 
niet correct functioneert. Cohesin is belangrijk voor meerdere cel functies zoals het in 
stand houden van zuster chromatide cohesie, genregulatie, DNA herstel en DNA schade 
signalering. De identificatie van pathogene mutaties in cohesin en geassocieerde 
factoren in CdLS patiënten riep de vraag op of deze personen verhoogd risico lopen 
wanneer blootstelling aan genotoxische agentia plaats vind. Twee fibroblast en vijf B-cell 
lymphoblastoïde lijnen werden geanalyseerd op de aanwezigheid van pathogene mutaties 
in de NIPBL en SMC1A genen. In een fibroblast en twee B-cell lymphoblastoïde lijnen zijn 
NIPBL mutaties gevonden. In de andere lijnen zijn geen causale genetische afwijkingen 
gevonden. Klonale survival proeven tonen aan dat CdLS cellen niet gevoeliger zijn voor 
ioniserende straling (IR) dan controle cellen. Blootstelling aan het DNA crosslink agens 
mitomycine C (MMC) leidt echter tot verhoogde gevoeligheid vergeleken met normale 
cellen. Hoewel CdLS cellen een normale overleving hebben na IR vertonen ze verhoogde 
niveaus van chromosomale afwijkingen na blootstelling G2, maar niet na blootstelling in G1. 
Dit suggereert een mogelijk defect in homologe recombinatie. Chromosomale afwijkingen 
zijn ook na MMC verhoogd. De verminderde overleving en verhoogde chromosomale 
afwijkingen zijn in alle CdLS cellen present ongeacht de aan- of afwezigheid van NIPBL 
mutaties. Deze studie toont aan dat CdLS cellen een verhoogde gevoeligheid hebben voor 
bepaalde agentia die DNA schade induceren, wat een potentieel gezondheidsrisico kan 
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